{"DataElement":{"publicId":"6648971","version":"2","preferredName":"Category of Question","preferredDefinition":"A classification of questionnaire data.","longName":"QSCAT","context":"NCI Standards","contextVersion":"1","DataElementConcept":{"publicId":"6641678","version":"1","preferredName":"Questionnaire Domain Questionnaire Category","preferredDefinition":"A subject domain utilized for the submission of information encompassing and representing data, vocabulary or records related to questionnaire._A classification of questionnaire data.","longName":"6607890v1.0:6641676v1.0","context":"NCI Standards","contextVersion":"1","ObjectClass":{"publicId":"6607890","version":"1","preferredName":"Questionnaire Domain","preferredDefinition":"A subject domain utilized for the submission of information encompassing and representing data, vocabulary or records related to questionnaire.","longName":"C49609","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Questionnaire Domain","conceptCode":"C49609","definition":"A subject domain utilized for the submission of information encompassing and representing data, vocabulary or records related to questionnaire.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"7F1D6CF4-BA8C-2E63-E053-F662850A5BE1","latestVersionIndicator":"Yes","beginDate":"2019-01-10","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-01-10","modifiedBy":"ONEDATA","dateModified":"2019-01-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"6641676","version":"1","preferredName":"Questionnaire Category","preferredDefinition":"A classification of questionnaire data.","longName":"C83368","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Questionnaire Category","conceptCode":"C83368","definition":"A classification of questionnaire data.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"81B9A29B-CE93-26DD-E053-F662850AFBD7","latestVersionIndicator":"Yes","beginDate":"2019-02-12","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-02-12","modifiedBy":"ONEDATA","dateModified":"2019-02-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2435019","version":"1","preferredName":"Conceptual Entity","preferredDefinition":"An organizational header for concepts representing mostly abstract entities.","longName":"C20181","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741B16D-87D8-26CD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"CDISC:Clinical Data Interchange Standards Consortium","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"81B9A29B-CEA4-26DD-E053-F662850AFBD7","latestVersionIndicator":"Yes","beginDate":"2019-02-12","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-02-12","modifiedBy":"MMADDINENI","dateModified":"2023-06-09","changeDescription":"2/12/19 Curated to support CDISC Initiative; tmt.","administrativeNotes":"06/09/203-Released upon review-MM","unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"6626803","version":"1.1","preferredName":"CDISC Questionnaire Category Terminology Category","preferredDefinition":"Terminology associated with the questionnaire domain categories of the Clinical Data Interchange Standards Consortium (CDISC) Standard Data Tabulation Model (SDTM)._A grouping of items based on some commonality or by user defined characteristics.","longName":"QSCAT","context":"NCI Standards","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"100","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"FACT/GOG-NTX V4","valueDescription":"Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity Version 4 Questionnaire","ValueMeaning":{"publicId":"6643070","version":"1","preferredName":"Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity Version 4 Questionnaire","longName":"6643070","preferredDefinition":"A standardized 38-item self-report rating scale to measure the effects of chemotherapy-induced neuropathy on the quality of life of cancer patients that is divided into five subscales: physical, social/family, emotional, and functional well-being, as well as a subscale to evaluate symptoms and concerns associated with chemotherapy-induced neuropathy. Originally developed by Cella, et al. in 1997, it combines the Functional Assessment of Cancer Therapy - General (FACT-G), and the Gynecologic Oncology Group - Neurotoxicity (GOG-Ntx) subscale.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity Version 4 Questionnaire","conceptCode":"C150915","definition":"A standardized 38-item self-report rating scale to measure the effects of chemotherapy-induced neuropathy on the quality of life of cancer patients that is divided into five subscales: physical, social/family, emotional, and functional well-being, as well as a subscale to evaluate symptoms and concerns associated with chemotherapy-induced neuropathy. Originally developed by Cella, et al. in 1997, it combines the Functional Assessment of Cancer Therapy - General (FACT-G), and the Gynecologic Oncology Group - Neurotoxicity (GOG-Ntx) subscale.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"81CE4750-461C-6019-E053-F662850AE483","latestVersionIndicator":"Yes","beginDate":"2019-02-13","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-02-13","modifiedBy":"ONEDATA","dateModified":"2019-02-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5BFF-0412-E063-731AD00A56D4","beginDate":"2019-02-13","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"EXACT","valueDescription":"Exacerbations of Chronic Pulmonary Disease Tool Patient-Reported Outcome Questionnaire","ValueMeaning":{"publicId":"6643033","version":"1","preferredName":"Exacerbations of Chronic Pulmonary Disease Tool Patient-Reported Outcome Questionnaire","longName":"6643033","preferredDefinition":"A standardized rating scale developed by Nancy Leidy and Lindsey Murray under the EXACT-PRO Initiative in 2013, which is used to make symptomatic assessment of chronic obstructive pulmonary disease (COPD) exacerbations. The questionnaire contains 14 items and evaluate the frequency, severity, and duration of COPD exacerbations.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Exacerbations of Chronic Pulmonary Disease Tool Patient-Reported Outcome Questionnaire","conceptCode":"C123666","definition":"A standardized rating scale developed by Nancy Leidy and Lindsey Murray under the EXACT-PRO Initiative in 2013, which is used to make symptomatic assessment of chronic obstructive pulmonary disease (COPD) exacerbations. The questionnaire contains 14 items and evaluate the frequency, severity, and duration of COPD exacerbations.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"81CE4750-434D-6019-E053-F662850AE483","latestVersionIndicator":"Yes","beginDate":"2019-02-13","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-02-13","modifiedBy":"ONEDATA","dateModified":"2019-02-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5C00-0412-E063-731AD00A56D4","beginDate":"2019-02-13","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"FKSI-15","valueDescription":"FKSI-15 Questionnaire","ValueMeaning":{"publicId":"6643081","version":"1","preferredName":"FKSI-15 Questionnaire","longName":"6643081","preferredDefinition":"A 15 item questionnaire developed to assess the symptom burden for patients with kidney cancer.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"FKSI-15 Questionnaire","conceptCode":"C118498","definition":"A 15 item questionnaire developed to assess the symptom burden for patients with kidney cancer.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"81CE4750-46FD-6019-E053-F662850AE483","latestVersionIndicator":"Yes","beginDate":"2019-02-13","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-02-13","modifiedBy":"ONEDATA","dateModified":"2019-02-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5C01-0412-E063-731AD00A56D4","beginDate":"2019-02-13","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"FKSI-DRS V4","valueDescription":"Functional Assessment of Cancer Therapy-Kidney Symptom Index-Disease-Related Symptoms Version 4 Questionnaire","ValueMeaning":{"publicId":"6642910","version":"1","preferredName":"Functional Assessment of Cancer Therapy-Kidney Symptom Index-Disease-Related Symptoms Version 4 Questionnaire","longName":"6642910","preferredDefinition":"A standardized 9-item self-report rating scale developed by Cella, et al. in 2007 to assess disease-related symptoms in patients with kidney cancer.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Functional Assessment of Cancer Therapy-Kidney Symptom Index-Disease-Related Symptoms Version 4 Questionnaire","conceptCode":"C150917","definition":"A standardized 9-item self-report rating scale developed by Cella, et al. in 2007 to assess disease-related symptoms in patients with kidney cancer.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"81CE4750-399C-6019-E053-F662850AE483","latestVersionIndicator":"Yes","beginDate":"2019-02-13","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-02-13","modifiedBy":"ONEDATA","dateModified":"2019-02-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5C02-0412-E063-731AD00A56D4","beginDate":"2019-02-13","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"FLU-IIQ ONCE DAILY","valueDescription":"Influenza Intensity and Impact Questionnaire Once Daily Version","ValueMeaning":{"publicId":"6643085","version":"1","preferredName":"Influenza Intensity and Impact Questionnaire Once Daily Version","longName":"6643085","preferredDefinition":"A standardized rating scale developed by Measured Solutions for Health (MESH) Pty Ltd. This instrument is the once daily version and is used to measure symptoms severity and the impact of influenza.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Influenza Intensity and Impact Questionnaire Once Daily Version","conceptCode":"C119093","definition":"A standardized rating scale developed by Measured Solutions for Health (MESH) Pty Ltd. This instrument is the once daily version and is used to measure symptoms severity and the impact of influenza.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"81CE4750-4749-6019-E053-F662850AE483","latestVersionIndicator":"Yes","beginDate":"2019-02-13","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-02-13","modifiedBy":"ONEDATA","dateModified":"2019-02-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5C03-0412-E063-731AD00A56D4","beginDate":"2019-02-13","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"FLU-IIQ TWICE DAILY","valueDescription":"Influenza Intensity and Impact Questionnaire Twice Daily Version","ValueMeaning":{"publicId":"6643087","version":"1","preferredName":"Influenza Intensity and Impact Questionnaire Twice Daily Version","longName":"6643087","preferredDefinition":"A standardized rating scale developed by Measured Solutions for Health (MESH) Pty Ltd. This instrument is the twice daily version and is used to measure symptoms severity and the impact of influenza.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Influenza Intensity and Impact Questionnaire Twice Daily Version","conceptCode":"C119094","definition":"A standardized rating scale developed by Measured Solutions for Health (MESH) Pty Ltd. This instrument is the twice daily version and is used to measure symptoms severity and the impact of influenza.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"81CE4750-476F-6019-E053-F662850AE483","latestVersionIndicator":"Yes","beginDate":"2019-02-13","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-02-13","modifiedBy":"ONEDATA","dateModified":"2019-02-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5C04-0412-E063-731AD00A56D4","beginDate":"2019-02-13","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"GAD-7","valueDescription":"Generalized Anxiety Disorder - 7 Questionnaire","ValueMeaning":{"publicId":"6643093","version":"1","preferredName":"Generalized Anxiety Disorder - 7 Questionnaire","longName":"6643093","preferredDefinition":"A seven item validated, self-reported questionnaire for screening, and assessing the severity of generalized anxiety disorder in clinical practice and research settings.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Generalized Anxiety Disorder - 7 Questionnaire","conceptCode":"C103519","definition":"A seven item validated, self-reported questionnaire for screening, and assessing the severity of generalized anxiety disorder in clinical practice and research settings.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"81CE4750-4801-6019-E053-F662850AE483","latestVersionIndicator":"Yes","beginDate":"2019-02-13","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-02-13","modifiedBy":"ONEDATA","dateModified":"2019-02-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5C05-0412-E063-731AD00A56D4","beginDate":"2019-02-13","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"HAEM-A-QOL","valueDescription":"Hemophilia Quality of Life Questionnaire Adult Version","ValueMeaning":{"publicId":"6643103","version":"1","preferredName":"Hemophilia Quality of Life Questionnaire Adult Version","longName":"6643103","preferredDefinition":"A standardized rating scale developed by Mackensen et al in 2005, which is used to measure the physical and emotional impacts on quality of life in adults with hemophilia. The questionnaire contains 46 items which are divided into 10 dimensions: physical health, feelings, self-perception, sports and leisure, work and school, coping, treatment, future, family planning and relationships/partners.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hemophilia Quality of Life Questionnaire Adult Version","conceptCode":"C122381","definition":"A standardized rating scale developed by Mackensen et al in 2005, which is used to measure the physical and emotional impacts on quality of life in adults with hemophilia. The questionnaire contains 46 items which are divided into 10 dimensions: physical health, feelings, self-perception, sports and leisure, work and school, coping, treatment, future, family planning and relationships/partners.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"81CE4750-48DF-6019-E053-F662850AE483","latestVersionIndicator":"Yes","beginDate":"2019-02-13","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-02-13","modifiedBy":"ONEDATA","dateModified":"2019-02-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5C06-0412-E063-731AD00A56D4","beginDate":"2019-02-13","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"HAEMO-QOL CHILDREN'S LONG VERSION AGE GROUP I","valueDescription":"Hemophilia Quality of Life Questionnaire Children's Long Version Age Group I","ValueMeaning":{"publicId":"6643105","version":"1","preferredName":"Hemophilia Quality of Life Questionnaire Children's Long Version Age Group I","longName":"6643105","preferredDefinition":"A standardized rating scale developed by the Haemo-QoL Study Group in 2002, which is used to measure the physical and emotional impacts on quality of life in children and adolescents with hemophilia. The children's long version age group I questionnaire contains 21 items for children 4 to 7 years of age.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hemophilia Quality of Life Questionnaire Children's Long Version Age Group I","conceptCode":"C122373","definition":"A standardized rating scale developed by the Haemo-QoL Study Group in 2002, which is used to measure the physical and emotional impacts on quality of life in children and adolescents with hemophilia. The children's long version age group I questionnaire contains 21 items for children 4 to 7 years of age.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"81CE4750-4905-6019-E053-F662850AE483","latestVersionIndicator":"Yes","beginDate":"2019-02-13","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-02-13","modifiedBy":"ONEDATA","dateModified":"2019-02-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5C07-0412-E063-731AD00A56D4","beginDate":"2019-02-13","endDate":null,"createdBy":"TAYLORT","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"HAEMO-QOL CHILDREN'S LONG VERSION AGE GROUP II","valueDescription":"Hemophilia Quality of Life Questionnaire Children's Long Version Age Group II","ValueMeaning":{"publicId":"6643107","version":"1","preferredName":"Hemophilia Quality of Life Questionnaire Children's Long Version Age Group II","longName":"6643107","preferredDefinition":"A standardized rating scale developed by the Haemo-QoL Study Group in 2002, which is used to measure the physical and emotional impacts on quality of life in children and adolescents with hemophilia. The children's long version age group II questionnaire contains 64 items for children 8 to 12 years of age.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hemophilia Quality of Life Questionnaire Children's Long Version Age Group II","conceptCode":"C122374","definition":"A standardized rating scale developed by the Haemo-QoL Study Group in 2002, which is used to measure the physical and emotional impacts on quality of life in children and adolescents with hemophilia. The children's long version age group II questionnaire contains 64 items for children 8 to 12 years of age.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"81CE4750-492B-6019-E053-F662850AE483","latestVersionIndicator":"Yes","beginDate":"2019-02-13","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-02-13","modifiedBy":"ONEDATA","dateModified":"2019-02-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5C08-0412-E063-731AD00A56D4","beginDate":"2019-02-13","endDate":null,"createdBy":"TAYLORT","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"HAEMO-QOL CHILDREN'S LONG VERSION AGE GROUP III","valueDescription":"Hemophilia Quality of Life Questionnaire Children's Long Version Age Group III","ValueMeaning":{"publicId":"6643109","version":"1","preferredName":"Hemophilia Quality of Life Questionnaire Children's Long Version Age Group III","longName":"6643109","preferredDefinition":"A standardized rating scale developed by the Haemo-QoL Study Group in 2002, which is used to measure the physical and emotional impacts on quality of life in children and adolescents with hemophilia. The children's long version age group III questionnaire contains 77 items for adolescents 13 to 16 years of age.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hemophilia Quality of Life Questionnaire Children's Long Version Age Group III","conceptCode":"C122375","definition":"A standardized rating scale developed by the Haemo-QoL Study Group in 2002, which is used to measure the physical and emotional impacts on quality of life in children and adolescents with hemophilia. The children's long version age group III questionnaire contains 77 items for adolescents 13 to 16 years of age.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"81CE4750-4951-6019-E053-F662850AE483","latestVersionIndicator":"Yes","beginDate":"2019-02-13","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-02-13","modifiedBy":"ONEDATA","dateModified":"2019-02-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5C09-0412-E063-731AD00A56D4","beginDate":"2019-02-13","endDate":null,"createdBy":"TAYLORT","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"HAEMO-QOL CHILDREN'S SHORT VERSION AGE GROUP I","valueDescription":"Hemophilia Quality of Life Questionnaire Children's Short Version Age Group I","ValueMeaning":{"publicId":"6643111","version":"1","preferredName":"Hemophilia Quality of Life Questionnaire Children's Short Version Age Group I","longName":"6643111","preferredDefinition":"A standardized rating scale developed by the Haemo-QoL Study Group in 2002, which is used to measure the physical and emotional impacts on quality of life in children and adolescents with hemophilia. The children's short version age group I questionnaire contains 16 items for children 4 to 7 years of age.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hemophilia Quality of Life Questionnaire Children's Short Version Age Group I","conceptCode":"C122376","definition":"A standardized rating scale developed by the Haemo-QoL Study Group in 2002, which is used to measure the physical and emotional impacts on quality of life in children and adolescents with hemophilia. The children's short version age group I questionnaire contains 16 items for children 4 to 7 years of age.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"81CE4750-4977-6019-E053-F662850AE483","latestVersionIndicator":"Yes","beginDate":"2019-02-13","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-02-13","modifiedBy":"ONEDATA","dateModified":"2019-02-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5C0A-0412-E063-731AD00A56D4","beginDate":"2019-02-13","endDate":null,"createdBy":"TAYLORT","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"HAEMO-QOL CHILDREN'S SHORT VERSION AGE GROUP II/III","valueDescription":"Hemophilia Quality of Life Questionnaire Children's Short Version Age Group II/III","ValueMeaning":{"publicId":"6643113","version":"1","preferredName":"Hemophilia Quality of Life Questionnaire Children's Short Version Age Group II/III","longName":"6643113","preferredDefinition":"A standardized rating scale developed by the Haemo-QoL Study Group in 2002, which is used to measure the physical and emotional impacts on quality of life in children and adolescents with hemophilia. The children's short version age group II/III questionnaire contains 35 items, which can be used for both children 8 to 12 years of age and adolescents 13 to 16 years of age.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hemophilia Quality of Life Questionnaire Children's Short Version Age Group II/III","conceptCode":"C122377","definition":"A standardized rating scale developed by the Haemo-QoL Study Group in 2002, which is used to measure the physical and emotional impacts on quality of life in children and adolescents with hemophilia. The children's short version age group II/III questionnaire contains 35 items, which can be used for both children 8 to 12 years of age and adolescents 13 to 16 years of age.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"81CE4750-499D-6019-E053-F662850AE483","latestVersionIndicator":"Yes","beginDate":"2019-02-13","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-02-13","modifiedBy":"ONEDATA","dateModified":"2019-02-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5C0B-0412-E063-731AD00A56D4","beginDate":"2019-02-13","endDate":null,"createdBy":"TAYLORT","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"HAEMO-QOL PARENT'S LONG VERSION AGE GROUP I","valueDescription":"Hemophilia Quality of Life Questionnaire Parent's Long Version Age Group I","ValueMeaning":{"publicId":"6643115","version":"1","preferredName":"Hemophilia Quality of Life Questionnaire Parent's Long Version Age Group I","longName":"6643115","preferredDefinition":"A standardized rating scale developed by the Haemo-QoL Study Group in 2002, which is used to measure the physical and emotional impacts on quality of life in children and adolescents with hemophilia. The parent's long version age group I questionnaire contains 21 items and corresponds to age group I of children 4 to 7 years of age.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hemophilia Quality of Life Questionnaire Parent's Long Version Age Group I","conceptCode":"C122378","definition":"A standardized rating scale developed by the Haemo-QoL Study Group in 2002, which is used to measure the physical and emotional impacts on quality of life in children and adolescents with hemophilia. The parent's long version age group I questionnaire contains 21 items and corresponds to age group I of children 4 to 7 years of age.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"81CE4750-49C3-6019-E053-F662850AE483","latestVersionIndicator":"Yes","beginDate":"2019-02-13","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-02-13","modifiedBy":"ONEDATA","dateModified":"2019-02-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5C0C-0412-E063-731AD00A56D4","beginDate":"2019-02-13","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"HAEMO-QOL PARENT'S LONG VERSION AGE GROUP II","valueDescription":"Hemophilia Quality of Life Questionnaire Parent's Long Version Age Group II","ValueMeaning":{"publicId":"6643117","version":"1","preferredName":"Hemophilia Quality of Life Questionnaire Parent's Long Version Age Group II","longName":"6643117","preferredDefinition":"A standardized rating scale developed by the Haemo-QoL Study Group in 2002, which is used to measure the physical and emotional impacts on quality of life in children and adolescents with hemophilia. The parent's long version age group II questionnaire contains 64 items and corresponds to age group II of children 8 to 12 years of age.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hemophilia Quality of Life Questionnaire Parent's Long Version Age Group II","conceptCode":"C122379","definition":"A standardized rating scale developed by the Haemo-QoL Study Group in 2002, which is used to measure the physical and emotional impacts on quality of life in children and adolescents with hemophilia. The parent's long version age group II questionnaire contains 64 items and corresponds to age group II of children 8 to 12 years of age.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"81CE4750-49E9-6019-E053-F662850AE483","latestVersionIndicator":"Yes","beginDate":"2019-02-13","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-02-13","modifiedBy":"ONEDATA","dateModified":"2019-02-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5C0D-0412-E063-731AD00A56D4","beginDate":"2019-02-13","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"HAEMO-QOL PARENT'S LONG VERSION AGE GROUP III","valueDescription":"Hemophilia Quality of Life Questionnaire Parent's Long Version Age Group III","ValueMeaning":{"publicId":"6643119","version":"1","preferredName":"Hemophilia Quality of Life Questionnaire Parent's Long Version Age Group III","longName":"6643119","preferredDefinition":"A standardized rating scale developed by the Haemo-QoL Study Group in 2002, which is used to measure the physical and emotional impacts on quality of life in children and adolescents with hemophilia. The parent's long version age group III questionnaire contains 77 items and corresponds to age group III of adolescents 13 to 16 years of age.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hemophilia Quality of Life Questionnaire Parent's Long Version Age Group III","conceptCode":"C122380","definition":"A standardized rating scale developed by the Haemo-QoL Study Group in 2002, which is used to measure the physical and emotional impacts on quality of life in children and adolescents with hemophilia. The parent's long version age group III questionnaire contains 77 items and corresponds to age group III of adolescents 13 to 16 years of age.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"81CE4750-4A0F-6019-E053-F662850AE483","latestVersionIndicator":"Yes","beginDate":"2019-02-13","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-02-13","modifiedBy":"ONEDATA","dateModified":"2019-02-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5C0E-0412-E063-731AD00A56D4","beginDate":"2019-02-13","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"HAMD 6 SELF-REPORT VERSION","valueDescription":"Hamilton Depression Rating Scale 6 Self-Report Version Questionnaire","ValueMeaning":{"publicId":"6643121","version":"1","preferredName":"Hamilton Depression Rating Scale 6 Self-Report Version Questionnaire","longName":"6643121","preferredDefinition":"A standardized 6-item self-report rating scale for the assessment of symptoms in patients diagnosed with depression. The original 17-item Hamilton Depression Scale, developed by Max Hamilton at the University of Leeds in 1960, was independently modified by Bech et al in 1975, using Rasch models, to create a melancholia subscale that contains six variables.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hamilton Depression Rating Scale 6 Self-Report Version Questionnaire","conceptCode":"C130314","definition":"A standardized 6-item self-report rating scale for the assessment of symptoms in patients diagnosed with depression. The original 17-item Hamilton Depression Scale, developed by Max Hamilton at the University of Leeds in 1960, was independently modified by Bech et al in 1975, using Rasch models, to create a melancholia subscale that contains six variables.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"81CE4750-4A35-6019-E053-F662850AE483","latestVersionIndicator":"Yes","beginDate":"2019-02-13","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-02-13","modifiedBy":"ONEDATA","dateModified":"2019-02-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5C0F-0412-E063-731AD00A56D4","beginDate":"2019-02-13","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"HAQ-DI WITH VAS","valueDescription":"Health Assessment Questionnaire Disability Index With Pain Visual Analog Scale Questionnaire","ValueMeaning":{"publicId":"6643122","version":"1","preferredName":"Health Assessment Questionnaire Disability Index With Pain Visual Analog Scale Questionnaire","longName":"6643122","preferredDefinition":"A standardized questionnaire developed by James F. Fries in 1983, which is originally used to measure outcome in patients with Rheumatoid Arthritis. It has also been applied to patients with HIV/AIDS and in studies of normal aging. The HAQ-DI With VAS is a generic instrument which focuses on self-reported, patient-oriented outcome measures. The questionnaire contains 8 categories of 46 items; dressing and grooming, arising, eating, walking, hygiene, reaching, grip, and activities. A 0-3 grade scale is used, where grade 0 represents category performed without any difficulty and grade 3 represents category performed with the greatest difficulty (unable to do).","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Health Assessment Questionnaire Disability Index With Pain Visual Analog Scale Questionnaire","conceptCode":"C106699","definition":"A standardized questionnaire developed by James F. Fries in 1983, which is originally used to measure outcome in patients with Rheumatoid Arthritis. It has also been applied to patients with HIV/AIDS and in studies of normal aging. The HAQ-DI With VAS is a generic instrument which focuses on self-reported, patient-oriented outcome measures. The questionnaire contains 8 categories of 46 items; dressing and grooming, arising, eating, walking, hygiene, reaching, grip, and activities. A 0-3 grade scale is used, where grade 0 represents category performed without any difficulty and grade 3 represents category performed with the greatest difficulty (unable to do).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"81CE4750-4A58-6019-E053-F662850AE483","latestVersionIndicator":"Yes","beginDate":"2019-02-13","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-02-13","modifiedBy":"ONEDATA","dateModified":"2019-02-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5C10-0412-E063-731AD00A56D4","beginDate":"2019-02-13","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"HAQ-DI WITHOUT VAS","valueDescription":"Health Assessment Questionnaire Disability Index Without Pain Visual Analog Scale","ValueMeaning":{"publicId":"6643124","version":"1","preferredName":"Health Assessment Questionnaire Disability Index Without Pain Visual Analog Scale","longName":"6643124","preferredDefinition":"A standardized 20-item self-report component of the Health Assessment Questionnaire, developed by Fries et al 1978, that assesses a patient's level of functional ability. The disability index utilizes a 4-point symptom rating scale to allow patients to grade eight categories of ability, including dressing and grooming, arising, eating, walking, hygiene, reach, grip, and common daily activities.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Health Assessment Questionnaire Disability Index Without Pain Visual Analog Scale","conceptCode":"C132534","definition":"A standardized 20-item self-report component of the Health Assessment Questionnaire, developed by Fries et al 1978, that assesses a patient's level of functional ability. The disability index utilizes a 4-point symptom rating scale to allow patients to grade eight categories of ability, including dressing and grooming, arising, eating, walking, hygiene, reach, grip, and common daily activities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"81CE4750-4A7E-6019-E053-F662850AE483","latestVersionIndicator":"Yes","beginDate":"2019-02-13","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-02-13","modifiedBy":"ONEDATA","dateModified":"2019-02-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5C11-0412-E063-731AD00A56D4","beginDate":"2019-02-13","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"FSS","valueDescription":"Fatigue Severity Scale","ValueMeaning":{"publicId":"6643092","version":"1","preferredName":"Fatigue Severity Scale","longName":"6643092","preferredDefinition":"A numeric scale to assess the severity of an individual's fatigue over the past week while performing a variety of usual tasks.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Fatigue Severity Scale","conceptCode":"C106621","definition":"A numeric scale to assess the severity of an individual's fatigue over the past week while performing a variety of usual tasks.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"81CE4750-47DE-6019-E053-F662850AE483","latestVersionIndicator":"Yes","beginDate":"2019-02-13","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-02-13","modifiedBy":"ONEDATA","dateModified":"2019-02-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5C12-0412-E063-731AD00A56D4","beginDate":"2019-02-13","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"IDS-SR","valueDescription":"Inventory of Depressive Symptomatology Self-Report Version Questionnaire","ValueMeaning":{"publicId":"6643125","version":"1","preferredName":"Inventory of Depressive Symptomatology Self-Report Version Questionnaire","longName":"6643125","preferredDefinition":"Inventory of Depressive Symptomatology - Self-Report (IDS-SR) (Copyright UT Southwestern Medical Center at Dallas. Rush, A.J., Carmody, T. and Reimitz, P.E. The Inventory of Depressive Symptomatology (IDS): Clinician (IDS-C) and self-report (IDS-SR) ratings of depressive symptoms. International Journal of Methods in Psychiatric Research, 9:45-59, 2000).","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Inventory of Depressive Symptomatology Self-Report Version Questionnaire","conceptCode":"C130315","definition":"A standardized 30-item self-report questionnaire that utilizes a 5-point rating scale for the assessment of the severity of depressive symptoms over the seven day period prior to evaluation. The questionnaire, which was created by Rush, et al. in 1986, originally consisted of 28 items including the nine diagnostic DSM-IV symptom domains used to characterize a major depressive episode, as well as items to address melancholic and atypical features. Two additional items were later added to address leaden paralysis and interpersonal rejection sensitivity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"81CE4750-4AA1-6019-E053-F662850AE483","latestVersionIndicator":"Yes","beginDate":"2019-02-13","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-02-13","modifiedBy":"ONEDATA","dateModified":"2019-02-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5C13-0412-E063-731AD00A56D4","beginDate":"2019-02-13","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"IPAQ-LF PHONE VERSION","valueDescription":"International Physical Activity Questionnaire (November 2002) Long Last 7 Days Telephone Format","ValueMeaning":{"publicId":"6643129","version":"1","preferredName":"International Physical Activity Questionnaire (November 2002) Long Last 7 Days Telephone Format","longName":"6643129","preferredDefinition":"A standardized 31-item questionnaire, developed by Booth et al. in 2000, that is administered over the telephone and assesses physical activity lasting at least 10 minutes during the past seven days.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"International Physical Activity Questionnaire (November 2002) Long Last 7 Days Telephone Format","conceptCode":"C141692","definition":"A standardized 31-item questionnaire, developed by Booth et al. in 2000, that is administered over the telephone and assesses physical activity lasting at least 10 minutes during the past seven days.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"81CE4750-4AED-6019-E053-F662850AE483","latestVersionIndicator":"Yes","beginDate":"2019-02-13","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-02-13","modifiedBy":"ONEDATA","dateModified":"2019-02-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5C14-0412-E063-731AD00A56D4","beginDate":"2019-02-13","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"FBRSI","valueDescription":"Functional Assessment of Cancer Therapy-Brain Symptom Index Questionnaire","ValueMeaning":{"publicId":"6643078","version":"1","preferredName":"Functional Assessment of Cancer Therapy-Brain Symptom Index Questionnaire","longName":"6643078","preferredDefinition":"A 24-item complement to the Functional Assessment of Cancer Therapy-Brain (FACT-Br) questionnaire, developed by Cella et al. in 2010, that is used to assess brain tumor symptoms.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Functional Assessment of Cancer Therapy-Brain Symptom Index Questionnaire","conceptCode":"C138336","definition":"A 24-item complement to the Functional Assessment of Cancer Therapy-Brain (FACT-Br) questionnaire, developed by Cella et al. in 2010, that is used to assess brain tumor symptoms.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"81CE4750-46B4-6019-E053-F662850AE483","latestVersionIndicator":"Yes","beginDate":"2019-02-13","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-02-13","modifiedBy":"ONEDATA","dateModified":"2019-02-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5C15-0412-E063-731AD00A56D4","beginDate":"2019-02-13","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"IPAQ-LF SELF-ADMINISTERED VERSION","valueDescription":"International Physical Activity Questionnaire (August 2002) Long Last 7 Days Self-Administered Format","ValueMeaning":{"publicId":"6643131","version":"1","preferredName":"International Physical Activity Questionnaire (August 2002) Long Last 7 Days Self-Administered Format","longName":"6643131","preferredDefinition":"A standardized self-administered 31-item questionnaire, developed by Booth et al. in 2000, that assesses physical activity lasting at least 10 minutes during the past seven days.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"International Physical Activity Questionnaire (August 2002) Long Last 7 Days Self-Administered Format","conceptCode":"C141691","definition":"A standardized self-administered 31-item questionnaire, developed by Booth et al. in 2000, that assesses physical activity lasting at least 10 minutes during the past seven days.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"81CE4750-4B13-6019-E053-F662850AE483","latestVersionIndicator":"Yes","beginDate":"2019-02-13","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-02-13","modifiedBy":"ONEDATA","dateModified":"2019-02-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5C16-0412-E063-731AD00A56D4","beginDate":"2019-02-13","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"FLSI","valueDescription":"Functional Assessment of Cancer Therapy-Lung Symptom Index Questionnaire","ValueMeaning":{"publicId":"6643083","version":"1","preferredName":"Functional Assessment of Cancer Therapy-Lung Symptom Index Questionnaire","longName":"6643083","preferredDefinition":"A brief subscale complement of the Functional Assessment of Cancer Therapy General Questionnaire, developed by Cella et al. in 2007, that is utilized to assess the major symptoms related to lung cancer, including dyspnea, pain, fatigue, cough, and weight loss.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Functional Assessment of Cancer Therapy-Lung Symptom Index Questionnaire","conceptCode":"C138338","definition":"A brief subscale complement of the Functional Assessment of Cancer Therapy General Questionnaire, developed by Cella et al. in 2007, that is utilized to assess the major symptoms related to lung cancer, including dyspnea, pain, fatigue, cough, and weight loss.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"81CE4750-4723-6019-E053-F662850AE483","latestVersionIndicator":"Yes","beginDate":"2019-02-13","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-02-13","modifiedBy":"ONEDATA","dateModified":"2019-02-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5C17-0412-E063-731AD00A56D4","beginDate":"2019-02-13","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"IPAQ-SF PHONE VERSION","valueDescription":"International Physical Activity Questionnaire (August 2002) Short Last 7 Days Telephone Format","ValueMeaning":{"publicId":"6643133","version":"1","preferredName":"International Physical Activity Questionnaire (August 2002) Short Last 7 Days Telephone Format","longName":"6643133","preferredDefinition":"A standardized 9-item questionnaire, developed by Booth et al. in 2000, that is administered over the telephone and assesses physical activity lasting at least 10 minutes during the past seven days.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"International Physical Activity Questionnaire (August 2002) Short Last 7 Days Telephone Format","conceptCode":"C141693","definition":"A standardized 9-item questionnaire, developed by Booth et al. in 2000, that is administered over the telephone and assesses physical activity lasting at least 10 minutes during the past seven days.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"81CE4750-4B39-6019-E053-F662850AE483","latestVersionIndicator":"Yes","beginDate":"2019-02-13","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-02-13","modifiedBy":"ONEDATA","dateModified":"2019-02-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5C18-0412-E063-731AD00A56D4","beginDate":"2019-02-13","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"FOSI","valueDescription":"Functional Assessment of Cancer Therapy-Ovarian Symptom Index Questionnaire","ValueMeaning":{"publicId":"6643089","version":"1","preferredName":"Functional Assessment of Cancer Therapy-Ovarian Symptom Index Questionnaire","longName":"6643089","preferredDefinition":"A standardized 8-item rating scale for the assessment of symptom response to treatment for advanced ovarian cancer that was originally developed by Cella, et al. in 1997 and derived from the ovarian cancer-specific subscale of the Functional Assessment of Cancer Therapy (FACT-O).","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Functional Assessment of Cancer Therapy-Ovarian Symptom Index Questionnaire","conceptCode":"C129109","definition":"A standardized 8-item rating scale for the assessment of symptom response to treatment for advanced ovarian cancer that was originally developed by Cella, et al. in 1997 and derived from the ovarian cancer-specific subscale of the Functional Assessment of Cancer Therapy (FACT-O).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"81CE4750-4795-6019-E053-F662850AE483","latestVersionIndicator":"Yes","beginDate":"2019-02-13","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-02-13","modifiedBy":"ONEDATA","dateModified":"2019-02-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5C19-0412-E063-731AD00A56D4","beginDate":"2019-02-13","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"IPAQ-SF SELF-ADMINISTERED VERSION","valueDescription":"International Physical Activity Questionnaire (August 2002) Short Last 7 Days Self-Administered Format","ValueMeaning":{"publicId":"6643135","version":"1","preferredName":"International Physical Activity Questionnaire (August 2002) Short Last 7 Days Self-Administered Format","longName":"6643135","preferredDefinition":"A standardized self-administered 9-item questionnaire, developed by Booth et al. in 2000, that assesses physical activity lasting at least 10 minutes during the past seven days.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"International Physical Activity Questionnaire (August 2002) Short Last 7 Days Self-Administered Format","conceptCode":"C141690","definition":"A standardized self-administered 9-item questionnaire, developed by Booth et al. in 2000, that assesses physical activity lasting at least 10 minutes during the past seven days.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"81CE4750-4B5F-6019-E053-F662850AE483","latestVersionIndicator":"Yes","beginDate":"2019-02-13","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-02-13","modifiedBy":"ONEDATA","dateModified":"2019-02-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5C1A-0412-E063-731AD00A56D4","beginDate":"2019-02-13","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"LEC-5 STANDARD VERSION","valueDescription":"Life Events Checklist for DSM-5 Standard Version Questionnaire","ValueMeaning":{"publicId":"6643141","version":"1","preferredName":"Life Events Checklist for DSM-5 Standard Version Questionnaire","longName":"6643141","preferredDefinition":"A standardized 17-item self-report measure, published in 2013, that is used to investigate exposure to potentially traumatic events that meet diagnostic criterion A for post-traumatic stress disorder (PTSD) according to the Diagnostic and Statistical Manual of Mental Disorders (DSM-5). The instrument is used to assess exposure to 16 event categories known to potentially result in PTSD or distress, as well as an additional item addressing any other extraordinarily stressful events not captured by the 16 categories, in adults 18 years of age and older.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Life Events Checklist for DSM-5 Standard Version Questionnaire","conceptCode":"C135740","definition":"A standardized 17-item self-report measure, published in 2013, that is used to investigate exposure to potentially traumatic events that meet diagnostic criterion A for post-traumatic stress disorder (PTSD) according to the Diagnostic and Statistical Manual of Mental Disorders (DSM-5). The instrument is used to assess exposure to 16 event categories known to potentially result in PTSD or distress, as well as an additional item addressing any other extraordinarily stressful events not captured by the 16 categories, in adults 18 years of age and older.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"81CE4750-4BE6-6019-E053-F662850AE483","latestVersionIndicator":"Yes","beginDate":"2019-02-13","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-02-13","modifiedBy":"ONEDATA","dateModified":"2019-02-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5C1B-0412-E063-731AD00A56D4","beginDate":"2019-02-13","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"FAMS","valueDescription":"Functional Assessment of Multiple Sclerosis Questionnaire","ValueMeaning":{"publicId":"6643072","version":"1","preferredName":"Functional Assessment of Multiple Sclerosis Questionnaire","longName":"6643072","preferredDefinition":"A standardized, disease-specific rating scale developed by Cella et al in 1996 to assess quality of life and functional status of individuals with multiple sclerosis. The questionnaire contains 58 items across 7 categories; mobility, symptoms, emotional well-being, general contentment, thinking and fatigue, family/social well-being, and additional concerns. The scoring algorithm for this questionnaire assigns a value from 0 (not at all) to 4 (very much) to each item in the response categories, and the total score ranges between 0 and 176.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Functional Assessment of Multiple Sclerosis Questionnaire","conceptCode":"C112521","definition":"A standardized, disease-specific rating scale developed by Cella et al in 1996 to assess quality of life and functional status of individuals with multiple sclerosis. The questionnaire contains 58 items across 7 categories; mobility, symptoms, emotional well-being, general contentment, thinking and fatigue, family/social well-being, and additional concerns. The scoring algorithm for this questionnaire assigns a value from 0 (not at all) to 4 (very much) to each item in the response categories, and the total score ranges between 0 and 176.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"81CE4750-4642-6019-E053-F662850AE483","latestVersionIndicator":"Yes","beginDate":"2019-02-13","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-02-13","modifiedBy":"ONEDATA","dateModified":"2019-02-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5C1C-0412-E063-731AD00A56D4","beginDate":"2019-02-13","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"MDQ-T","valueDescription":"Menstrual Distress Questionnaire Form-T (Today)","ValueMeaning":{"publicId":"6643145","version":"1","preferredName":"Menstrual Distress Questionnaire Form-T (Today)","longName":"6643145","preferredDefinition":"A standardized rating scale developed by Rudolf H. Moos in 1968, which is used to measure cyclical perimenstrual symptoms. The form-T version of this questionnaire allows an individual to describe her experiences on a specific day. This questionnaire contains 47 items","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Menstrual Distress Questionnaire Form-T (Today)","conceptCode":"C123660","definition":"A standardized rating scale developed by Rudolf H. Moos in 1968, which is used to measure cyclical perimenstrual symptoms. The form-T version of this questionnaire allows an individual to describe her experiences on a specific day. This questionnaire contains 47 items","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"81CE4750-4C32-6019-E053-F662850AE483","latestVersionIndicator":"Yes","beginDate":"2019-02-13","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-02-13","modifiedBy":"ONEDATA","dateModified":"2019-02-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5C1D-0412-E063-731AD00A56D4","beginDate":"2019-02-13","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"GDS","valueDescription":"Geriatric Depression Scale Questionnaire","ValueMeaning":{"publicId":"6643096","version":"1","preferredName":"Geriatric Depression Scale Questionnaire","longName":"6643096","preferredDefinition":"A standardized rating scale developed by Yesavage et al in 1983, which is a self-report assessment used to identify depression in older adults. The questionnaire contains 30 items. All questions are answered 'yes' or 'no'.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Geriatric Depression Scale Questionnaire","conceptCode":"C106697","definition":"A standardized rating scale developed by Yesavage et al in 1983, which is a self-report assessment used to identify depression in older adults. The questionnaire contains 30 items. All questions are answered 'yes' or 'no'.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"81CE4750-484A-6019-E053-F662850AE483","latestVersionIndicator":"Yes","beginDate":"2019-02-13","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-02-13","modifiedBy":"ONEDATA","dateModified":"2019-02-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5C1E-0412-E063-731AD00A56D4","beginDate":"2019-02-13","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"GDS SHORT FORM","valueDescription":"Geriatric Depression Scale Short Form Questionnaire","ValueMeaning":{"publicId":"6643098","version":"1","preferredName":"Geriatric Depression Scale Short Form Questionnaire","longName":"6643098","preferredDefinition":"A standardized rating scale developed by Sheikh et al in 1986, which is a shorter version derived from the original GDS and used to identify depression in older adults. The questionnaire contains 15 items. All questions are answered 'yes' or 'no'.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Geriatric Depression Scale Short Form Questionnaire","conceptCode":"C106698","definition":"A standardized rating scale developed by Sheikh et al in 1986, which is a shorter version derived from the original GDS and used to identify depression in older adults. The questionnaire contains 15 items. All questions are answered 'yes' or 'no'.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"81CE4750-4870-6019-E053-F662850AE483","latestVersionIndicator":"Yes","beginDate":"2019-02-13","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-02-13","modifiedBy":"ONEDATA","dateModified":"2019-02-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5C1F-0412-E063-731AD00A56D4","beginDate":"2019-02-13","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"SMDDS V1.0","valueDescription":"Symptoms of Major Depressive Disorder Scale v1.0 Questionnaire","ValueMeaning":{"publicId":"6643802","version":"1","preferredName":"Symptoms of Major Depressive Disorder Scale v1.0 Questionnaire","longName":"6643802","preferredDefinition":"A standardized 35-item patient-reported outcome instrument, created by McCarrier et al. in 2015, that utilizes a 7-day recall period and a five-point verbal rating scale to assess symptoms of major depressive disorder.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Symptoms of Major Depressive Disorder Scale v1.0 Questionnaire","conceptCode":"C155328","definition":"A standardized 35-item patient-reported outcome instrument, created by McCarrier et al. in 2015, that utilizes a 7-day recall period and a five-point verbal rating scale to assess symptoms of major depressive disorder.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"81E18CEC-E8C3-621D-E053-F662850AC981","latestVersionIndicator":"Yes","beginDate":"2019-02-14","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-02-14","modifiedBy":"ONEDATA","dateModified":"2019-02-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5C20-0412-E063-731AD00A56D4","beginDate":"2019-02-14","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"SIQ","valueDescription":"Suicidal Ideation Questionnaire","ValueMeaning":{"publicId":"6643808","version":"1","preferredName":"Suicidal Ideation Questionnaire","longName":"6643808","preferredDefinition":"A standardized 30-item self-report questionnaire developed by William M. Reynolds in 1987 that utilizes a seven-point rating scale to assess the frequency of suicidal thoughts in adolescents grades 10 to 12.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Suicidal Ideation Questionnaire","conceptCode":"C150920","definition":"A standardized 30-item self-report questionnaire developed by William M. Reynolds in 1987 that utilizes a seven-point rating scale to assess the frequency of suicidal thoughts in adolescents grades 10 to 12.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"81E18CEC-E935-621D-E053-F662850AC981","latestVersionIndicator":"Yes","beginDate":"2019-02-14","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-02-14","modifiedBy":"ONEDATA","dateModified":"2019-02-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5C21-0412-E063-731AD00A56D4","beginDate":"2019-02-14","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"PEDSQL NEUROMUSCULAR MODULE ACUTE V3 TODDLER PARENT REPORT","valueDescription":"Pediatric Quality of Life Neuromuscular Module Acute Version 3.0 Parent of Toddler Questionnaire","ValueMeaning":{"publicId":"6643816","version":"1","preferredName":"Pediatric Quality of Life Neuromuscular Module Acute Version 3.0 Parent of Toddler Questionnaire","longName":"6643816","preferredDefinition":"A 25-item disease specific complement to the Pediatric Quality of Life Inventory instrument published by Sarah Davis et al. in 2010 that utilizes a 5-point Likert scale to measure three dimensions of parent reported health related quality of life over the past seven days in children ages 2 to 4 years with neuromuscular disorders.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pediatric Quality of Life Neuromuscular Module Acute Version 3.0 Parent of Toddler Questionnaire","conceptCode":"C138340","definition":"A 25-item disease specific complement to the Pediatric Quality of Life Inventory instrument published by Sarah Davis et al. in 2010 that utilizes a 5-point Likert scale to measure three dimensions of parent reported health related quality of life over the past seven days in children ages 2 to 4 years with neuromuscular disorders.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"81E18CEC-E9CD-621D-E053-F662850AC981","latestVersionIndicator":"Yes","beginDate":"2019-02-14","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-02-14","modifiedBy":"ONEDATA","dateModified":"2019-02-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5C22-0412-E063-731AD00A56D4","beginDate":"2019-02-14","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"NPI","valueDescription":"Neuropsychiatric Inventory Questionnaire","ValueMeaning":{"publicId":"6643817","version":"1","preferredName":"Neuropsychiatric Inventory Questionnaire","longName":"6643817","preferredDefinition":"A standardized rating scale originally developed and copyrighted by Jeffrey L. Cummings in 1994 as well as published in the journal Neurology (Cummings J.L., The Neuropsychiatric Inventory: Assessing psychopathology in dementia patients. Neurology May 1997 48:10S-16S) which is used to assess the severity of an individual's neuropathic behaviors based on a observations made by the patient's caregiver. This instrument contains 12 neuropsychiatric areas associated with dementia such as delusions, anxiety, motor disturbances, and appetite. Each behavior is evaluated only if the individual displays the behavior. For these behaviors, the frequency is assessed on a scale of 0-4 with 0 being occasionally and 4 being very frequently, the severity is assessed on a scale of 1-3 with 1 being mild and 3 being marked, and the level of distress each behavior inflicts on the caregiver is assessed on a scale of 0-5 with 0 being not distressing and 5 being extremely distressing.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Neuropsychiatric Inventory - 12 Item Version Questionnaire","conceptCode":"C100772","definition":"A standardized rating scale originally developed and copyrighted by Jeffrey L. Cummings in 1994 as well as published in the journal Neurology (Cummings J.L., The Neuropsychiatric Inventory: Assessing psychopathology in dementia patients. Neurology May 1997 48:10S-16S) which is used to assess the severity of an individual's neuropathic behaviors based on a observations made by the patient's caregiver. This instrument contains 12 neuropsychiatric areas associated with dementia such as delusions, anxiety, motor disturbances, and appetite. Each behavior is evaluated only if the individual displays the behavior. For these behaviors, the frequency is assessed on a scale of 0-4 with 0 being occasionally and 4 being very frequently, the severity is assessed on a scale of 1-3 with 1 being mild and 3 being marked, and the level of distress each behavior inflicts on the caregiver is assessed on a scale of 0-5 with 0 being not distressing and 5 being extremely distressing.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"81E18CEC-E9F0-621D-E053-F662850AC981","latestVersionIndicator":"Yes","beginDate":"2019-02-14","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-02-14","modifiedBy":"ONEDATA","dateModified":"2019-02-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5C23-0412-E063-731AD00A56D4","beginDate":"2019-02-14","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"MFIS","valueDescription":"Modified Fatigue Impact Scale Questionnaire","ValueMeaning":{"publicId":"6643582","version":"1","preferredName":"Modified Fatigue Impact Scale Questionnaire","longName":"6643582","preferredDefinition":"A standardized rating scale developed by Fisk et al in 1994, which assesses how fatigue may affect a person and the impact of fatigue on quality of life. The questionnaire contains 21 questions which are scored ranging from 0 (never) to 4 (almost always).","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Modified Fatigue Impact Scale Questionnaire","conceptCode":"C113877","definition":"A standardized rating scale developed by Fisk et al in 1994, which assesses how fatigue may affect a person and the impact of fatigue on quality of life. The questionnaire contains 21 questions which are scored ranging from 0 (never) to 4 (almost always).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"81E08FC2-6560-6DE6-E053-F662850A1E6E","latestVersionIndicator":"Yes","beginDate":"2019-02-14","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-02-14","modifiedBy":"ONEDATA","dateModified":"2019-02-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5C24-0412-E063-731AD00A56D4","beginDate":"2019-02-14","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"MMRC","valueDescription":"Modified Medical Research Council Dyspnea Scale Questionnaire","ValueMeaning":{"publicId":"6643598","version":"1","preferredName":"Modified Medical Research Council Dyspnea Scale Questionnaire","longName":"6643598","preferredDefinition":"A standardized rating scale developed by Mahler and Wells in 1988, which is a general scale used to measure the rating of dyspnea or breathlessness. The questionnaire contains 1 question and a 0-4 grade answer scale, where grade 0 represents the lowest level of dyspnea impairment perceived, and level 4 represents the greatest dyspnea impairment.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Modified Medical Research Council Dyspnea Scale Questionnaire","conceptCode":"C106700","definition":"A standardized rating scale developed by Mahler and Wells in 1988, which is a general scale used to measure the rating of dyspnea or breathlessness. The questionnaire contains 1 question and a 0-4 grade answer scale, where grade 0 represents the lowest level of dyspnea impairment perceived, and level 4 represents the greatest dyspnea impairment.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"81E08FC2-6690-6DE6-E053-F662850A1E6E","latestVersionIndicator":"Yes","beginDate":"2019-02-14","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-02-14","modifiedBy":"ONEDATA","dateModified":"2019-02-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5C25-0412-E063-731AD00A56D4","beginDate":"2019-02-14","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"NPS","valueDescription":"Neuropathic Pain Scale Questionnaire","ValueMeaning":{"publicId":"6643616","version":"1","preferredName":"Neuropathic Pain Scale Questionnaire","longName":"6643616","preferredDefinition":"A standardized survey developed and copyrighted by Brad Galer and Mark Jensen in 1997 and published in the journal Neurology (BS Galer and MP Jensen. Development and preliminary validation of a pain measure specific to neuropathic pain: The Neuropathic Pain Scale. Neurology. 1997, 48:332-338.) which is used to assess specific pain qualities associated with neuropathic pain. This instrument consists of 10 items that can be completed by the patient. Each item is rated on a scale of 0-10 with 0 representing none and 10 representing the worst. However, one item is multi-level with open ended responses.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Neuropathic Pain Scale Questionnaire","conceptCode":"C103522","definition":"A standardized survey developed and copyrighted by Brad Galer and Mark Jensen in 1997 and published in the journal Neurology (BS Galer and MP Jensen. Development and preliminary validation of a pain measure specific to neuropathic pain: The Neuropathic Pain Scale. Neurology. 1997, 48:332-338.) which is used to assess specific pain qualities associated with neuropathic pain. This instrument consists of 10 items that can be completed by the patient. Each item is rated on a scale of 0-10 with 0 representing none and 10 representing the worst. However, one item is multi-level with open ended responses.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"81E08FC2-6806-6DE6-E053-F662850A1E6E","latestVersionIndicator":"Yes","beginDate":"2019-02-14","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-02-14","modifiedBy":"ONEDATA","dateModified":"2019-02-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5C27-0412-E063-731AD00A56D4","beginDate":"2019-02-14","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"OCI","valueDescription":"Ocular Comfort Index Questionnaire","ValueMeaning":{"publicId":"6643574","version":"1","preferredName":"Ocular Comfort Index Questionnaire","longName":"6643574","preferredDefinition":"A standardized rating scale originally developed by Johnson and Murphy in 2007. This instrument is used to assess ocular surface irritation and grade the severity of dry eye syndrome.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Ocular Comfort Index Questionnaire","conceptCode":"C119095","definition":"A standardized rating scale originally developed by Johnson and Murphy in 2007. This instrument is used to assess ocular surface irritation and grade the severity of dry eye syndrome.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"81E08FC2-64C8-6DE6-E053-F662850A1E6E","latestVersionIndicator":"Yes","beginDate":"2019-02-14","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-02-14","modifiedBy":"ONEDATA","dateModified":"2019-02-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5C28-0412-E063-731AD00A56D4","beginDate":"2019-02-14","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"PDDS","valueDescription":"Patient Determined Disease Steps Questionnaire","ValueMeaning":{"publicId":"6643588","version":"1","preferredName":"Patient Determined Disease Steps Questionnaire","longName":"6643588","preferredDefinition":"A standardized rating scale developed by Hohol et al in 1995, which is a self-assessment scale of functional disability in multiple sclerosis patients primarily based on ambulation. The questionnaire contains 1 question which is scored ranging from 0 (normal) to 8 (bedridden). A score of 0 to 2 indicates mild disability; a score of 3 to 5 indicates moderate disability; a score of 6 to 8 indicates severe disability.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Patient Determined Disease Steps Questionnaire","conceptCode":"C112524","definition":"A standardized rating scale developed by Hohol et al in 1995, which is a self-assessment scale of functional disability in multiple sclerosis patients primarily based on ambulation. The questionnaire contains 1 question which is scored ranging from 0 (normal) to 8 (bedridden). A score of 0 to 2 indicates mild disability; a score of 3 to 5 indicates moderate disability; a score of 6 to 8 indicates severe disability.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"81E08FC2-65D2-6DE6-E053-F662850A1E6E","latestVersionIndicator":"Yes","beginDate":"2019-02-14","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-02-14","modifiedBy":"ONEDATA","dateModified":"2019-02-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5C29-0412-E063-731AD00A56D4","beginDate":"2019-02-14","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"PGI","valueDescription":"Patient Global Impression Generic Modification Version Questionnaire","ValueMeaning":{"publicId":"6643546","version":"1","preferredName":"Patient Global Impression Generic Modification Version Questionnaire","longName":"6643546","preferredDefinition":"Patient Global Impression (PGI) generic modification for any disease/condition concept use case (Modified from Guy W: ECDEU Assessment Manual for Psychopharmacology. Rockville, MD: U.S. Department of Health, Education, and Welfare; 1976).","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Patient Global Impression Generic Modification Version Questionnaire","conceptCode":"C135739","definition":"Patient Global Impression (PGI) generic modification for any disease/condition concept use case (Modified from Guy W: ECDEU Assessment Manual for Psychopharmacology. Rockville, MD: U.S. Department of Health, Education, and Welfare; 1976).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"81E08FC2-6294-6DE6-E053-F662850A1E6E","latestVersionIndicator":"Yes","beginDate":"2019-02-14","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-02-14","modifiedBy":"ONEDATA","dateModified":"2019-02-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5C2A-0412-E063-731AD00A56D4","beginDate":"2019-02-14","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"MADRS","valueDescription":"Montgomery-Asberg Depression Rating Scale Questionnaire","ValueMeaning":{"publicId":"6643143","version":"1","preferredName":"Montgomery-Asberg Depression Rating Scale Questionnaire","longName":"6643143","preferredDefinition":"A standardized rating scale developed by Montgomery and Asberg in in 1978, which is used to measure the severity of depressive symptoms in patients with depression. The questionnaire contains 10 items on a scale of 0 to 6.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Montgomery-Asberg Depression Rating Scale Questionnaire","conceptCode":"C122382","definition":"A standardized rating scale developed by Montgomery and Asberg in in 1978, which is used to measure the severity of depressive symptoms in patients with depression. The questionnaire contains 10 items on a scale of 0 to 6.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"81CE4750-4C0C-6019-E053-F662850AE483","latestVersionIndicator":"Yes","beginDate":"2019-02-13","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-02-13","modifiedBy":"ONEDATA","dateModified":"2019-02-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5C2B-0412-E063-731AD00A56D4","beginDate":"2019-02-13","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"FIQR","valueDescription":"Revised Fibromyalgia Impact Questionnaire","ValueMeaning":{"publicId":"6643080","version":"1","preferredName":"Revised Fibromyalgia Impact Questionnaire","longName":"6643080","preferredDefinition":"A standardized survey originally developed in the late 1980s and subsequently copyrighted by Robert M Bennett and Ronald Friend and published in the Arthritis Research and Therapy journal (Bennett RM, Friend R, Jones KD, Ward R, Han BK, and Ross RL. The Revised Fibromyalgia Impact Questionnaire (FIQR): validation and psychometric properties. Arthritis Research and Therapy 2009, 11:R120) which is used to evaluate an individual's fibromyalgia symptoms and the extent they interfere with daily living. This instrument is a self-administered questionnaire with 3 sections with a total of 21 items pertaining to the difficulty of performing an activity, the overall impact of fibromyalgia, and the intensity of common fibromyalgia symptoms all within the past 7 days. Each item is ranked on a scale from 0-10.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Revised Fibromyalgia Impact Questionnaire","conceptCode":"C103518","definition":"A standardized survey originally developed in the late 1980s and subsequently copyrighted by Robert M Bennett and Ronald Friend and published in the Arthritis Research and Therapy journal (Bennett RM, Friend R, Jones KD, Ward R, Han BK, and Ross RL. The Revised Fibromyalgia Impact Questionnaire (FIQR): validation and psychometric properties. Arthritis Research and Therapy 2009, 11:R120) which is used to evaluate an individual's fibromyalgia symptoms and the extent they interfere with daily living. This instrument is a self-administered questionnaire with 3 sections with a total of 21 items pertaining to the difficulty of performing an activity, the overall impact of fibromyalgia, and the intensity of common fibromyalgia symptoms all within the past 7 days. Each item is ranked on a scale from 0-10.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"81CE4750-46DA-6019-E053-F662850AE483","latestVersionIndicator":"Yes","beginDate":"2019-02-13","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-02-13","modifiedBy":"ONEDATA","dateModified":"2019-02-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5C2C-0412-E063-731AD00A56D4","beginDate":"2019-02-13","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"GCGI","valueDescription":"STANDARDS General Clinical Global Impressions Questionnaire","ValueMeaning":{"publicId":"6643095","version":"1","preferredName":"STANDARDS General Clinical Global Impressions Questionnaire","longName":"6643095","preferredDefinition":"Version 1 (2012-08-07) of the general clinical global impression of pain questionnaire created by the STANDARDS (Standardized Analgesic Database for Research, Discovery, and Submissions) committee and sponsored by ACTTION (Analgesic Clinical Trial Translations, Innovations, Opportunities, and Networks).","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"STANDARDS General Clinical Global Impressions Questionnaire","conceptCode":"C105169","definition":"Version 1 (2012-08-07) of the general clinical global impression of pain questionnaire created by the STANDARDS (Standardized Analgesic Database for Research, Discovery, and Submissions) committee and sponsored by ACTTION (Analgesic Clinical Trial Translations, Innovations, Opportunities, and Networks).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"81CE4750-4827-6019-E053-F662850AE483","latestVersionIndicator":"Yes","beginDate":"2019-02-13","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-02-13","modifiedBy":"ONEDATA","dateModified":"2019-02-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5C2D-0412-E063-731AD00A56D4","beginDate":"2019-02-13","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"MPAI-4","valueDescription":"Mayo-Portland Adaptability Inventory-4 Questionnaire","ValueMeaning":{"publicId":"6643576","version":"1","preferredName":"Mayo-Portland Adaptability Inventory-4 Questionnaire","longName":"6643576","preferredDefinition":"A standardized rating scale modified and revised by Muriel et al in 2005, which is used to measure global brain injury outcome and functional status of subjects in the post-acute period following acquired brain injury (ABI)/traumatic brain injury (TBI), as well as to evaluate rehabilitation programs providing services to people with brain injuries. The questionnaire contains 35 questions and generates 3 subscales: ability index, adjustment index, and participation index. This instrument is scored on a 5-point Likert scale.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Mayo-Portland Adaptability Inventory-4 Questionnaire","conceptCode":"C115798","definition":"A standardized rating scale modified and revised by Muriel et al in 2005, which is used to measure global brain injury outcome and functional status of subjects in the post-acute period following acquired brain injury (ABI)/traumatic brain injury (TBI), as well as to evaluate rehabilitation programs providing services to people with brain injuries. The questionnaire contains 35 questions and generates 3 subscales: ability index, adjustment index, and participation index. This instrument is scored on a 5-point Likert scale.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"81E08FC2-64EE-6DE6-E053-F662850A1E6E","latestVersionIndicator":"Yes","beginDate":"2019-02-14","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-02-14","modifiedBy":"ONEDATA","dateModified":"2019-02-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5C2E-0412-E063-731AD00A56D4","beginDate":"2019-02-14","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"WOMAC VA 3.1 INDEX","valueDescription":"Western Ontario and McMaster Universities Osteoarthritis Index Version 3.1 Visual Analog Scale Format Questionnaire","ValueMeaning":{"publicId":"6643417","version":"1","preferredName":"Western Ontario and McMaster Universities Osteoarthritis Index Version 3.1 Visual Analog Scale Format Questionnaire","longName":"6643417","preferredDefinition":"A standardized rating scale developed by Nicholas Bellamy with the Western Ontario and McMaster Universities in 1982, which is used to assess pain, stiffness, and physical function in patients with hip and/or knee osteoarthritis. The questionnaire contains 24 items which are divided into 3 subscales: pain, stiffness and physical function. This version of the questionnaire uses the 100mm visual analog scaling format.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Western Ontario and McMaster Universities Osteoarthritis Index Version 3.1 Visual Analog Scale Format Questionnaire","conceptCode":"C122386","definition":"A standardized rating scale developed by Nicholas Bellamy with the Western Ontario and McMaster Universities in 1982, which is used to assess pain, stiffness, and physical function in patients with hip and/or knee osteoarthritis. The questionnaire contains 24 items which are divided into 3 subscales: pain, stiffness and physical function. This version of the questionnaire uses the 100mm visual analog scaling format.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"81DF52B1-9CA2-4DD9-E053-F662850A2BAE","latestVersionIndicator":"Yes","beginDate":"2019-02-14","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-02-14","modifiedBy":"ONEDATA","dateModified":"2019-02-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5C2F-0412-E063-731AD00A56D4","beginDate":"2019-02-14","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"WOMAC NRS 3.1 INDEX","valueDescription":"Western Ontario and McMaster Universities Osteoarthritis Index Version 3.1 Numerical Rating Scale Format Questionnaire","ValueMeaning":{"publicId":"6643419","version":"1","preferredName":"Western Ontario and McMaster Universities Osteoarthritis Index Version 3.1 Numerical Rating Scale Format Questionnaire","longName":"6643419","preferredDefinition":"A standardized rating scale developed by Nicholas Bellamy with the Western Ontario and McMaster Universities in 1982, which is used to assess pain, stiffness, and physical function in patients with hip and/or knee osteoarthritis. The questionnaire contains 24 items which are divided into 3 subscales: pain, stiffness and physical function. This version of the questionnaire uses the 11-point numerical rating scaling format.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Western Ontario and McMaster Universities Osteoarthritis Index Version 3.1 Numerical Rating Scale Format Questionnaire","conceptCode":"C122385","definition":"A standardized rating scale developed by Nicholas Bellamy with the Western Ontario and McMaster Universities in 1982, which is used to assess pain, stiffness, and physical function in patients with hip and/or knee osteoarthritis. The questionnaire contains 24 items which are divided into 3 subscales: pain, stiffness and physical function. This version of the questionnaire uses the 11-point numerical rating scaling format.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"81DF52B1-9CC8-4DD9-E053-F662850A2BAE","latestVersionIndicator":"Yes","beginDate":"2019-02-14","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-02-14","modifiedBy":"ONEDATA","dateModified":"2019-02-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5C30-0412-E063-731AD00A56D4","beginDate":"2019-02-14","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"WOMAC LK 3.1 INDEX","valueDescription":"Western Ontario and McMaster Universities Osteoarthritis Index Version 3.1 Likert Scale Format Questionnaire","ValueMeaning":{"publicId":"6643421","version":"1","preferredName":"Western Ontario and McMaster Universities Osteoarthritis Index Version 3.1 Likert Scale Format Questionnaire","longName":"6643421","preferredDefinition":"A standardized rating scale developed by Nicholas Bellamy with the Western Ontario and McMaster Universities in 1982, which is used to assess pain, stiffness, and physical function in patients with hip and/or knee osteoarthritis. The questionnaire contains 24 items which are divided into 3 subscales: pain, stiffness and physical function. This version of the questionnaire uses the 5-point Likert scaling format.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Western Ontario and McMaster Universities Osteoarthritis Index Version 3.1 Likert Scale Format Questionnaire","conceptCode":"C122384","definition":"A standardized rating scale developed by Nicholas Bellamy with the Western Ontario and McMaster Universities in 1982, which is used to assess pain, stiffness, and physical function in patients with hip and/or knee osteoarthritis. The questionnaire contains 24 items which are divided into 3 subscales: pain, stiffness and physical function. This version of the questionnaire uses the 5-point Likert scaling format.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"81DF52B1-9CEE-4DD9-E053-F662850A2BAE","latestVersionIndicator":"Yes","beginDate":"2019-02-14","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-02-14","modifiedBy":"ONEDATA","dateModified":"2019-02-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5C31-0412-E063-731AD00A56D4","beginDate":"2019-02-14","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"WLQ","valueDescription":"Work Limitations Questionnaire","ValueMeaning":{"publicId":"6643423","version":"1","preferredName":"Work Limitations Questionnaire","longName":"6643423","preferredDefinition":"A standardized rating scale originally developed by Lerner et al in 1998. This instrument is used to measure the degree to which health problems interfere with specific aspects of job performance and health-related productivity loss in employed individuals.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Work Limitations Questionnaire","conceptCode":"C119096","definition":"A standardized rating scale originally developed by Lerner et al in 1998. This instrument is used to measure the degree to which health problems interfere with specific aspects of job performance and health-related productivity loss in employed individuals.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"81DF52B1-9D14-4DD9-E053-F662850A2BAE","latestVersionIndicator":"Yes","beginDate":"2019-02-14","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-02-14","modifiedBy":"ONEDATA","dateModified":"2019-02-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5C32-0412-E063-731AD00A56D4","beginDate":"2019-02-14","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"WHODAS 2.0 - 36-ITEM SELF","valueDescription":"World Health Organization Disability Assessment Schedule 2.0 36-item Version Self-administered Questionnaire","ValueMeaning":{"publicId":"6643425","version":"1","preferredName":"World Health Organization Disability Assessment Schedule 2.0 36-item Version Self-administered Questionnaire","longName":"6643425","preferredDefinition":"A standardized 36-item self-report questionnaire that utilizes a 5-point rating scale to assess an individual's ability to perform activities in six domains of functioning over the 30 days prior to evaluation in order to calculate a global disability score. The questionnaire was developed in 2010 by the World Health Organization (WHO) Classification, Terminology and Standards team, within the framework of the WHO/National Institutes of Health (NIH) Joint Project on Assessment and Classification of Disability.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"World Health Organization Disability Assessment Schedule 2.0 36-item Version Self-administered Questionnaire","conceptCode":"C130321","definition":"A standardized 36-item self-report questionnaire that utilizes a 5-point rating scale to assess an individual's ability to perform activities in six domains of functioning over the 30 days prior to evaluation in order to calculate a global disability score. The questionnaire was developed in 2010 by the World Health Organization (WHO) Classification, Terminology and Standards team, within the framework of the WHO/National Institutes of Health (NIH) Joint Project on Assessment and Classification of Disability.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"81DF52B1-9D3A-4DD9-E053-F662850A2BAE","latestVersionIndicator":"Yes","beginDate":"2019-02-14","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-02-14","modifiedBy":"ONEDATA","dateModified":"2019-02-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5C33-0412-E063-731AD00A56D4","beginDate":"2019-02-14","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"MDS-UPDRS","valueDescription":"Movement Disorder Society Unified Parkinson's Disease Rating Scale Questionnaire","ValueMeaning":{"publicId":"6643462","version":"1","preferredName":"Movement Disorder Society Unified Parkinson's Disease Rating Scale Questionnaire","longName":"6643462","preferredDefinition":"A standardized rating scale developed and copyrighted by the Movement Disorders Society in 2008 and published in the journal Movement Disorders (C.G. Goetz et al. Movement Disorder Society-Sponsored Revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): Scale Presentation and Clinimetric Testing Results. Movement Disorders, 23(15):2129-2170.) which is used to evaluate the severity of an individual's Parkinson's disease symptoms. This instrument contains four parts consisting of non-motor and motor experiences in daily living, a motor examination and an assessment of motor complications which is completed during an interview and physical examination. Each symptom is rated on a scale of 0-4 with 0 being normal and 4 being severe.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Movement Disorder Society Unified Parkinson's Disease Rating Scale Questionnaire","conceptCode":"C100769","definition":"A standardized rating scale developed and copyrighted by the Movement Disorders Society in 2008 and published in the journal Movement Disorders (C.G. Goetz et al. Movement Disorder Society-Sponsored Revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): Scale Presentation and Clinimetric Testing Results. Movement Disorders, 23(15):2129-2170.) which is used to evaluate the severity of an individual's Parkinson's disease symptoms. This instrument contains four parts consisting of non-motor and motor experiences in daily living, a motor examination and an assessment of motor complications which is completed during an interview and physical examination. Each symptom is rated on a scale of 0-4 with 0 being normal and 4 being severe.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"81DFACE8-A00C-5C5C-E053-F662850AD99A","latestVersionIndicator":"Yes","beginDate":"2019-02-14","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-02-14","modifiedBy":"ONEDATA","dateModified":"2019-02-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5C34-0412-E063-731AD00A56D4","beginDate":"2019-02-14","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"MHIS-NACC","valueDescription":"Modified Hachinski Ischemic Scale-NACC Version Questionnaire","ValueMeaning":{"publicId":"6643590","version":"1","preferredName":"Modified Hachinski Ischemic Scale-NACC Version Questionnaire","longName":"6643590","preferredDefinition":"A standardized rating scale originally developed by Hachinski et al in 1975 and later modified by Rosen et al in 1980 to clinically differentiate two most common types of dementia: senile dementia of the Alzheimer type (SDAT), a primary degenerative disease, and primary degenerative disease (MID), a vascular disorder. The modified version of the questionnaire contains 8 features for more accurate diagnosis of MID, the vascular dementia type. This questionnaire can be scored between 0 and 18, where a score greater than 7 suggests vascular involvement.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Modified Hachinski Ischemic Scale-NACC Version Questionnaire","conceptCode":"C112523","definition":"A standardized rating scale originally developed by Hachinski et al in 1975 and later modified by Rosen et al in 1980 to clinically differentiate two most common types of dementia: senile dementia of the Alzheimer type (SDAT), a primary degenerative disease, and primary degenerative disease (MID), a vascular disorder. The modified version of the questionnaire contains 8 features for more accurate diagnosis of MID, the vascular dementia type. This questionnaire can be scored between 0 and 18, where a score greater than 7 suggests vascular involvement.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"81E08FC2-65F8-6DE6-E053-F662850A1E6E","latestVersionIndicator":"Yes","beginDate":"2019-02-14","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-02-14","modifiedBy":"ONEDATA","dateModified":"2019-02-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5C35-0412-E063-731AD00A56D4","beginDate":"2019-02-14","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"MSIS-29 V1","valueDescription":"Multiple Sclerosis Impact Scale Version 1 Questionnaire","ValueMeaning":{"publicId":"6643566","version":"1","preferredName":"Multiple Sclerosis Impact Scale Version 1 Questionnaire","longName":"6643566","preferredDefinition":"A standardized rating scale developed by Hobart et al in 2001, which is used to assess the physical and psychological impact of multiple sclerosis (MS) on an individual's quality of life. The version 1 questionnaire contains 29 questions on a scale from 1 (not at all) to 5 (extremely).","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Multiple Sclerosis Impact Scale Version 1 Questionnaire","conceptCode":"C123664","definition":"A standardized rating scale developed by Hobart et al in 2001, which is used to assess the physical and psychological impact of multiple sclerosis (MS) on an individual's quality of life. The version 1 questionnaire contains 29 questions on a scale from 1 (not at all) to 5 (extremely).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"81E08FC2-6430-6DE6-E053-F662850A1E6E","latestVersionIndicator":"Yes","beginDate":"2019-02-14","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-02-14","modifiedBy":"ONEDATA","dateModified":"2019-02-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5C36-0412-E063-731AD00A56D4","beginDate":"2019-02-14","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"MSIS-29 V2","valueDescription":"Multiple Sclerosis Impact Scale Version 2 Questionnaire","ValueMeaning":{"publicId":"6643564","version":"1","preferredName":"Multiple Sclerosis Impact Scale Version 2 Questionnaire","longName":"6643564","preferredDefinition":"A standardized rating scale developed by Hobart et al in 2001, which is used to assess the physical and psychological impact of multiple sclerosis (MS) on an individual's quality of life. The version 2 questionnaire contains 29 questions on a scale from 1 (not at all) to 4 (extremely).","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Multiple Sclerosis Impact Scale Version 2 Questionnaire","conceptCode":"C123665","definition":"A standardized rating scale developed by Hobart et al in 2001, which is used to assess the physical and psychological impact of multiple sclerosis (MS) on an individual's quality of life. The version 2 questionnaire contains 29 questions on a scale from 1 (not at all) to 4 (extremely).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"81E08FC2-640A-6DE6-E053-F662850A1E6E","latestVersionIndicator":"Yes","beginDate":"2019-02-14","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-02-14","modifiedBy":"ONEDATA","dateModified":"2019-02-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5C37-0412-E063-731AD00A56D4","beginDate":"2019-02-14","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"MSQOL-54","valueDescription":"Multiple Sclerosis Quality of Life-54 Instrument Questionnaire","ValueMeaning":{"publicId":"6643580","version":"1","preferredName":"Multiple Sclerosis Quality of Life-54 Instrument Questionnaire","longName":"6643580","preferredDefinition":"A standardized rating scale developed by Vickrey et al in 1995 and 1997, which combines items that are generic and disease-specific to assess quality of life and the level of physical, emotional, and cognitive functions in patients with multiple sclerosis. The questionnaire contains 54 questions and generates 12 subscales: physical function, role limitations due to physical problems, role limitations due to emotional problems, pain, emotional well-being, energy, health perceptions, social function, cognitive function, health distress, sexual function and overall quality of life.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Multiple Sclerosis Quality of Life-54 Instrument Questionnaire","conceptCode":"C113878","definition":"A standardized rating scale developed by Vickrey et al in 1995 and 1997, which combines items that are generic and disease-specific to assess quality of life and the level of physical, emotional, and cognitive functions in patients with multiple sclerosis. The questionnaire contains 54 questions and generates 12 subscales: physical function, role limitations due to physical problems, role limitations due to emotional problems, pain, emotional well-being, energy, health perceptions, social function, cognitive function, health distress, sexual function and overall quality of life.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"81E08FC2-653A-6DE6-E053-F662850A1E6E","latestVersionIndicator":"Yes","beginDate":"2019-02-14","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-02-14","modifiedBy":"ONEDATA","dateModified":"2019-02-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5C38-0412-E063-731AD00A56D4","beginDate":"2019-02-14","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"MSWS-12","valueDescription":"12-Item Multiple Sclerosis Walking Scale Questionnaire","ValueMeaning":{"publicId":"6643568","version":"1","preferredName":"12-Item Multiple Sclerosis Walking Scale Questionnaire","longName":"6643568","preferredDefinition":"A standardized rating scale developed by Hobart et al in 2003, which is used to measure the impact of multiple sclerosis (MS) on an individual's walking ability. The questionnaire contains 12 items on a scale from 1 (not at all) to 5 (extremely).","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"12-Item Multiple Sclerosis Walking Scale Questionnaire","conceptCode":"C123663","definition":"A standardized rating scale developed by Hobart et al in 2003, which is used to measure the impact of multiple sclerosis (MS) on an individual's walking ability. The questionnaire contains 12 items on a scale from 1 (not at all) to 5 (extremely).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"81E08FC2-6456-6DE6-E053-F662850A1E6E","latestVersionIndicator":"Yes","beginDate":"2019-02-14","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-02-14","modifiedBy":"ONEDATA","dateModified":"2019-02-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5C39-0412-E063-731AD00A56D4","beginDate":"2019-02-14","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"NCCN-FACT FBLSI-18 V2","valueDescription":"National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Bladder Symptom Index-18 Version 2 Questionnaire","ValueMeaning":{"publicId":"6643554","version":"1","preferredName":"National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Bladder Symptom Index-18 Version 2 Questionnaire","longName":"6643554","preferredDefinition":"A standardized 18-item rating scale that assesses the symptoms of bladder cancer that are perceived as most important by patients and clinicians. Originally developed by Cella et al. in 2004, it is a modified version of the Functional Assessment of Cancer Therapy for patients with Bladder cancer (FACT-Bl), incorporating two additional items: 'I feel weak all over,' and 'I feel light-headed (dizzy)'.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Bladder Symptom Index-18 Version 2 Questionnaire","conceptCode":"C129107","definition":"A standardized 18-item rating scale that assesses the symptoms of bladder cancer that are perceived as most important by patients and clinicians. Originally developed by Cella et al. in 2004, it is a modified version of the Functional Assessment of Cancer Therapy for patients with Bladder cancer (FACT-Bl), incorporating two additional items: 'I feel weak all over,' and 'I feel light-headed (dizzy)'.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"81E08FC2-634C-6DE6-E053-F662850A1E6E","latestVersionIndicator":"Yes","beginDate":"2019-02-14","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-02-14","modifiedBy":"ONEDATA","dateModified":"2019-02-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5C3A-0412-E063-731AD00A56D4","beginDate":"2019-02-14","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"UPS","valueDescription":"Urgency Perception Scale Questionnaire","ValueMeaning":{"publicId":"6643443","version":"1","preferredName":"Urgency Perception Scale Questionnaire","longName":"6643443","preferredDefinition":"A standardized rating scale developed and published by Linda Cardozo, Karin Coyne and Eboo Versi in 2004 and copyrighted by Pfizer which is used to assess an individual's sense of urinary urgency. This instrument consists of one item in which the individual rates their experience when they have the desire to urinate. The item has three responses that receive a score of 0, 1, or 2.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Urgency Perception Scale Questionnaire","conceptCode":"C103530","definition":"A standardized rating scale developed and published by Linda Cardozo, Karin Coyne and Eboo Versi in 2004 and copyrighted by Pfizer which is used to assess an individual's sense of urinary urgency. This instrument consists of one item in which the individual rates their experience when they have the desire to urinate. The item has three responses that receive a score of 0, 1, or 2.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"81DF52B1-9E90-4DD9-E053-F662850A2BAE","latestVersionIndicator":"Yes","beginDate":"2019-02-14","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-02-14","modifiedBy":"ONEDATA","dateModified":"2019-02-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5C3B-0412-E063-731AD00A56D4","beginDate":"2019-02-14","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"TSQM V1.4","valueDescription":"Treatment Satisfaction Questionnaire for Medication Version 1.4","ValueMeaning":{"publicId":"6643447","version":"1","preferredName":"Treatment Satisfaction Questionnaire for Medication Version 1.4","longName":"6643447","preferredDefinition":"A standardized 14-item self-report scale developed by Atkinson et al in 2004 to assess the major dimensions of patients' satisfaction with medication. The instrument, which permits comparisons across medication types and patient conditions, provides scores on four scales: side effects, effectiveness, convenience, and global satisfaction.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Treatment Satisfaction Questionnaire for Medication Version 1.4","conceptCode":"C132535","definition":"A standardized 14-item self-report scale developed by Atkinson et al in 2004 to assess the major dimensions of patients' satisfaction with medication. The instrument, which permits comparisons across medication types and patient conditions, provides scores on four scales: side effects, effectiveness, convenience, and global satisfaction.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"81DF52B1-9EDC-4DD9-E053-F662850A2BAE","latestVersionIndicator":"Yes","beginDate":"2019-02-14","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-02-14","modifiedBy":"ONEDATA","dateModified":"2019-02-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5C3C-0412-E063-731AD00A56D4","beginDate":"2019-02-14","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"TSCYC","valueDescription":"Trauma Symptom Checklist for Young Children Questionnaire","ValueMeaning":{"publicId":"6643449","version":"1","preferredName":"Trauma Symptom Checklist for Young Children Questionnaire","longName":"6643449","preferredDefinition":"A standardized 90-item caretaker-report questionnaire developed by Briere et al. in 1999, that utilizes a four-point Likert rating scale to evaluate severity of posttraumatic stress and related symptoms in children ages 3-12 years who have experienced traumatic events.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Trauma Symptom Checklist for Young Children Questionnaire","conceptCode":"C147588","definition":"A standardized 90-item caretaker-report questionnaire developed by Briere et al. in 1999, that utilizes a four-point Likert rating scale to evaluate severity of posttraumatic stress and related symptoms in children ages 3-12 years who have experienced traumatic events.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"81DF52B1-9F02-4DD9-E053-F662850A2BAE","latestVersionIndicator":"Yes","beginDate":"2019-02-14","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-02-14","modifiedBy":"ONEDATA","dateModified":"2019-02-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5C3D-0412-E063-731AD00A56D4","beginDate":"2019-02-14","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"TSCC","valueDescription":"Trauma Symptom Checklist for Children Questionnaire","ValueMeaning":{"publicId":"6643451","version":"1","preferredName":"Trauma Symptom Checklist for Children Questionnaire","longName":"6643451","preferredDefinition":"A standardized 54-item self-report questionnaire developed by Briere et al. in 1996, that utilizes a four-point Likert rating scale to evaluate severity of posttraumatic stress and related symptoms in children ages 10-17 years who have experienced traumatic events.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Trauma Symptom Checklist for Children Questionnaire","conceptCode":"C147587","definition":"A standardized 54-item self-report questionnaire developed by Briere et al. in 1996, that utilizes a four-point Likert rating scale to evaluate severity of posttraumatic stress and related symptoms in children ages 10-17 years who have experienced traumatic events.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"81DF52B1-9F28-4DD9-E053-F662850A2BAE","latestVersionIndicator":"Yes","beginDate":"2019-02-14","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-02-14","modifiedBy":"ONEDATA","dateModified":"2019-02-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5C3E-0412-E063-731AD00A56D4","beginDate":"2019-02-14","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"SWLS","valueDescription":"Satisfaction With Life Scale Questionnaire","ValueMeaning":{"publicId":"6643455","version":"1","preferredName":"Satisfaction With Life Scale Questionnaire","longName":"6643455","preferredDefinition":"A standardized rating scale developed by Diener et al in 1985, which is used to measure global cognitive judgments of satisfaction with one's life. The questionnaire contains 5 questions and is scored ranging from 1 (Strongly disagree) to 7 (Strongly agree).","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Satisfaction With Life Scale Questionnaire","conceptCode":"C115799","definition":"A standardized rating scale developed by Diener et al in 1985, which is used to measure global cognitive judgments of satisfaction with one's life. The questionnaire contains 5 questions and is scored ranging from 1 (Strongly disagree) to 7 (Strongly agree).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"81DF52B1-9F74-4DD9-E053-F662850A2BAE","latestVersionIndicator":"Yes","beginDate":"2019-02-14","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-02-14","modifiedBy":"ONEDATA","dateModified":"2019-02-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5C3F-0412-E063-731AD00A56D4","beginDate":"2019-02-14","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"SOWS SUBJECTIVE","valueDescription":"Subjective Opiate Withdrawal Scale Questionnaire","ValueMeaning":{"publicId":"6643457","version":"1","preferredName":"Subjective Opiate Withdrawal Scale Questionnaire","longName":"6643457","preferredDefinition":"A standardized rating scale developed by Leonard Handelsman and colleagues in 1987 to evaluate the severity of an individual's opiate withdrawal signs and symptoms. This instrument contains 16 items or symptoms that pertain to opiate withdrawal, which are completed by the individual. Each item is rated on a scale of 0 to 4 with 0 being not at all and 4 being extremely.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Subjective Opiate Withdrawal Scale Questionnaire","conceptCode":"C102123","definition":"A standardized rating scale developed by Leonard Handelsman and colleagues in 1987 to evaluate the severity of an individual's opiate withdrawal signs and symptoms. This instrument contains 16 items or symptoms that pertain to opiate withdrawal, which are completed by the individual. Each item is rated on a scale of 0 to 4 with 0 being not at all and 4 being extremely.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"81DF52B1-9F9A-4DD9-E053-F662850A2BAE","latestVersionIndicator":"Yes","beginDate":"2019-02-14","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-02-14","modifiedBy":"ONEDATA","dateModified":"2019-02-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5C40-0412-E063-731AD00A56D4","beginDate":"2019-02-14","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"PHQ SCREENER VERSION","valueDescription":"Patient Health Questionnaire Screener Version","ValueMeaning":{"publicId":"6643562","version":"1","preferredName":"Patient Health Questionnaire Screener Version","longName":"6643562","preferredDefinition":"A standardized rating scale developed by Spitzer et al in 1999, which is used to screen and diagnose mental health disorders of depression, anxiety, alcohol, eating, and somatoform. The screener version of this instrument contains 59 items.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Patient Health Questionnaire Screener Version","conceptCode":"C125761","definition":"A standardized rating scale developed by Spitzer et al in 1999, which is used to screen and diagnose mental health disorders of depression, anxiety, alcohol, eating, and somatoform. The screener version of this instrument contains 59 items.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"81E08FC2-63E4-6DE6-E053-F662850A1E6E","latestVersionIndicator":"Yes","beginDate":"2019-02-14","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-02-14","modifiedBy":"ONEDATA","dateModified":"2019-02-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5C41-0412-E063-731AD00A56D4","beginDate":"2019-02-14","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"PEDSQL NEUROMUSCULAR MODULE ACUTE V3 CHILD","valueDescription":"Pediatric Quality of Life Neuromuscular Module Acute Version 3.0 Child Report Questionnaire","ValueMeaning":{"publicId":"6643534","version":"1","preferredName":"Pediatric Quality of Life Neuromuscular Module Acute Version 3.0 Child Report Questionnaire","longName":"6643534","preferredDefinition":"A 25-item disease specific complement to the Pediatric Quality of Life Inventory instrument published by Sarah Davis et al. in 2010 that utilizes a 5-point Likert scale to measure three dimensions of patient reported health related quality of life over the past seven days in children ages 8 to 12 years with neuromuscular disorders.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pediatric Quality of Life Neuromuscular Module Acute Version 3.0 Child Report Questionnaire","conceptCode":"C138339","definition":"A 25-item disease specific complement to the Pediatric Quality of Life Inventory instrument published by Sarah Davis et al. in 2010 that utilizes a 5-point Likert scale to measure three dimensions of patient reported health related quality of life over the past seven days in children ages 8 to 12 years with neuromuscular disorders.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"81E08FC2-61B0-6DE6-E053-F662850A1E6E","latestVersionIndicator":"Yes","beginDate":"2019-02-14","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-02-14","modifiedBy":"ONEDATA","dateModified":"2019-02-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5C42-0412-E063-731AD00A56D4","beginDate":"2019-02-14","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"PEDSQL NEUROMUSCULAR MODULE ACUTE V3 CHILD PARENT REPORT","valueDescription":"Pediatric Quality of Life Neuromuscular Module Acute Version 3.0 Parent Report for Child Questionnaire","ValueMeaning":{"publicId":"6643532","version":"1","preferredName":"Pediatric Quality of Life Neuromuscular Module Acute Version 3.0 Parent Report for Child Questionnaire","longName":"6643532","preferredDefinition":"A 25-item disease-specific complement to the Pediatric Quality of Life Inventory instrument published by Sarah Davis et al. in 2010 that utilizes a 5-point Likert scale to measure three dimensions of parent reported health related quality of life over the past seven days in children ages 8 to 12 years with neuromuscular disorders.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pediatric Quality of Life Neuromuscular Module Acute Version 3.0 Parent Report for Child Questionnaire","conceptCode":"C138341","definition":"A 25-item disease-specific complement to the Pediatric Quality of Life Inventory instrument published by Sarah Davis et al. in 2010 that utilizes a 5-point Likert scale to measure three dimensions of parent reported health related quality of life over the past seven days in children ages 8 to 12 years with neuromuscular disorders.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"81E08FC2-618A-6DE6-E053-F662850A1E6E","latestVersionIndicator":"Yes","beginDate":"2019-02-14","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-02-14","modifiedBy":"ONEDATA","dateModified":"2019-02-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5C43-0412-E063-731AD00A56D4","beginDate":"2019-02-14","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"PEDSQL NEUROMUSCULAR MODULE ACUTE V3 TEEN PARENT REPORT","valueDescription":"Pediatric Quality of Life Neuromuscular Module Acute Version 3.0 Parent Report for Teen Questionnaire","ValueMeaning":{"publicId":"6643530","version":"1","preferredName":"Pediatric Quality of Life Neuromuscular Module Acute Version 3.0 Parent Report for Teen Questionnaire","longName":"6643530","preferredDefinition":"A 25-item disease-specific complement to the Pediatric Quality of Life Inventory instrument published by Sarah Davis et al. in 2010 that utilizes a 5-point Likert scale to measure three dimensions of parent reported health related quality of life over the past seven days in children ages 13 to 18 years with neuromuscular disorders.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pediatric Quality of Life Neuromuscular Module Acute Version 3.0 Parent Report for Teen Questionnaire","conceptCode":"C138342","definition":"A 25-item disease-specific complement to the Pediatric Quality of Life Inventory instrument published by Sarah Davis et al. in 2010 that utilizes a 5-point Likert scale to measure three dimensions of parent reported health related quality of life over the past seven days in children ages 13 to 18 years with neuromuscular disorders.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"81E08FC2-6164-6DE6-E053-F662850A1E6E","latestVersionIndicator":"Yes","beginDate":"2019-02-14","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-02-14","modifiedBy":"ONEDATA","dateModified":"2019-02-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5C44-0412-E063-731AD00A56D4","beginDate":"2019-02-14","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"PEDSQL NEUROMUSCULAR MODULE ACUTE V3 YOUNG ADULT PARENT REPORT","valueDescription":"Pediatric Quality of Life Neuromuscular Module Acute Version 3.0 Parent Report for Young Adults Questionnaire","ValueMeaning":{"publicId":"6643528","version":"1","preferredName":"Pediatric Quality of Life Neuromuscular Module Acute Version 3.0 Parent Report for Young Adults Questionnaire","longName":"6643528","preferredDefinition":"A 25-item disease-specific complement to the Pediatric Quality of Life Inventory instrument published by Sarah Davis et al. in 2010 that utilizes a 5-point Likert scale to measure three dimensions of parent reported health related quality of life over the past seven days in individuals ages 18 to 25 years with neuromuscular disorders.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pediatric Quality of Life Neuromuscular Module Acute Version 3.0 Parent Report for Young Adults Questionnaire","conceptCode":"C138343","definition":"A 25-item disease-specific complement to the Pediatric Quality of Life Inventory instrument published by Sarah Davis et al. in 2010 that utilizes a 5-point Likert scale to measure three dimensions of parent reported health related quality of life over the past seven days in individuals ages 18 to 25 years with neuromuscular disorders.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"81E08FC2-613E-6DE6-E053-F662850A1E6E","latestVersionIndicator":"Yes","beginDate":"2019-02-14","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-02-14","modifiedBy":"ONEDATA","dateModified":"2019-02-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5C45-0412-E063-731AD00A56D4","beginDate":"2019-02-14","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"PEDSQL NEUROMUSCULAR MODULE ACUTE V3 YOUNG CHILD PARENT REPORT","valueDescription":"Pediatric Quality of Life Neuromuscular Module Acute Version 3.0 Parent Report for Young Child Questionnaire","ValueMeaning":{"publicId":"6643526","version":"1","preferredName":"Pediatric Quality of Life Neuromuscular Module Acute Version 3.0 Parent Report for Young Child Questionnaire","longName":"6643526","preferredDefinition":"A 25-item disease specific complement to the Pediatric Quality of Life Inventory instrument published by Sarah Davis et al. in 2010 that utilizes a 5-point Likert scale to measure three dimensions of parent reported health related quality of life over the past seven days in children ages 5 to 7 years with neuromuscular disorders.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pediatric Quality of Life Neuromuscular Module Acute Version 3.0 Parent Report for Young Child Questionnaire","conceptCode":"C138344","definition":"A 25-item disease specific complement to the Pediatric Quality of Life Inventory instrument published by Sarah Davis et al. in 2010 that utilizes a 5-point Likert scale to measure three dimensions of parent reported health related quality of life over the past seven days in children ages 5 to 7 years with neuromuscular disorders.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"81E08FC2-6118-6DE6-E053-F662850A1E6E","latestVersionIndicator":"Yes","beginDate":"2019-02-14","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-02-14","modifiedBy":"ONEDATA","dateModified":"2019-02-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5C46-0412-E063-731AD00A56D4","beginDate":"2019-02-14","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"PEDSQL NEUROMUSCULAR MODULE ACUTE V3 TEEN","valueDescription":"Pediatric Quality of Life Neuromuscular Module Acute Version 3.0 Teen Report Questionnaire","ValueMeaning":{"publicId":"6643524","version":"1","preferredName":"Pediatric Quality of Life Neuromuscular Module Acute Version 3.0 Teen Report Questionnaire","longName":"6643524","preferredDefinition":"A 25-item disease-specific complement to the Pediatric Quality of Life Inventory instrument published by Sarah Davis et al. in 2010 that utilizes a 5-point Likert scale to measure three dimensions of patient reported health related quality of life over the past seven days in children ages 13 to 18 years with neuromuscular disorders.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pediatric Quality of Life Neuromuscular Module Acute Version 3.0 Teen Report Questionnaire","conceptCode":"C138345","definition":"A 25-item disease-specific complement to the Pediatric Quality of Life Inventory instrument published by Sarah Davis et al. in 2010 that utilizes a 5-point Likert scale to measure three dimensions of patient reported health related quality of life over the past seven days in children ages 13 to 18 years with neuromuscular disorders.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"81E08FC2-60F2-6DE6-E053-F662850A1E6E","latestVersionIndicator":"Yes","beginDate":"2019-02-14","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-02-14","modifiedBy":"ONEDATA","dateModified":"2019-02-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5C47-0412-E063-731AD00A56D4","beginDate":"2019-02-14","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"PEDSQL NEUROMUSCULAR MODULE ACUTE V3 YOUNG ADULT","valueDescription":"Pediatric Quality of Life Neuromuscular Module Acute Version 3.0 Young Adult Report Questionnaire","ValueMeaning":{"publicId":"6643522","version":"1","preferredName":"Pediatric Quality of Life Neuromuscular Module Acute Version 3.0 Young Adult Report Questionnaire","longName":"6643522","preferredDefinition":"A 25-item disease specific complement to the Pediatric Quality of Life Inventory instrument published by Sarah Davis et al. in 2010 that utilizes a 5-point Likert scale to measure three dimensions of patient reported health related quality of life over the past seven days in individuals ages 18 to 25 years with neuromuscular disorders.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pediatric Quality of Life Neuromuscular Module Acute Version 3.0 Young Adult Report Questionnaire","conceptCode":"C138346","definition":"A 25-item disease specific complement to the Pediatric Quality of Life Inventory instrument published by Sarah Davis et al. in 2010 that utilizes a 5-point Likert scale to measure three dimensions of patient reported health related quality of life over the past seven days in individuals ages 18 to 25 years with neuromuscular disorders.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"81E08FC2-60CC-6DE6-E053-F662850A1E6E","latestVersionIndicator":"Yes","beginDate":"2019-02-14","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-02-14","modifiedBy":"ONEDATA","dateModified":"2019-02-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5C48-0412-E063-731AD00A56D4","beginDate":"2019-02-14","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"PEDSQL NEUROMUSCULAR MODULE ACUTE V3 YOUNG CHILD","valueDescription":"Pediatric Quality of Life Neuromuscular Module Acute Version 3.0 Young Child Report Questionnaire","ValueMeaning":{"publicId":"6643520","version":"1","preferredName":"Pediatric Quality of Life Neuromuscular Module Acute Version 3.0 Young Child Report Questionnaire","longName":"6643520","preferredDefinition":"A 17-item disease specific complement to the Pediatric Quality of Life Inventory instrument published by Sarah Davis et al. in 2010 that utilizes a 5-point Likert scale to measure one dimension of patient reported health related quality of life over the past seven days in children ages 5 to 7 years with neuromuscular disorders.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pediatric Quality of Life Neuromuscular Module Acute Version 3.0 Young Child Report Questionnaire","conceptCode":"C138347","definition":"A 17-item disease specific complement to the Pediatric Quality of Life Inventory instrument published by Sarah Davis et al. in 2010 that utilizes a 5-point Likert scale to measure one dimension of patient reported health related quality of life over the past seven days in children ages 5 to 7 years with neuromuscular disorders.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"81E08FC2-60A6-6DE6-E053-F662850A1E6E","latestVersionIndicator":"Yes","beginDate":"2019-02-14","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-02-14","modifiedBy":"ONEDATA","dateModified":"2019-02-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5C49-0412-E063-731AD00A56D4","beginDate":"2019-02-14","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"PEDSQL NEUROMUSCULAR MODULE V3 CHILD","valueDescription":"Pediatric Quality of Life Neuromuscular Module Version 3.0 Child Report Questionnaire","ValueMeaning":{"publicId":"6643518","version":"1","preferredName":"Pediatric Quality of Life Neuromuscular Module Version 3.0 Child Report Questionnaire","longName":"6643518","preferredDefinition":"A 25-item disease specific complement to the Pediatric Quality of Life Inventory instrument published by Sarah Davis et al. in 2010 that utilizes a 5-point Likert scale to measure three dimensions of patient reported health related quality of life over the past month in children ages 8 to 12 years with neuromuscular disorders.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pediatric Quality of Life Neuromuscular Module Version 3.0 Child Report Questionnaire","conceptCode":"C138348","definition":"A 25-item disease specific complement to the Pediatric Quality of Life Inventory instrument published by Sarah Davis et al. in 2010 that utilizes a 5-point Likert scale to measure three dimensions of patient reported health related quality of life over the past month in children ages 8 to 12 years with neuromuscular disorders.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"81E08FC2-6080-6DE6-E053-F662850A1E6E","latestVersionIndicator":"Yes","beginDate":"2019-02-14","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-02-14","modifiedBy":"ONEDATA","dateModified":"2019-02-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5C4A-0412-E063-731AD00A56D4","beginDate":"2019-02-14","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"PEDSQL NEUROMUSCULAR MODULE V3 TODDLER PARENT REPORT","valueDescription":"Pediatric Quality of Life Neuromuscular Module Version 3.0 Parent of Toddler Questionnaire","ValueMeaning":{"publicId":"6643516","version":"1","preferredName":"Pediatric Quality of Life Neuromuscular Module Version 3.0 Parent of Toddler Questionnaire","longName":"6643516","preferredDefinition":"A 25-item disease specific complement to the Pediatric Quality of Life Inventory instrument published by Sarah Davis et al. in 2010 that utilizes a 5-point Likert scale to measure three dimensions of parent reported health related quality of life over the past month in children ages 2 to 4 years with neuromuscular disorders.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pediatric Quality of Life Neuromuscular Module Version 3.0 Parent of Toddler Questionnaire","conceptCode":"C138349","definition":"A 25-item disease specific complement to the Pediatric Quality of Life Inventory instrument published by Sarah Davis et al. in 2010 that utilizes a 5-point Likert scale to measure three dimensions of parent reported health related quality of life over the past month in children ages 2 to 4 years with neuromuscular disorders.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"81E08FC2-605A-6DE6-E053-F662850A1E6E","latestVersionIndicator":"Yes","beginDate":"2019-02-14","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-02-14","modifiedBy":"ONEDATA","dateModified":"2019-02-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5C4B-0412-E063-731AD00A56D4","beginDate":"2019-02-14","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"PEDSQL NEUROMUSCULAR MODULE V3 CHILD PARENT REPORT","valueDescription":"Pediatric Quality of Life Neuromuscular Module Version 3.0 Parent Report for Child Questionnaire","ValueMeaning":{"publicId":"6643514","version":"1","preferredName":"Pediatric Quality of Life Neuromuscular Module Version 3.0 Parent Report for Child Questionnaire","longName":"6643514","preferredDefinition":"A 25-item disease specific complement to the Pediatric Quality of Life Inventory instrument published by Sarah Davis et al. in 2010 that utilizes a 5-point Likert scale to measure three dimensions of parent reported health related quality of life over the past month in children ages 8 to 12 years with neuromuscular disorders.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pediatric Quality of Life Neuromuscular Module Version 3.0 Parent Report for Child Questionnaire","conceptCode":"C138350","definition":"A 25-item disease specific complement to the Pediatric Quality of Life Inventory instrument published by Sarah Davis et al. in 2010 that utilizes a 5-point Likert scale to measure three dimensions of parent reported health related quality of life over the past month in children ages 8 to 12 years with neuromuscular disorders.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"81E08FC2-6034-6DE6-E053-F662850A1E6E","latestVersionIndicator":"Yes","beginDate":"2019-02-14","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-02-14","modifiedBy":"ONEDATA","dateModified":"2019-02-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5C4C-0412-E063-731AD00A56D4","beginDate":"2019-02-14","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"PEDSQL NEUROMUSCULAR MODULE V3 TEEN PARENT REPORT","valueDescription":"Pediatric Quality of Life Neuromuscular Module Version 3.0 Parent Report for Teen Questionnaire","ValueMeaning":{"publicId":"6643512","version":"1","preferredName":"Pediatric Quality of Life Neuromuscular Module Version 3.0 Parent Report for Teen Questionnaire","longName":"6643512","preferredDefinition":"A 25-item disease specific complement to the Pediatric Quality of Life Inventory instrument published by Sarah Davis et al. in 2010 that utilizes a 5-point Likert scale to measure three dimensions of parent reported health related quality of life over the past month in children ages 13 to 18 years with neuromuscular disorders.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pediatric Quality of Life Neuromuscular Module Version 3.0 Parent Report for Teen Questionnaire","conceptCode":"C138351","definition":"A 25-item disease specific complement to the Pediatric Quality of Life Inventory instrument published by Sarah Davis et al. in 2010 that utilizes a 5-point Likert scale to measure three dimensions of parent reported health related quality of life over the past month in children ages 13 to 18 years with neuromuscular disorders.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"81E08FC2-600E-6DE6-E053-F662850A1E6E","latestVersionIndicator":"Yes","beginDate":"2019-02-14","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-02-14","modifiedBy":"ONEDATA","dateModified":"2019-02-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5C4D-0412-E063-731AD00A56D4","beginDate":"2019-02-14","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"PEDSQL NEUROMUSCULAR MODULE V3 YOUNG ADULT PARENT REPORT","valueDescription":"Pediatric Quality of Life Neuromuscular Module Version 3.0 Parent Report for Young Adults Report Questionnaire","ValueMeaning":{"publicId":"6643510","version":"1","preferredName":"Pediatric Quality of Life Neuromuscular Module Version 3.0 Parent Report for Young Adults Report Questionnaire","longName":"6643510","preferredDefinition":"A 25-item disease specific complement to the Pediatric Quality of Life Inventory instrument published by Sarah Davis et al. in 2010 that utilizes a 5-point Likert scale to measure three dimensions of parent reported health related quality of life over the past month in individuals ages 18 to 25 years with neuromuscular disorders.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pediatric Quality of Life Neuromuscular Module Version 3.0 Parent Report for Young Adults Report Questionnaire","conceptCode":"C138352","definition":"A 25-item disease specific complement to the Pediatric Quality of Life Inventory instrument published by Sarah Davis et al. in 2010 that utilizes a 5-point Likert scale to measure three dimensions of parent reported health related quality of life over the past month in individuals ages 18 to 25 years with neuromuscular disorders.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"81E08FC2-5FE8-6DE6-E053-F662850A1E6E","latestVersionIndicator":"Yes","beginDate":"2019-02-14","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-02-14","modifiedBy":"ONEDATA","dateModified":"2019-02-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5C4E-0412-E063-731AD00A56D4","beginDate":"2019-02-14","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"PEDSQL NEUROMUSCULAR MODULE V3 YOUNG CHILD PARENT REPORT","valueDescription":"Pediatric Quality of Life Neuromuscular Module Version 3.0 Parent Report for Young Child Questionnaire","ValueMeaning":{"publicId":"6643508","version":"1","preferredName":"Pediatric Quality of Life Neuromuscular Module Version 3.0 Parent Report for Young Child Questionnaire","longName":"6643508","preferredDefinition":"A 25-item disease specific complement to the Pediatric Quality of Life Inventory instrument published by Sarah Davis et al. in 2010 that utilizes a 5-point Likert scale to measure three dimensions of parent reported health related quality of life over the past month in children ages 5 to 7 years with neuromuscular disorders.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pediatric Quality of Life Neuromuscular Module Version 3.0 Parent Report for Young Child Questionnaire","conceptCode":"C138353","definition":"A 25-item disease specific complement to the Pediatric Quality of Life Inventory instrument published by Sarah Davis et al. in 2010 that utilizes a 5-point Likert scale to measure three dimensions of parent reported health related quality of life over the past month in children ages 5 to 7 years with neuromuscular disorders.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"81E08FC2-5FC2-6DE6-E053-F662850A1E6E","latestVersionIndicator":"Yes","beginDate":"2019-02-14","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-02-14","modifiedBy":"ONEDATA","dateModified":"2019-02-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5C4F-0412-E063-731AD00A56D4","beginDate":"2019-02-14","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"PEDSQL NEUROMUSCULAR MODULE V3 TEEN","valueDescription":"Pediatric Quality of Life Neuromuscular Module Version 3.0 Teen Report Questionnaire","ValueMeaning":{"publicId":"6643506","version":"1","preferredName":"Pediatric Quality of Life Neuromuscular Module Version 3.0 Teen Report Questionnaire","longName":"6643506","preferredDefinition":"A 25-item disease specific complement to the Pediatric Quality of Life Inventory instrument published by Sarah Davis et al. in 2010 that utilizes a 5-point Likert scale to measure three dimensions of patient reported health related quality of life over the past month in children ages 13 to 18 years with neuromuscular disorders.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pediatric Quality of Life Neuromuscular Module Version 3.0 Teen Report Questionnaire","conceptCode":"C138354","definition":"A 25-item disease specific complement to the Pediatric Quality of Life Inventory instrument published by Sarah Davis et al. in 2010 that utilizes a 5-point Likert scale to measure three dimensions of patient reported health related quality of life over the past month in children ages 13 to 18 years with neuromuscular disorders.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"81E08FC2-5F9C-6DE6-E053-F662850A1E6E","latestVersionIndicator":"Yes","beginDate":"2019-02-14","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-02-14","modifiedBy":"ONEDATA","dateModified":"2019-02-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5C50-0412-E063-731AD00A56D4","beginDate":"2019-02-14","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"PEDSQL NEUROMUSCULAR MODULE V3 YOUNG ADULT","valueDescription":"Pediatric Quality of Life Neuromuscular Module Version 3.0 Young Adult Report Questionnaire","ValueMeaning":{"publicId":"6643504","version":"1","preferredName":"Pediatric Quality of Life Neuromuscular Module Version 3.0 Young Adult Report Questionnaire","longName":"6643504","preferredDefinition":"A 25-item disease specific complement to the Pediatric Quality of Life Inventory instrument published by Sarah Davis et al. in 2010 that utilizes a 5-point Likert scale to measure three dimensions of patient reported health related quality of life over the past month in patients ages 18 to 25 years with neuromuscular disorders.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pediatric Quality of Life Neuromuscular Module Version 3.0 Young Adult Report Questionnaire","conceptCode":"C138355","definition":"A 25-item disease specific complement to the Pediatric Quality of Life Inventory instrument published by Sarah Davis et al. in 2010 that utilizes a 5-point Likert scale to measure three dimensions of patient reported health related quality of life over the past month in patients ages 18 to 25 years with neuromuscular disorders.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"81E08FC2-5F76-6DE6-E053-F662850A1E6E","latestVersionIndicator":"Yes","beginDate":"2019-02-14","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-02-14","modifiedBy":"ONEDATA","dateModified":"2019-02-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5C51-0412-E063-731AD00A56D4","beginDate":"2019-02-14","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"PEDSQL NEUROMUSCULAR MODULE V3 YOUNG CHILD","valueDescription":"Pediatric Quality of Life Neuromuscular Module Version 3.0 Young Child Report Questionnaire","ValueMeaning":{"publicId":"6643502","version":"1","preferredName":"Pediatric Quality of Life Neuromuscular Module Version 3.0 Young Child Report Questionnaire","longName":"6643502","preferredDefinition":"A 17-item disease specific complement to the Pediatric Quality of Life Inventory instrument published by Sarah Davis et al. in 2010 that utilizes a 5-point Likert scale to measure one dimension of patient reported health related quality of life over the past month in children ages 5 to 7 years with neuromuscular disorders.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pediatric Quality of Life Neuromuscular Module Version 3.0 Young Child Report Questionnaire","conceptCode":"C138356","definition":"A 17-item disease specific complement to the Pediatric Quality of Life Inventory instrument published by Sarah Davis et al. in 2010 that utilizes a 5-point Likert scale to measure one dimension of patient reported health related quality of life over the past month in children ages 5 to 7 years with neuromuscular disorders.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"81E08FC2-5F50-6DE6-E053-F662850A1E6E","latestVersionIndicator":"Yes","beginDate":"2019-02-14","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-02-14","modifiedBy":"ONEDATA","dateModified":"2019-02-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5C52-0412-E063-731AD00A56D4","beginDate":"2019-02-14","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"PSQI","valueDescription":"Pittsburgh Sleep Quality Index","ValueMeaning":{"publicId":"6643603","version":"1","preferredName":"Pittsburgh Sleep Quality Index","longName":"6643603","preferredDefinition":"A self-rated questionnaire which assesses sleep quality and disturbances over a one month time interval.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pittsburgh Sleep Quality Index","conceptCode":"C103849","definition":"A self-rated questionnaire which assesses sleep quality and disturbances over a one month time interval.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"81E08FC2-66FF-6DE6-E053-F662850A1E6E","latestVersionIndicator":"Yes","beginDate":"2019-02-14","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-02-14","modifiedBy":"ONEDATA","dateModified":"2019-02-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5C53-0412-E063-731AD00A56D4","beginDate":"2019-02-14","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"PROSQOLI","valueDescription":"Prostate Cancer Specific Quality of Life Instrument Questionnaire","ValueMeaning":{"publicId":"6643558","version":"1","preferredName":"Prostate Cancer Specific Quality of Life Instrument Questionnaire","longName":"6643558","preferredDefinition":"A standardized rating scale developed by Stockler et al in 1999 which is used to assess health-related quality of life in patients with advanced hormone-resistant prostate cancer. The instrument contains 9 linear analogue self-assessment scales measuring symptoms, function, and overall well-being, and a six-point ordinal adjectival scale of present pain intensity from the McGill Pain Questionnaire.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Prostate Cancer Specific Quality of Life Instrument Questionnaire","conceptCode":"C127372","definition":"A standardized rating scale developed by Stockler et al in 1999 which is used to assess health-related quality of life in patients with advanced hormone-resistant prostate cancer. The instrument contains 9 linear analogue self-assessment scales measuring symptoms, function, and overall well-being, and a six-point ordinal adjectival scale of present pain intensity from the McGill Pain Questionnaire.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"81E08FC2-6398-6DE6-E053-F662850A1E6E","latestVersionIndicator":"Yes","beginDate":"2019-02-14","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-02-14","modifiedBy":"ONEDATA","dateModified":"2019-02-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5C54-0412-E063-731AD00A56D4","beginDate":"2019-02-14","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"RAND SOCIAL SUPPORT SURVEY INSTRUMENT","valueDescription":"RAND Social Support Survey Instrument Questionnaire","ValueMeaning":{"publicId":"6643536","version":"1","preferredName":"RAND Social Support Survey Instrument Questionnaire","longName":"6643536","preferredDefinition":"A standardized 19-item survey developed by Cathy Donalds Helbourne and Anita L. Stewart in 1991 for the assessment of recent thinking about the various dimensions of social support in patients with chronic conditions in the Medical Outcomes Study (MOS). The instrument measures five dimensions of social support: emotional support, informational support, tangible support, positive social interaction, and affectionate support.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"RAND Social Support Survey Instrument Questionnaire","conceptCode":"C135745","definition":"A standardized 19-item survey developed by Cathy Donalds Helbourne and Anita L. Stewart in 1991 for the assessment of recent thinking about the various dimensions of social support in patients with chronic conditions in the Medical Outcomes Study (MOS). The instrument measures five dimensions of social support: emotional support, informational support, tangible support, positive social interaction, and affectionate support.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"81E08FC2-61D6-6DE6-E053-F662850A1E6E","latestVersionIndicator":"Yes","beginDate":"2019-02-14","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-02-14","modifiedBy":"ONEDATA","dateModified":"2019-02-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5C55-0412-E063-731AD00A56D4","beginDate":"2019-02-14","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"RPQ","valueDescription":"Rivermead Post-Concussion Symptoms Questionnaire","ValueMeaning":{"publicId":"6643572","version":"1","preferredName":"Rivermead Post-Concussion Symptoms Questionnaire","longName":"6643572","preferredDefinition":"A standardized rating scale originally developed by King et al in 1995, which is used to measure the severity of symptoms following a mild or moderate traumatic brain injury (TBI). The questionnaire requires a subject to rate the severity of 16 different cognitive, somatic, and emotional symptoms after a TBI on a scale of 0 to 4: not experienced at all (0), no more of a problem (1), a mild problem (2), a moderate problem (3), or a severe problem (4).","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Rivermead Post-Concussion Symptoms Questionnaire","conceptCode":"C119103","definition":"A standardized rating scale originally developed by King et al in 1995, which is used to measure the severity of symptoms following a mild or moderate traumatic brain injury (TBI). The questionnaire requires a subject to rate the severity of 16 different cognitive, somatic, and emotional symptoms after a TBI on a scale of 0 to 4: not experienced at all (0), no more of a problem (1), a mild problem (2), a moderate problem (3), or a severe problem (4).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"81E08FC2-64A2-6DE6-E053-F662850A1E6E","latestVersionIndicator":"Yes","beginDate":"2019-02-14","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-02-14","modifiedBy":"ONEDATA","dateModified":"2019-02-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5C56-0412-E063-731AD00A56D4","beginDate":"2019-02-14","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"SF36 V1.0 ACUTE","valueDescription":"Short Form 36 Health Survey Acute, US Version 1.0 Questionnaire","ValueMeaning":{"publicId":"6643476","version":"1","preferredName":"Short Form 36 Health Survey Acute, US Version 1.0 Questionnaire","longName":"6643476","preferredDefinition":"A standardized, multipurpose, general health survey developed by John E. Ware and copyrighted by the Medical Outcomes Trust and Quality Metric Inc. in 1988 and 2002, which is used to assess the patient's functional health and overall well-being. This first version contains 36 questions that refer to the patient's symptoms or status within the past week and can be completed by the patient. For each question the patient must choose from five different responses.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Short Form 36 Health Survey Acute, US Version 1.0 Questionnaire","conceptCode":"C102120","definition":"A standardized, multipurpose, general health survey developed by John E. Ware and copyrighted by the Medical Outcomes Trust and Quality Metric Inc. in 1988 and 2002, which is used to assess the patient's functional health and overall well-being. This first version contains 36 questions that refer to the patient's symptoms or status within the past week and can be completed by the patient. For each question the patient must choose from five different responses.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"81DFACE8-A116-5C5C-E053-F662850AD99A","latestVersionIndicator":"Yes","beginDate":"2019-02-14","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-02-14","modifiedBy":"ONEDATA","dateModified":"2019-02-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5C57-0412-E063-731AD00A56D4","beginDate":"2019-02-14","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"SDS","valueDescription":"Sheehan Disability Scale Questionnaire","ValueMeaning":{"publicId":"6643592","version":"1","preferredName":"Sheehan Disability Scale Questionnaire","longName":"6643592","preferredDefinition":"A standardized questionnaire developed by David Sheehan in 1983, which is used to measure functional impairments caused by panic, anxiety, phobic, or depressive symptoms in three inter-related domains; work/school, social and family life. It is also used in many other chronic medical illnesses due to its generic design. The Sheehan Disability Scale generates 4 scores: a work disability score, a social life disability score, a family life disability score and a total score. This questionnaire contains 6 items, with which patients can rate the extent of their functional impairments on a 10-point visual analog scale.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Sheehan Disability Scale Questionnaire","conceptCode":"C111384","definition":"A standardized questionnaire developed by David Sheehan in 1983, which is used to measure functional impairments caused by panic, anxiety, phobic, or depressive symptoms in three inter-related domains; work/school, social and family life. It is also used in many other chronic medical illnesses due to its generic design. The Sheehan Disability Scale generates 4 scores: a work disability score, a social life disability score, a family life disability score and a total score. This questionnaire contains 6 items, with which patients can rate the extent of their functional impairments on a 10-point visual analog scale.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"81E08FC2-661E-6DE6-E053-F662850A1E6E","latestVersionIndicator":"Yes","beginDate":"2019-02-14","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-02-14","modifiedBy":"ONEDATA","dateModified":"2019-02-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5C58-0412-E063-731AD00A56D4","beginDate":"2019-02-14","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"SOWS SHORT","valueDescription":"Short Opiate Withdrawal Scale Questionnaire","ValueMeaning":{"publicId":"6643605","version":"1","preferredName":"Short Opiate Withdrawal Scale Questionnaire","longName":"6643605","preferredDefinition":"A standardized survey developed and published by Michael Gossop in the journal Addictive Behaviors which is used to assess the signs and symptoms associated with opiate withdrawal. This instrument is a shorter version of the Opiate Withdrawal Scale (OWS) containing 10 items related to symptoms such as stomach cramps, heart pounding and runny eyes. Each item is rated as none, mild, moderate or severe.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Short Opiate Withdrawal Scale Questionnaire","conceptCode":"C103529","definition":"A standardized survey developed and published by Michael Gossop in the journal Addictive Behaviors which is used to assess the signs and symptoms associated with opiate withdrawal. This instrument is a shorter version of the Opiate Withdrawal Scale (OWS) containing 10 items related to symptoms such as stomach cramps, heart pounding and runny eyes. Each item is rated as none, mild, moderate or severe.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"81E08FC2-6725-6DE6-E053-F662850A1E6E","latestVersionIndicator":"Yes","beginDate":"2019-02-14","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-02-14","modifiedBy":"ONEDATA","dateModified":"2019-02-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5C59-0412-E063-731AD00A56D4","beginDate":"2019-02-14","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"SOBDA","valueDescription":"Shortness of Breath with Daily Activities Questionnaire","ValueMeaning":{"publicId":"6643570","version":"1","preferredName":"Shortness of Breath with Daily Activities Questionnaire","longName":"6643570","preferredDefinition":"A standardized rating scale developed by Wilcox et al in 2013, which is used to evaluate the impact of treatment on shortness of breath (SOB) in patients with COPD and to assess how SOB affects daily activities. This questionnaire contains 13 items.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Shortness of Breath with Daily Activities Questionnaire","conceptCode":"C123659","definition":"A standardized rating scale developed by Wilcox et al in 2013, which is used to evaluate the impact of treatment on shortness of breath (SOB) in patients with COPD and to assess how SOB affects daily activities. This questionnaire contains 13 items.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"81E08FC2-647C-6DE6-E053-F662850A1E6E","latestVersionIndicator":"Yes","beginDate":"2019-02-14","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-02-14","modifiedBy":"ONEDATA","dateModified":"2019-02-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5C5A-0412-E063-731AD00A56D4","beginDate":"2019-02-14","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"SGRQ PAST 3 MONTHS VERSION","valueDescription":"St. George's Respiratory Questionnaire Past 3 Months Version","ValueMeaning":{"publicId":"6643586","version":"1","preferredName":"St. George's Respiratory Questionnaire Past 3 Months Version","longName":"6643586","preferredDefinition":"St. George's Respiratory Questionnaire (SGRQ) Past 3 Months Version (copyright P.W. Jones, St. George's University of London).","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"St. George's Respiratory Questionnaire Past 3 Months Version","conceptCode":"C112525","definition":"A standardized, disease-specific rating scale developed by Jones et al in 1992, which is used to determine the impact on overall health, daily life and perceived well-being in patients with obstructive airway disease. The questionnaire contains 51 items across 2 parts; Symptoms component (frequency and severity with a 3-month performance recall); Impact component (activities that are causes to, or limited by breathlessness).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"81E08FC2-65AC-6DE6-E053-F662850A1E6E","latestVersionIndicator":"Yes","beginDate":"2019-02-14","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-02-14","modifiedBy":"ONEDATA","dateModified":"2019-02-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5C5B-0412-E063-731AD00A56D4","beginDate":"2019-02-14","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"SGRQ PAST 4 WEEKS VERSION","valueDescription":"St. George's Respiratory Questionnaire Past 4 Weeks Version","ValueMeaning":{"publicId":"6643584","version":"1","preferredName":"St. George's Respiratory Questionnaire Past 4 Weeks Version","longName":"6643584","preferredDefinition":"A standardized, disease-specific rating scale developed by Jones et al in 1992, which is used to determine the impact on overall health, daily life and perceived well-being in patients with obstructive airway disease. The questionnaire contains 51 items across 2 parts; Symptoms component (frequency and severity with a 4-week performance recall); Impact component (activities that are causes to, or limited by breathlessness).","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"St. George's Respiratory Questionnaire Past 4 Weeks Version","conceptCode":"C112526","definition":"A standardized, disease-specific rating scale developed by Jones et al in 1992, which is used to determine the impact on overall health, daily life and perceived well-being in patients with obstructive airway disease. The questionnaire contains 51 items across 2 parts; Symptoms component (frequency and severity with a 4-week performance recall); Impact component (activities that are causes to, or limited by breathlessness).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"81E08FC2-6586-6DE6-E053-F662850A1E6E","latestVersionIndicator":"Yes","beginDate":"2019-02-14","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-02-14","modifiedBy":"ONEDATA","dateModified":"2019-02-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5C5C-0412-E063-731AD00A56D4","beginDate":"2019-02-14","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"PI","valueDescription":"STANDARDS Pain Intensity Questionnaire","ValueMeaning":{"publicId":"6643602","version":"1","preferredName":"STANDARDS Pain Intensity Questionnaire","longName":"6643602","preferredDefinition":"Version 1 (2012-08-07) of the pain intensity questionnaire created by the STANDARDS (Standardized Analgesic Database for Research, Discovery, and Submissions) committee and sponsored by ACTTION (Analgesic Clinical Trial Translations, Innovations, Opportunities, and Networks).","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"STANDARDS Pain Intensity Questionnaire","conceptCode":"C105167","definition":"Version 1 (2012-08-07) of the pain intensity questionnaire created by the STANDARDS (Standardized Analgesic Database for Research, Discovery, and Submissions) committee and sponsored by ACTTION (Analgesic Clinical Trial Translations, Innovations, Opportunities, and Networks).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"81E08FC2-66DC-6DE6-E053-F662850A1E6E","latestVersionIndicator":"Yes","beginDate":"2019-02-14","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-02-14","modifiedBy":"ONEDATA","dateModified":"2019-02-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5C5D-0412-E063-731AD00A56D4","beginDate":"2019-02-14","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"PR","valueDescription":"STANDARDS Pain Relief Questionnaire","ValueMeaning":{"publicId":"6643600","version":"1","preferredName":"STANDARDS Pain Relief Questionnaire","longName":"6643600","preferredDefinition":"Version 1 (2012-08-07) of the pain relief questionnaire created by the STANDARDS (Standardized Analgesic Database for Research, Discovery, and Submissions) committee and sponsored by ACTTION (Analgesic Clinical Trial Translations, Innovations, Opportunities, and Networks).","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"STANDARDS Pain Relief Questionnaire","conceptCode":"C105168","definition":"Version 1 (2012-08-07) of the pain relief questionnaire created by the STANDARDS (Standardized Analgesic Database for Research, Discovery, and Submissions) committee and sponsored by ACTTION (Analgesic Clinical Trial Translations, Innovations, Opportunities, and Networks).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"81E08FC2-66B6-6DE6-E053-F662850A1E6E","latestVersionIndicator":"Yes","beginDate":"2019-02-14","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-02-14","modifiedBy":"ONEDATA","dateModified":"2019-02-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5C5E-0412-E063-731AD00A56D4","beginDate":"2019-02-14","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"CRQ-SAS FIRST ADMINISTRATION VERSION","valueDescription":"Chronic Respiratory Questionnaire Self-Administered Standardized Format First Administration Version Questionnaire","ValueMeaning":{"publicId":"6643007","version":"1","preferredName":"Chronic Respiratory Questionnaire Self-Administered Standardized Format First Administration Version Questionnaire","longName":"6643007","preferredDefinition":"A standardized rating scale developed by Schunemann et al in 2003, which is a self-administered instrument used to measure the health-related quality of life (HRQL) in patients with chronic airflow limitation. The first administration version contains 20 items and four domains: dyspnea, fatigue, emotional functioning and mastery.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Chronic Respiratory Questionnaire Self-Administered Standardized Format First Administration Version Questionnaire","conceptCode":"C121002","definition":"A standardized rating scale developed by Schunemann et al in 2003, which is a self-administered instrument used to measure the health-related quality of life (HRQL) in patients with chronic airflow limitation. The first administration version contains 20 items and four domains: dyspnea, fatigue, emotional functioning and mastery.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"81CE4750-411F-6019-E053-F662850AE483","latestVersionIndicator":"Yes","beginDate":"2019-02-13","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-02-13","modifiedBy":"ONEDATA","dateModified":"2019-02-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5C5F-0412-E063-731AD00A56D4","beginDate":"2019-02-13","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"CHART-SF PAPER VERSION","valueDescription":"Craig Handicap Assessment and Reporting Technique - Short Form Paper Version Questionnaire","ValueMeaning":{"publicId":"6642999","version":"1","preferredName":"Craig Handicap Assessment and Reporting Technique - Short Form Paper Version Questionnaire","longName":"6642999","preferredDefinition":"A standardized rating scale originally developed by Whiteneck et al in 1992 and modified in 2000, which is used to measure the degree to which impairments and disabilities result in handicaps in the years after initial rehabilitation. The paper version questionnaire contains 19 questions and generates 6 subscales: physical independence, cognitive independence, mobility, occupation, social integration and economic self-sufficiency.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Craig Handicap Assessment and Reporting Technique - Short Form Paper Version Questionnaire","conceptCode":"C119101","definition":"A standardized rating scale originally developed by Whiteneck et al in 1992 and modified in 2000, which is used to measure the degree to which impairments and disabilities result in handicaps in the years after initial rehabilitation. The paper version questionnaire contains 19 questions and generates 6 subscales: physical independence, cognitive independence, mobility, occupation, social integration and economic self-sufficiency.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"81CE4750-4087-6019-E053-F662850AE483","latestVersionIndicator":"Yes","beginDate":"2019-02-13","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-02-13","modifiedBy":"ONEDATA","dateModified":"2019-02-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5C60-0412-E063-731AD00A56D4","beginDate":"2019-02-13","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"CRQ-SAS FOLLOW-UP ADMINISTRATION VERSION","valueDescription":"Chronic Respiratory Questionnaire Self-Administered Standardized Format Follow-Up Administration Version Questionnaire","ValueMeaning":{"publicId":"6643009","version":"1","preferredName":"Chronic Respiratory Questionnaire Self-Administered Standardized Format Follow-Up Administration Version Questionnaire","longName":"6643009","preferredDefinition":"A standardized rating scale developed by Schunemann et al in 2003, which is a self-administered instrument used to measure the health-related quality of life (HRQL) in patients with chronic airflow limitation. The follow-up administration version contains 20 items and four domains: dyspnea, fatigue, emotional functioning and mastery.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Chronic Respiratory Questionnaire Self-Administered Standardized Format Follow-Up Administration Version Questionnaire","conceptCode":"C121003","definition":"A standardized rating scale developed by Schunemann et al in 2003, which is a self-administered instrument used to measure the health-related quality of life (HRQL) in patients with chronic airflow limitation. The follow-up administration version contains 20 items and four domains: dyspnea, fatigue, emotional functioning and mastery.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"81CE4750-4145-6019-E053-F662850AE483","latestVersionIndicator":"Yes","beginDate":"2019-02-13","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-02-13","modifiedBy":"ONEDATA","dateModified":"2019-02-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5C61-0412-E063-731AD00A56D4","beginDate":"2019-02-13","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"DRRI-2","valueDescription":"Deployment Risk and Resilience Inventory-2 Questionnaire","ValueMeaning":{"publicId":"6643017","version":"1","preferredName":"Deployment Risk and Resilience Inventory-2 Questionnaire","longName":"6643017","preferredDefinition":"A revision of the Deployment Risk and Resilience Inventory instrument, originally developed by King et al. in 2003, that utilizes 17 distinct scales to assess predeployment, deployment, and postdeployment psychosocial risk and resilience factors in returning war veterans.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Deployment Risk and Resilience Inventory-2 Questionnaire","conceptCode":"C141694","definition":"A revision of the Deployment Risk and Resilience Inventory instrument, originally developed by King et al. in 2003, that utilizes 17 distinct scales to assess predeployment, deployment, and postdeployment psychosocial risk and resilience factors in returning war veterans.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"81CE4750-41DD-6019-E053-F662850AE483","latestVersionIndicator":"Yes","beginDate":"2019-02-13","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-02-13","modifiedBy":"ONEDATA","dateModified":"2019-02-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5C62-0412-E063-731AD00A56D4","beginDate":"2019-02-13","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"EPIC-26","valueDescription":"The Expanded Prostate Cancer Index Composite Short Form Questionnaire","ValueMeaning":{"publicId":"6643026","version":"1","preferredName":"The Expanded Prostate Cancer Index Composite Short Form Questionnaire","longName":"6643026","preferredDefinition":"A standardized rating scale developed by Szymanski et al in 2010, which is used to monitor health-related quality of life outcomes in patients with prostate cancer. This instrument contains five symptom domains (urinary incontinence, urinary irritative/obstructive, sexual, bowel, hormonal) and 26 items, scored from 0 (worst) to 100 (best).","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"The Expanded Prostate Cancer Index Composite Short Form Questionnaire","conceptCode":"C127367","definition":"A standardized rating scale developed by Szymanski et al in 2010, which is used to monitor health-related quality of life outcomes in patients with prostate cancer. This instrument contains five symptom domains (urinary incontinence, urinary irritative/obstructive, sexual, bowel, hormonal) and 26 items, scored from 0 (worst) to 100 (best).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"81CE4750-4298-6019-E053-F662850AE483","latestVersionIndicator":"Yes","beginDate":"2019-02-13","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-02-13","modifiedBy":"ONEDATA","dateModified":"2019-02-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5C63-0412-E063-731AD00A56D4","beginDate":"2019-02-13","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"ACT","valueDescription":"Asthma Control Test Questionnaire","ValueMeaning":{"publicId":"6642920","version":"1","preferredName":"Asthma Control Test Questionnaire","longName":"6642920","preferredDefinition":"A standardized rating scale developed by Nathan et al in 2004, which is used to identify patients with poorly controlled asthma. This questionnaire contains 5 items.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Asthma Control Test Questionnaire","conceptCode":"C123658","definition":"A standardized rating scale developed by Nathan et al in 2004, which is used to identify patients with poorly controlled asthma. This questionnaire contains 5 items.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"81CE4750-3A5A-6019-E053-F662850AE483","latestVersionIndicator":"Yes","beginDate":"2019-02-13","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-02-13","modifiedBy":"ONEDATA","dateModified":"2019-02-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5C64-0412-E063-731AD00A56D4","beginDate":"2019-02-13","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"FACT-BMT V4","valueDescription":"Functional Assessment of Cancer Therapy-Bone Marrow Transplant Version 4 Questionnaire","ValueMeaning":{"publicId":"6643050","version":"1","preferredName":"Functional Assessment of Cancer Therapy-Bone Marrow Transplant Version 4 Questionnaire","longName":"6643050","preferredDefinition":"A standardized, self-administered 12-item subscale, validated by McQuellen et al. in 1997 that, in combination with the general Functional Assessment of Cancer Therapy (FACT) instrument, utilizes a five-point Likert scale and covers four specific domains of well-being to measure quality of life in bone marrow transplantation patients.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Functional Assessment of Cancer Therapy-Bone Marrow Transplant Version 4 Questionnaire","conceptCode":"C147583","definition":"A standardized, self-administered 12-item subscale, validated by McQuellen et al. in 1997 that, in combination with the general Functional Assessment of Cancer Therapy (FACT) instrument, utilizes a five-point Likert scale and covers four specific domains of well-being to measure quality of life in bone marrow transplantation patients.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"81CE4750-44A0-6019-E053-F662850AE483","latestVersionIndicator":"Yes","beginDate":"2019-02-13","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-02-13","modifiedBy":"ONEDATA","dateModified":"2019-02-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5C65-0412-E063-731AD00A56D4","beginDate":"2019-02-13","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"FACT-BRM V4","valueDescription":"Functional Assessment of Cancer Therapy-Biologic Response Modifiers Version 4 Questionnaire","ValueMeaning":{"publicId":"6643052","version":"1","preferredName":"Functional Assessment of Cancer Therapy-Biologic Response Modifiers Version 4 Questionnaire","longName":"6643052","preferredDefinition":"A standardized 40-item self-report rating scale to measure quality of life in cancer patients receiving treatment with biologic response modifiers that is divided into six subscales: physical, social/family, emotional, and functional well-being, as well as two subscales related to physical and mental symptoms common to treatment with biologic response modifiers. Originally developed by Cella, et al. in 1997, it combines the Functional Assessment of Cancer Therapy - General (FACT-G), and two Biologic Response Modifier (BRM) subscales.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Functional Assessment of Cancer Therapy-Biologic Response Modifiers Version 4 Questionnaire","conceptCode":"C150914","definition":"A standardized 40-item self-report rating scale to measure quality of life in cancer patients receiving treatment with biologic response modifiers that is divided into six subscales: physical, social/family, emotional, and functional well-being, as well as two subscales related to physical and mental symptoms common to treatment with biologic response modifiers. Originally developed by Cella, et al. in 1997, it combines the Functional Assessment of Cancer Therapy - General (FACT-G), and two Biologic Response Modifier (BRM) subscales.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"81CE4750-44C6-6019-E053-F662850AE483","latestVersionIndicator":"Yes","beginDate":"2019-02-13","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-02-13","modifiedBy":"ONEDATA","dateModified":"2019-02-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5C66-0412-E063-731AD00A56D4","beginDate":"2019-02-13","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"IIEF","valueDescription":"International Index of Erectile Function Questionnaire","ValueMeaning":{"publicId":"6643127","version":"1","preferredName":"International Index of Erectile Function Questionnaire","longName":"6643127","preferredDefinition":"A standardized survey developed and published by Raymond C. Rosen and colleagues in 1997 which is used to assess erectile function. This instrument is a self-administered questionnaire with 15 items each with as set of 5 or 6 response options associated with a score of 1-5 or 1-6.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"International Index of Erectile Function Questionnaire","conceptCode":"C103521","definition":"A standardized survey developed and published by Raymond C. Rosen and colleagues in 1997 which is used to assess erectile function. This instrument is a self-administered questionnaire with 15 items each with as set of 5 or 6 response options associated with a score of 1-5 or 1-6.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"81CE4750-4AC7-6019-E053-F662850AE483","latestVersionIndicator":"Yes","beginDate":"2019-02-13","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-02-13","modifiedBy":"ONEDATA","dateModified":"2019-02-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5C67-0412-E063-731AD00A56D4","beginDate":"2019-02-13","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"FACT-C V4","valueDescription":"Functional Assessment of Cancer Therapy-Colorectal Version 4 Questionnaire","ValueMeaning":{"publicId":"6643054","version":"1","preferredName":"Functional Assessment of Cancer Therapy-Colorectal Version 4 Questionnaire","longName":"6643054","preferredDefinition":"A standardized 36-item self-report rating scale to measure quality of life in patients with colorectal cancer that is divided into five subscales: physical, social/family, emotional, and functional well-being, as well as a colorectal cancer specific subscale. Originally developed by Cella, et al. in 1997, it combines the Functional Assessment of Cancer Therapy - General (FACT-G), and the Colorectal Cancer Subscale (CCS).","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Functional Assessment of Cancer Therapy-Colorectal Version 4 Questionnaire","conceptCode":"C150912","definition":"A standardized 36-item self-report rating scale to measure quality of life in patients with colorectal cancer that is divided into five subscales: physical, social/family, emotional, and functional well-being, as well as a colorectal cancer specific subscale. Originally developed by Cella, et al. in 1997, it combines the Functional Assessment of Cancer Therapy - General (FACT-G), and the Colorectal Cancer Subscale (CCS).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"81CE4750-44EC-6019-E053-F662850AE483","latestVersionIndicator":"Yes","beginDate":"2019-02-13","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-02-13","modifiedBy":"ONEDATA","dateModified":"2019-02-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5C68-0412-E063-731AD00A56D4","beginDate":"2019-02-13","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"FACT-G V4","valueDescription":"Functional Assessment of Cancer Therapy-General Version 4 Questionnaire","ValueMeaning":{"publicId":"6643056","version":"1","preferredName":"Functional Assessment of Cancer Therapy-General Version 4 Questionnaire","longName":"6643056","preferredDefinition":"A standardized rating scale originally developed by Cella et al in 1993, which is used for general measurements of quality of life in patients with any form of cancer, or other chronic illness condition. The version 4 of this instrument contains 27 items which are divided into four domains: physical well-being, social/family well-being, emotional well-being, and functional well-being.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Functional Assessment of Cancer Therapy-General Version 4 Questionnaire","conceptCode":"C127369","definition":"A standardized rating scale originally developed by Cella et al in 1993, which is used for general measurements of quality of life in patients with any form of cancer, or other chronic illness condition. The version 4 of this instrument contains 27 items which are divided into four domains: physical well-being, social/family well-being, emotional well-being, and functional well-being.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"81CE4750-4512-6019-E053-F662850AE483","latestVersionIndicator":"Yes","beginDate":"2019-02-13","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-02-13","modifiedBy":"ONEDATA","dateModified":"2019-02-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5C69-0412-E063-731AD00A56D4","beginDate":"2019-02-13","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"FACT-HEP V4","valueDescription":"Functional Assessment of Cancer Therapy-Hepatobiliary Version 4 Questionnaire","ValueMeaning":{"publicId":"6643058","version":"1","preferredName":"Functional Assessment of Cancer Therapy-Hepatobiliary Version 4 Questionnaire","longName":"6643058","preferredDefinition":"A standardized 45-item self-report questionnaire that utilizes a 5-point rating scale to evaluate quality of life in patients with hepatobiliary cancers. The questionnaire, composed of the 27-item Functional Assessment of Cancer Therapy-General (FACT-G) and 18 additional hepatobiliary specific items, was developed by Heffernan and Cella et al. in 2002 and is divided into five subscales: physical well-being, social/family well-being, emotional well-being, functional well-being, and additional concerns.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Functional Assessment of Cancer Therapy-Hepatobiliary Version 4 Questionnaire","conceptCode":"C130312","definition":"A standardized 45-item self-report questionnaire that utilizes a 5-point rating scale to evaluate quality of life in patients with hepatobiliary cancers. The questionnaire, composed of the 27-item Functional Assessment of Cancer Therapy-General (FACT-G) and 18 additional hepatobiliary specific items, was developed by Heffernan and Cella et al. in 2002 and is divided into five subscales: physical well-being, social/family well-being, emotional well-being, functional well-being, and additional concerns.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"81CE4750-4538-6019-E053-F662850AE483","latestVersionIndicator":"Yes","beginDate":"2019-02-13","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-02-13","modifiedBy":"ONEDATA","dateModified":"2019-02-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5C6A-0412-E063-731AD00A56D4","beginDate":"2019-02-13","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"FACT-L V4","valueDescription":"Functional Assessment of Cancer Therapy-Lung Version 4 Questionnaire","ValueMeaning":{"publicId":"6643060","version":"1","preferredName":"Functional Assessment of Cancer Therapy-Lung Version 4 Questionnaire","longName":"6643060","preferredDefinition":"A standardized 34-item self-report rating scale to measure quality of life in patients with lung cancer that is divided into five subscales: physical, social/family, emotional, and functional well-being, as well as a subscale that is specific to issues faced by lung cancer patients. Originally developed by Cella, et al. in 1997, it combines the Functional Assessment of Cancer Therapy - General (FACT-G), and the Lung Cancer Subscale (LCS).","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Functional Assessment of Cancer Therapy-Lung Version 4 Questionnaire","conceptCode":"C150916","definition":"A standardized 34-item self-report rating scale to measure quality of life in patients with lung cancer that is divided into five subscales: physical, social/family, emotional, and functional well-being, as well as a subscale that is specific to issues faced by lung cancer patients. Originally developed by Cella, et al. in 1997, it combines the Functional Assessment of Cancer Therapy - General (FACT-G), and the Lung Cancer Subscale (LCS).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"81CE4750-455E-6019-E053-F662850AE483","latestVersionIndicator":"Yes","beginDate":"2019-02-13","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-02-13","modifiedBy":"ONEDATA","dateModified":"2019-02-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5C6B-0412-E063-731AD00A56D4","beginDate":"2019-02-13","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"FACT-LEU V4","valueDescription":"Functional Assessment of Cancer Therapy-Leukemia Version 4 Questionnaire","ValueMeaning":{"publicId":"6643062","version":"1","preferredName":"Functional Assessment of Cancer Therapy-Leukemia Version 4 Questionnaire","longName":"6643062","preferredDefinition":"A standardized 44-item self-report questionnaire that utilizes a 5-point rating scale to evaluate quality of life in patients with acute and chronic leukemia. The questionnaire, composed of the 27-item Functional Assessment of Cancer Therapy-General (FACT-G) and 17 additional leukemia specific items, was developed by Cella et al. in 2012 and is divided into five subscales: physical well-being, social/family well-being, emotional well-being, functional well-being, and additional concerns.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Functional Assessment of Cancer Therapy-Leukemia Version 4 Questionnaire","conceptCode":"C130311","definition":"A standardized 44-item self-report questionnaire that utilizes a 5-point rating scale to evaluate quality of life in patients with acute and chronic leukemia. The questionnaire, composed of the 27-item Functional Assessment of Cancer Therapy-General (FACT-G) and 17 additional leukemia specific items, was developed by Cella et al. in 2012 and is divided into five subscales: physical well-being, social/family well-being, emotional well-being, functional well-being, and additional concerns.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"81CE4750-4584-6019-E053-F662850AE483","latestVersionIndicator":"Yes","beginDate":"2019-02-13","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-02-13","modifiedBy":"ONEDATA","dateModified":"2019-02-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5C6C-0412-E063-731AD00A56D4","beginDate":"2019-02-13","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"FACT-LYM V4","valueDescription":"Functional Assessment of Cancer Therapy-Lymphoma Version 4 Questionnaire","ValueMeaning":{"publicId":"6643064","version":"1","preferredName":"Functional Assessment of Cancer Therapy-Lymphoma Version 4 Questionnaire","longName":"6643064","preferredDefinition":"A standardized 49-item self-report questionnaire that utilizes a 5-point rating scale to evaluate quality of life in patients with Non-Hodgkin lymphoma. The questionnaire, composed of the 27-item Functional Assessment of Cancer Therapy-General (FACT-G) and 22 additional Non-Hodgkin lymphoma specific items, was developed by Cella et al. in 2005 and is divided into five subscales: physical well-being, social/family well-being, emotional well-being, functional well-being, and additional concerns.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Functional Assessment of Cancer Therapy-Lymphoma Version 4 Questionnaire","conceptCode":"C130313","definition":"A standardized 49-item self-report questionnaire that utilizes a 5-point rating scale to evaluate quality of life in patients with Non-Hodgkin lymphoma. The questionnaire, composed of the 27-item Functional Assessment of Cancer Therapy-General (FACT-G) and 22 additional Non-Hodgkin lymphoma specific items, was developed by Cella et al. in 2005 and is divided into five subscales: physical well-being, social/family well-being, emotional well-being, functional well-being, and additional concerns.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"81CE4750-45AA-6019-E053-F662850AE483","latestVersionIndicator":"Yes","beginDate":"2019-02-13","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-02-13","modifiedBy":"ONEDATA","dateModified":"2019-02-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5C6D-0412-E063-731AD00A56D4","beginDate":"2019-02-13","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"FACT-P V4","valueDescription":"Functional Assessment of Cancer Therapy-Prostate Version 4 Questionnaire","ValueMeaning":{"publicId":"6643066","version":"1","preferredName":"Functional Assessment of Cancer Therapy-Prostate Version 4 Questionnaire","longName":"6643066","preferredDefinition":"A standardized rating scale originally developed by Cella et al in 1993 and modified by Esper et al in 1997, which includes a 12-item prostate cancer subscale (PCS) in addition to the original 27 items from FACT-G. FACT-P contains 39 items and measures both general health-related quality of life as well as prostate cancer-specific quality of life; the total score is based on both FACT-G and PCS.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Functional Assessment of Cancer Therapy-Prostate Version 4 Questionnaire","conceptCode":"C127371","definition":"A standardized rating scale originally developed by Cella et al in 1993 and modified by Esper et al in 1997, which includes a 12-item prostate cancer subscale (PCS) in addition to the original 27 items from FACT-G. FACT-P contains 39 items and measures both general health-related quality of life as well as prostate cancer-specific quality of life; the total score is based on both FACT-G and PCS.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"81CE4750-45D0-6019-E053-F662850AE483","latestVersionIndicator":"Yes","beginDate":"2019-02-13","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-02-13","modifiedBy":"ONEDATA","dateModified":"2019-02-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5C6E-0412-E063-731AD00A56D4","beginDate":"2019-02-13","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"FACT-TAXANE V4","valueDescription":"Functional Assessment of Cancer Therapy-Taxane Version 4 Questionnaire","ValueMeaning":{"publicId":"6643068","version":"1","preferredName":"Functional Assessment of Cancer Therapy-Taxane Version 4 Questionnaire","longName":"6643068","preferredDefinition":"A standardized 43-item self-report rating scale to measure the health related quality of life in patients receiving taxane containing chemotherapy. Originally developed by Cella, et al. in 1997, it combines the 27-item Functional Assessment of Cancer Therapy - General (FACT-G), which is divided into five subscales: physical, social/family, emotional, and functional well-being, with a Taxane subscale that combines the 11-item Neurotoxicity subscale and 5 additional questions assessing symptoms related to arthralgia, myalgia, and skin discoloration.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Functional Assessment of Cancer Therapy-Taxane Version 4 Questionnaire","conceptCode":"C150913","definition":"A standardized 43-item self-report rating scale to measure the health related quality of life in patients receiving taxane containing chemotherapy. Originally developed by Cella, et al. in 1997, it combines the 27-item Functional Assessment of Cancer Therapy - General (FACT-G), which is divided into five subscales: physical, social/family, emotional, and functional well-being, with a Taxane subscale that combines the 11-item Neurotoxicity subscale and 5 additional questions assessing symptoms related to arthralgia, myalgia, and skin discoloration.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"81CE4750-45F6-6019-E053-F662850AE483","latestVersionIndicator":"Yes","beginDate":"2019-02-13","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-02-13","modifiedBy":"ONEDATA","dateModified":"2019-02-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5C6F-0412-E063-731AD00A56D4","beginDate":"2019-02-13","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"EPIC-CP","valueDescription":"Expanded Prostate Cancer Index Composite for Clinical Practice Questionnaire","ValueMeaning":{"publicId":"6643028","version":"1","preferredName":"Expanded Prostate Cancer Index Composite for Clinical Practice Questionnaire","longName":"6643028","preferredDefinition":"A standardized rating scale developed by Chang et al in 2011, which is used to measure urinary incontinence, urinary irritation, and the bowel, sexual and hormonal health related quality of life in patients with prostate cancer. This instrument contains 16 items.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Expanded Prostate Cancer Index Composite for Clinical Practice Questionnaire","conceptCode":"C127368","definition":"A standardized rating scale developed by Chang et al in 2011, which is used to measure urinary incontinence, urinary irritation, and the bowel, sexual and hormonal health related quality of life in patients with prostate cancer. This instrument contains 16 items.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"81CE4750-42BE-6019-E053-F662850AE483","latestVersionIndicator":"Yes","beginDate":"2019-02-13","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-02-13","modifiedBy":"ONEDATA","dateModified":"2019-02-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5C70-0412-E063-731AD00A56D4","beginDate":"2019-02-13","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"EQ-5D-3L","valueDescription":"European Quality of Life Five Dimension Three Level Questionnaire","ValueMeaning":{"publicId":"6643029","version":"1","preferredName":"European Quality of Life Five Dimension Three Level Questionnaire","longName":"6643029","preferredDefinition":"A standardized rating scale which is used as a measure of health outcome. This instrument is a descriptive system consisting of 5 dimensions: mobility, self-care, usual activity, pain/discomfort, and anxiety/depression. Each dimension has 3 levels ranging from no problem to extreme problem or incapable, which are assessed by the patient.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"European Quality of Life Five Dimension Three Level Questionnaire","conceptCode":"C66957","definition":"A standardized rating scale which is used as a measure of health outcome. This instrument is a descriptive system consisting of 5 dimensions: mobility, self-care, usual activity, pain/discomfort, and anxiety/depression. Each dimension has 3 levels ranging from no problem to extreme problem or incapable, which are assessed by the patient.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"81CE4750-42E1-6019-E053-F662850AE483","latestVersionIndicator":"Yes","beginDate":"2019-02-13","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-02-13","modifiedBy":"ONEDATA","dateModified":"2019-02-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5C71-0412-E063-731AD00A56D4","beginDate":"2019-02-13","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"EQ-5D-5L","valueDescription":"European Quality of Life Five Dimension Five Level Scale Questionnaire","ValueMeaning":{"publicId":"6643030","version":"1","preferredName":"European Quality of Life Five Dimension Five Level Scale Questionnaire","longName":"6643030","preferredDefinition":"A standardized rating scale which is used as a measure of health outcome. This instrument is a descriptive system consisting of 5 dimensions: mobility, self-care, usual activity, pain/discomfort, and anxiety/depression. Each dimension has 5 levels ranging from no problem to extreme problem or incapable, which are assessed by the patient.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"European Quality of Life Five Dimension Five Level Scale Questionnaire","conceptCode":"C102117","definition":"A standardized rating scale which is used as a measure of health outcome. This instrument is a descriptive system consisting of 5 dimensions: mobility, self-care, usual activity, pain/discomfort, and anxiety/depression. Each dimension has 5 levels ranging from no problem to extreme problem or incapable, which are assessed by the patient.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"81CE4750-4304-6019-E053-F662850AE483","latestVersionIndicator":"Yes","beginDate":"2019-02-13","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-02-13","modifiedBy":"ONEDATA","dateModified":"2019-02-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5C72-0412-E063-731AD00A56D4","beginDate":"2019-02-13","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"EXPANDED DRS-PI CAREGIVER VERSION","valueDescription":"Expanded Disability Rating Scale - Postacute Interview Caregiver Version Questionnaire","ValueMeaning":{"publicId":"6643035","version":"1","preferredName":"Expanded Disability Rating Scale - Postacute Interview Caregiver Version Questionnaire","longName":"6643035","preferredDefinition":"A standardized rating scale developed by Rappaport et al in 1982, which is used to track recovery of an individual from coma to community and to capture functional changes over the course of recovery for individuals with moderate to severe TBI. The caregiver version of this instrument has 30 items.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Expanded Disability Rating Scale - Postacute Interview Caregiver Version Questionnaire","conceptCode":"C125759","definition":"A standardized rating scale developed by Rappaport et al in 1982, which is used to track recovery of an individual from coma to community and to capture functional changes over the course of recovery for individuals with moderate to severe TBI. The caregiver version of this instrument has 30 items.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"81CE4750-4373-6019-E053-F662850AE483","latestVersionIndicator":"Yes","beginDate":"2019-02-13","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-02-13","modifiedBy":"ONEDATA","dateModified":"2019-02-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5C73-0412-E063-731AD00A56D4","beginDate":"2019-02-13","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"EXPANDED DRS-PI SURVIVOR VERSION","valueDescription":"Expanded Disability Rating Scale - Postacute Interview Survivor Version Questionnaire","ValueMeaning":{"publicId":"6643037","version":"1","preferredName":"Expanded Disability Rating Scale - Postacute Interview Survivor Version Questionnaire","longName":"6643037","preferredDefinition":"A standardized rating scale developed by Rappaport et al in 1982, which is used to track recovery of an individual from coma to community and to capture functional changes over the course of recovery for individuals with moderate to severe TBI. The survivor version of this instrument has 26 items.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Expanded Disability Rating Scale - Postacute Interview Survivor Version Questionnaire","conceptCode":"C125760","definition":"A standardized rating scale developed by Rappaport et al in 1982, which is used to track recovery of an individual from coma to community and to capture functional changes over the course of recovery for individuals with moderate to severe TBI. The survivor version of this instrument has 26 items.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"81CE4750-4399-6019-E053-F662850AE483","latestVersionIndicator":"Yes","beginDate":"2019-02-13","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-02-13","modifiedBy":"ONEDATA","dateModified":"2019-02-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5C74-0412-E063-731AD00A56D4","beginDate":"2019-02-13","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"FACIT-DYSPNEA 33 ITEM BANK","valueDescription":"Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank Questionnaire","ValueMeaning":{"publicId":"6643039","version":"1","preferredName":"Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank Questionnaire","longName":"6643039","preferredDefinition":"A standardized 33-item repository of test questions developed by Choi et al. in 2011 as part of the Functional Assessment of Chronic Illness Therapy (FACIT) Measurement System developed by Cella et al. in 1987, from which a subset may be administered to evaluate dyspnea severity and limitations in function caused by dyspnea in people with COPD.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank Questionnaire","conceptCode":"C155325","definition":"A standardized 33-item repository of test questions developed by Choi et al. in 2011 as part of the Functional Assessment of Chronic Illness Therapy (FACIT) Measurement System developed by Cella et al. in 1987, from which a subset may be administered to evaluate dyspnea severity and limitations in function caused by dyspnea in people with COPD.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"81CE4750-43BF-6019-E053-F662850AE483","latestVersionIndicator":"Yes","beginDate":"2019-02-13","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-02-13","modifiedBy":"ONEDATA","dateModified":"2019-02-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5C75-0412-E063-731AD00A56D4","beginDate":"2019-02-13","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"FACIT-DYSPNEA SF","valueDescription":"FACIT-Dyspnea 10 Item Short Form","ValueMeaning":{"publicId":"6643040","version":"1","preferredName":"FACIT-Dyspnea 10 Item Short Form","longName":"6643040","preferredDefinition":"A patient-reported outcome measure designed to evaluate an individual's shortness of breath across ten functional activities over the past 7 days.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"FACIT-Dyspnea 10 Item Short Form","conceptCode":"C121853","definition":"A patient-reported outcome measure designed to evaluate an individual's shortness of breath across ten functional activities over the past 7 days.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"81CE4750-43E2-6019-E053-F662850AE483","latestVersionIndicator":"Yes","beginDate":"2019-02-13","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-02-13","modifiedBy":"ONEDATA","dateModified":"2019-02-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5C76-0412-E063-731AD00A56D4","beginDate":"2019-02-13","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"FACIT-F V4","valueDescription":"Functional Assessment of Chronic Illness Therapy-Fatigue Version 4 Questionnaire","ValueMeaning":{"publicId":"6643042","version":"1","preferredName":"Functional Assessment of Chronic Illness Therapy-Fatigue Version 4 Questionnaire","longName":"6643042","preferredDefinition":"A standardized rating scale originally developed by Yellen et al in 1997 and modified by Cella et al in 2002, which includes a 13-item fatigue scale, as well as 13 items from the original FACT-G of the emotional and functional well-being sections. This instrument measures fatigue/tiredness and its impact on daily activities and functioning in a number of chronic diseases.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Functional Assessment of Chronic Illness Therapy-Fatigue Version 4 Questionnaire","conceptCode":"C129105","definition":"A standardized rating scale originally developed by Yellen et al in 1997 and modified by Cella et al in 2002, which includes a 13-item fatigue scale, as well as 13 items from the original FACT-G of the emotional and functional well-being sections. This instrument measures fatigue/tiredness and its impact on daily activities and functioning in a number of chronic diseases.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"81CE4750-4408-6019-E053-F662850AE483","latestVersionIndicator":"Yes","beginDate":"2019-02-13","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-02-13","modifiedBy":"ONEDATA","dateModified":"2019-02-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5C77-0412-E063-731AD00A56D4","beginDate":"2019-02-13","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"FACIT-FATIGUE 13-ITEM V4","valueDescription":"Functional Assessment of Chronic Illness Therapy-Fatigue 13-Item Scale Version 4 Questionnaire","ValueMeaning":{"publicId":"6643044","version":"1","preferredName":"Functional Assessment of Chronic Illness Therapy-Fatigue 13-Item Scale Version 4 Questionnaire","longName":"6643044","preferredDefinition":"A standardized 10-item self-report, interviewer, or telephone administered questionnaire, part of the Functional Assessment of Chronic Illness Therapy (FACIT) Measurement System developed by Cella et al. in 1987, that utilizes a five-point Likert rating scale to evaluate shortness of breath across a range of functional activities over the past 7 days in individuals with chronic obstructive pulmonary disease.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Functional Assessment of Chronic Illness Therapy-Fatigue 13-Item Scale Version 4 Questionnaire","conceptCode":"C147585","definition":"A standardized 10-item self-report, interviewer, or telephone administered questionnaire, part of the Functional Assessment of Chronic Illness Therapy (FACIT) Measurement System developed by Cella et al. in 1987, that utilizes a five-point Likert rating scale to evaluate shortness of breath across a range of functional activities over the past 7 days in individuals with chronic obstructive pulmonary disease.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"81CE4750-442E-6019-E053-F662850AE483","latestVersionIndicator":"Yes","beginDate":"2019-02-13","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-02-13","modifiedBy":"ONEDATA","dateModified":"2019-02-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5C78-0412-E063-731AD00A56D4","beginDate":"2019-02-13","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"FACT-B V4","valueDescription":"Functional Assessment of Cancer Therapy-Breast Version 4 Questionnaire","ValueMeaning":{"publicId":"6643046","version":"1","preferredName":"Functional Assessment of Cancer Therapy-Breast Version 4 Questionnaire","longName":"6643046","preferredDefinition":"A standardized 37-item self-report rating scale to measure quality of life in patients with breast cancer that is divided into five subscales: physical, social/family, emotional, and functional well-being, as well as additional concerns for breast cancer. Originally developed by Cella, et al. in 1997, it combines the Functional Assessment of Cancer Therapy - General (FACT-G) and the Breast Cancer Subscale (BCS).","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Functional Assessment of Cancer Therapy-Breast Version 4 Questionnaire","conceptCode":"C129108","definition":"A standardized 37-item self-report rating scale to measure quality of life in patients with breast cancer that is divided into five subscales: physical, social/family, emotional, and functional well-being, as well as additional concerns for breast cancer. Originally developed by Cella, et al. in 1997, it combines the Functional Assessment of Cancer Therapy - General (FACT-G) and the Breast Cancer Subscale (BCS).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"81CE4750-4454-6019-E053-F662850AE483","latestVersionIndicator":"Yes","beginDate":"2019-02-13","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-02-13","modifiedBy":"ONEDATA","dateModified":"2019-02-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5C79-0412-E063-731AD00A56D4","beginDate":"2019-02-13","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"FACT-BL V4","valueDescription":"Functional Assessment of Cancer Therapy-Bladder Version 4 Questionnaire","ValueMeaning":{"publicId":"6643048","version":"1","preferredName":"Functional Assessment of Cancer Therapy-Bladder Version 4 Questionnaire","longName":"6643048","preferredDefinition":"A standardized 39-item self-report rating scale to measure quality of life in patients with bladder cancer that is divided into five subscales: physical, social/family, emotional, and functional well-being, as well as a bladder cancer subscale to assess urinary tract, intestinal and sexual symptoms. Originally developed by Cella, et al. in 1997, it combines the Functional Assessment of Cancer Therapy - General (FACT-G), and the Bladder Cancer Subscale (BICS).","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Functional Assessment of Cancer Therapy-Bladder Version 4 Questionnaire","conceptCode":"C155326","definition":"A standardized 39-item self-report rating scale to measure quality of life in patients with bladder cancer that is divided into five subscales: physical, social/family, emotional, and functional well-being, as well as a bladder cancer subscale to assess urinary tract, intestinal and sexual symptoms. Originally developed by Cella, et al. in 1997, it combines the Functional Assessment of Cancer Therapy - General (FACT-G), and the Bladder Cancer Subscale (BICS).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"81CE4750-447A-6019-E053-F662850AE483","latestVersionIndicator":"Yes","beginDate":"2019-02-13","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-02-13","modifiedBy":"ONEDATA","dateModified":"2019-02-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5C7A-0412-E063-731AD00A56D4","beginDate":"2019-02-13","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"HADS","valueDescription":"Hospital Anxiety and Depression Scale Questionnaire","ValueMeaning":{"publicId":"6643101","version":"1","preferredName":"Hospital Anxiety and Depression Scale Questionnaire","longName":"6643101","preferredDefinition":"A standardized survey developed and copyrighted by A. S. Zigmond and R. P. Snaith in 1983, 1992, 1994 and published in the Acta Psychiatrica Scandinavica journal (A.S. Zigmond and R.P. Snaith. The Hospital Anxiety and Depression Scale. Acta psychiart. scand. 1983, 67:361-370) which is used to detect depression and anxiety in individuals in a hospital or medical outpatient clinic. This instrument is a self-administered questionnaire consisting of 14 items that assess how the individual has felt over the past week. Each item as 4 response options that are associated with a score of 0 to 3.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hospital Anxiety and Depression Scale Questionnaire","conceptCode":"C103520","definition":"A standardized survey developed and copyrighted by A. S. Zigmond and R. P. Snaith in 1983, 1992, 1994 and published in the Acta Psychiatrica Scandinavica journal (A.S. Zigmond and R.P. Snaith. The Hospital Anxiety and Depression Scale. Acta psychiart. scand. 1983, 67:361-370) which is used to detect depression and anxiety in individuals in a hospital or medical outpatient clinic. This instrument is a self-administered questionnaire consisting of 14 items that assess how the individual has felt over the past week. Each item as 4 response options that are associated with a score of 0 to 3.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"81CE4750-48B9-6019-E053-F662850AE483","latestVersionIndicator":"Yes","beginDate":"2019-02-13","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-02-13","modifiedBy":"ONEDATA","dateModified":"2019-02-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5C7B-0412-E063-731AD00A56D4","beginDate":"2019-02-13","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"IVIS","valueDescription":"Impact of Visual Impairment Scale Questionnaire","ValueMeaning":{"publicId":"6643137","version":"1","preferredName":"Impact of Visual Impairment Scale Questionnaire","longName":"6643137","preferredDefinition":"A standardized rating scale developed by the National Multiple Sclerosis Society in 1997, which was based on items derived from the Functional Capacities Assessment developed by the Michigan Commission for the Blind. This questionnaire measures the level of visual function and difficulties with simple visual tasks such as reading and watching television. The questionnaire contains 5 questions which are scored ranging from 0 (not at all difficult) to 3 (could not do due to visual problems).","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Impact of Visual Impairment Scale Questionnaire","conceptCode":"C113876","definition":"A standardized rating scale developed by the National Multiple Sclerosis Society in 1997, which was based on items derived from the Functional Capacities Assessment developed by the Michigan Commission for the Blind. This questionnaire measures the level of visual function and difficulties with simple visual tasks such as reading and watching television. The questionnaire contains 5 questions which are scored ranging from 0 (not at all difficult) to 3 (could not do due to visual problems).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"81CE4750-4B85-6019-E053-F662850AE483","latestVersionIndicator":"Yes","beginDate":"2019-02-13","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-02-13","modifiedBy":"ONEDATA","dateModified":"2019-02-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5C7C-0412-E063-731AD00A56D4","beginDate":"2019-02-13","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"SIQR","valueDescription":"Symptom Impact Questionnaire","ValueMeaning":{"publicId":"6643607","version":"1","preferredName":"Symptom Impact Questionnaire","longName":"6643607","preferredDefinition":"A standardized survey developed and copyrighted by Ronald Friend and Robert Bennett that is published in the journal Arthritis Research and Therapy. This instrument was developed along with the Revised Fibromyalgia Questionnaire (FIQR) and was intended for use in assessing symptoms associated with rheumatoid arthritis and systemic lupus erythematous. There are three sections including function, overall impact and symptoms with a total of 21 items. Each item is rated on a 0-10 scale with 0 being none and 10 being the most severe.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Symptom Impact Questionnaire","conceptCode":"C103528","definition":"A standardized survey developed and copyrighted by Ronald Friend and Robert Bennett that is published in the journal Arthritis Research and Therapy. This instrument was developed along with the Revised Fibromyalgia Questionnaire (FIQR) and was intended for use in assessing symptoms associated with rheumatoid arthritis and systemic lupus erythematous. There are three sections including function, overall impact and symptoms with a total of 21 items. Each item is rated on a 0-10 scale with 0 being none and 10 being the most severe.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"81E08FC2-674B-6DE6-E053-F662850A1E6E","latestVersionIndicator":"Yes","beginDate":"2019-02-14","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-02-14","modifiedBy":"ONEDATA","dateModified":"2019-02-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5C7D-0412-E063-731AD00A56D4","beginDate":"2019-02-14","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"ODI V2.1A","valueDescription":"The Oswestry Disability Index Version 2.1a Questionnaire","ValueMeaning":{"publicId":"6643612","version":"1","preferredName":"The Oswestry Disability Index Version 2.1a Questionnaire","longName":"6643612","preferredDefinition":"A standardized survey initially developed by John O'Brien in 1976 then published in 1980 by Jeremy Fairbank. This version (2.1a) is copyrighted by Jeremy Fairbank and is used in the assessment and management of spinal disorders. There are 10 items pertaining to a variety of topics including personal care, walking, standing, sleeping and traveling. Each item has six responses.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"The Oswestry Disability Index Version 2.1a Questionnaire","conceptCode":"C103525","definition":"A standardized survey initially developed by John O'Brien in 1976 then published in 1980 by Jeremy Fairbank. This version (2.1a) is copyrighted by Jeremy Fairbank and is used in the assessment and management of spinal disorders. There are 10 items pertaining to a variety of topics including personal care, walking, standing, sleeping and traveling. Each item has six responses.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"81E08FC2-67BA-6DE6-E053-F662850A1E6E","latestVersionIndicator":"Yes","beginDate":"2019-02-14","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-02-14","modifiedBy":"ONEDATA","dateModified":"2019-02-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5C7E-0412-E063-731AD00A56D4","beginDate":"2019-02-14","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"ACQ","valueDescription":"Asthma Control Questionnaire","ValueMeaning":{"publicId":"6626805","version":"1","preferredName":"Asthma Control Questionnaire","longName":"6626805","preferredDefinition":"A standardized rating scale developed by Juniper et al in 1999, which is used to assess both the adequacy of and change in asthma control. This questionnaire contains 7 items using a 7-point scale.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Asthma Control Questionnaire","conceptCode":"C122370","definition":"A standardized rating scale developed by Juniper et al in 1999, which is used to assess both the adequacy of and change in asthma control. This questionnaire contains 7 items using a 7-point scale.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"80D70FE5-B76B-6A4C-E053-F662850A9EA8","latestVersionIndicator":"Yes","beginDate":"2019-02-01","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-02-01","modifiedBy":"ONEDATA","dateModified":"2019-02-01","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5C7F-0412-E063-731AD00A56D4","beginDate":"2019-02-01","endDate":null,"createdBy":"TAYLORT","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"ADAS-COG","valueDescription":"Alzheimer's Disease Assessment Scale-Cognitive CDISC Version Questionnaire","ValueMeaning":{"publicId":"6642918","version":"1","preferredName":"Alzheimer's Disease Assessment Scale-Cognitive CDISC Version Questionnaire","longName":"6642918","preferredDefinition":"The CDISC version of the Alzheimer's Disease Assessment Scale-Cognitive (CDISC ADAS-Cog) containing 15 summary-level tests. This version is based on combining the total pool of ADAS-Cog tests that were observed during a review of multiple case report forms administered in clinical trials of Alzheimer's disease, as well as the CRF administered in the Alzheimer's Disease Neuroimaging Initiative (ADNI) observational study.  (Modified from Mohs RC, Rosen WG, Davis KL. The Alzheimer's disease assessment scale: an instrument for assessing treatment efficacy. Psychopharmacol Bull 1983;19(3):448-450. Rosen WG, Mohs RC, Davis KL. A new rating scale for Alzheimer's disease. Am J Psychiatry 1984;141(11):1356-1364. Mohs RC, Knopman D, Petersen RC et al. Development of cognitive instruments for use in clinical trials of antidementia drugs: additions to the Alzheimer's Disease Assessment Scale that broaden its scope. The Alzheimer's Disease Cooperative Study. Alzheimer Dis Assoc Disord 1997;11 Suppl 2:S13-S21. Wouters H, van Gool WA, Schmand B, Lindeboom R. Revising the ADAS-cog for a more accurate assessment of cognitive impairment. Alzheimer Dis Assoc Disord 2008;22(3):236-244.).","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Alzheimer's Disease Assessment Scale-Cognitive CDISC Version Questionnaire","conceptCode":"C100762","definition":"The CDISC version of the Alzheimer's Disease Assessment Scale-Cognitive (CDISC ADAS-Cog) containing 15 summary-level tests. This version is based on combining the total pool of ADAS-Cog tests that were observed during a review of multiple case report forms administered in clinical trials of Alzheimer's disease, as well as the CRF administered in the Alzheimer's Disease Neuroimaging Initiative (ADNI) observational study.  (Modified from Mohs RC, Rosen WG, Davis KL. The Alzheimer's disease assessment scale: an instrument for assessing treatment efficacy. Psychopharmacol Bull 1983;19(3):448-450. Rosen WG, Mohs RC, Davis KL. A new rating scale for Alzheimer's disease. Am J Psychiatry 1984;141(11):1356-1364. Mohs RC, Knopman D, Petersen RC et al. Development of cognitive instruments for use in clinical trials of antidementia drugs: additions to the Alzheimer's Disease Assessment Scale that broaden its scope. The Alzheimer's Disease Cooperative Study. Alzheimer Dis Assoc Disord 1997;11 Suppl 2:S13-S21. Wouters H, van Gool WA, Schmand B, Lindeboom R. Revising the ADAS-cog for a more accurate assessment of cognitive impairment. Alzheimer Dis Assoc Disord 2008;22(3):236-244.).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"81CE4750-3A34-6019-E053-F662850AE483","latestVersionIndicator":"Yes","beginDate":"2019-02-13","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-02-13","modifiedBy":"ONEDATA","dateModified":"2019-02-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5C80-0412-E063-731AD00A56D4","beginDate":"2019-02-13","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"AQ20","valueDescription":"Airway Questionnaire 20","ValueMeaning":{"publicId":"6642928","version":"1","preferredName":"Airway Questionnaire 20","longName":"6642928","preferredDefinition":"A standardized rating scale developed by Barley et al in 1988 to measure health status and detect changes in quality of life in asthmatic patients. The questionnaire contains 20 questions and each can be answered with Yes, No, or N/A (Not Applicable).","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Airway Questionnaire 20","conceptCode":"C112518","definition":"A standardized rating scale developed by Barley et al in 1988 to measure health status and detect changes in quality of life in asthmatic patients. The questionnaire contains 20 questions and each can be answered with Yes, No, or N/A (Not Applicable).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"81CE4750-3AF2-6019-E053-F662850AE483","latestVersionIndicator":"Yes","beginDate":"2019-02-13","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-02-13","modifiedBy":"ONEDATA","dateModified":"2019-02-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5C81-0412-E063-731AD00A56D4","beginDate":"2019-02-13","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"ADCS-ADL","valueDescription":"Alzheimer's Disease Cooperative Study Activities of Daily Living Inventory Questionnaire","ValueMeaning":{"publicId":"6642916","version":"1","preferredName":"Alzheimer's Disease Cooperative Study Activities of Daily Living Inventory Questionnaire","longName":"6642916","preferredDefinition":"A standardized questionnaire developed by Galasko et al in 1997 as part of the Alzheimer's disease cooperative study, which is used to measure the performance of activities of daily living by patients diagnosed with Alzheimer's disease. The questionnaire contains 23 items (and a number of sub-items within the 23 main items) with a range of preset answers that are assigned points based on performance.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Alzheimer's Disease Cooperative Study Activities of Daily Living Inventory Questionnaire","conceptCode":"C105166","definition":"A standardized questionnaire developed by Galasko et al in 1997 as part of the Alzheimer's disease cooperative study, which is used to measure the performance of activities of daily living by patients diagnosed with Alzheimer's disease. The questionnaire contains 23 items (and a number of sub-items within the 23 main items) with a range of preset answers that are assigned points based on performance.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"81CE4750-3A0E-6019-E053-F662850AE483","latestVersionIndicator":"Yes","beginDate":"2019-02-13","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-02-13","modifiedBy":"ONEDATA","dateModified":"2019-02-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5C82-0412-E063-731AD00A56D4","beginDate":"2019-02-13","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"ADCS-ADL MCI","valueDescription":"Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory Mild Cognitive Impairment Questionnaire","ValueMeaning":{"publicId":"6642914","version":"1","preferredName":"Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory Mild Cognitive Impairment Questionnaire","longName":"6642914","preferredDefinition":"A standardized questionnaire developed by Galasko et al in 1997 as part of the Alzheimer's disease cooperative study, which is used to measure the performance of activities of daily living by patients diagnosed with Alzheimer's disease, exhibiting evidence of mild cognitive impairment (MCI). The questionnaire contains 24 items (and a number of sub-items within the 24 main items) with a range of preset answers that are assigned points based on performance.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory Mild Cognitive Impairment Questionnaire","conceptCode":"C106888","definition":"A standardized questionnaire developed by Galasko et al in 1997 as part of the Alzheimer's disease cooperative study, which is used to measure the performance of activities of daily living by patients diagnosed with Alzheimer's disease, exhibiting evidence of mild cognitive impairment (MCI). The questionnaire contains 24 items (and a number of sub-items within the 24 main items) with a range of preset answers that are assigned points based on performance.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"81CE4750-39E8-6019-E053-F662850AE483","latestVersionIndicator":"Yes","beginDate":"2019-02-13","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-02-13","modifiedBy":"ONEDATA","dateModified":"2019-02-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5C83-0412-E063-731AD00A56D4","beginDate":"2019-02-13","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"ADCS-ADL SEVERE DEMENTIA","valueDescription":"Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory Severe Dementia Questionnaire","ValueMeaning":{"publicId":"6642912","version":"1","preferredName":"Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory Severe Dementia Questionnaire","longName":"6642912","preferredDefinition":"A standardized questionnaire developed by Galasko et al in 1997 as part of the Alzheimer's disease cooperative study, which is used to measure the performance of activities of daily living by patients diagnosed with advanced stage or severe Alzheimer's disease. The questionnaire contains 19 items (and a number of sub-items within the 19 main items) with a range of preset answers that are assigned points based on performance.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory Severe Dementia Questionnaire","conceptCode":"C106889","definition":"A standardized questionnaire developed by Galasko et al in 1997 as part of the Alzheimer's disease cooperative study, which is used to measure the performance of activities of daily living by patients diagnosed with advanced stage or severe Alzheimer's disease. The questionnaire contains 19 items (and a number of sub-items within the 19 main items) with a range of preset answers that are assigned points based on performance.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"81CE4750-39C2-6019-E053-F662850AE483","latestVersionIndicator":"Yes","beginDate":"2019-02-13","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-02-13","modifiedBy":"ONEDATA","dateModified":"2019-02-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5C84-0412-E063-731AD00A56D4","beginDate":"2019-02-13","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"ADCS-CGIC","valueDescription":"Alzheimer's Disease Cooperative Study-Clinical Global Impression of Change Questionnaire","ValueMeaning":{"publicId":"6642922","version":"1","preferredName":"Alzheimer's Disease Cooperative Study-Clinical Global Impression of Change Questionnaire","longName":"6642922","preferredDefinition":"Alzheimer's Disease Cooperative Study-Clinical Global Impression of Change (ADCS-CGIC) (Schneider LS, Olin JT, Doody RS, Clark CM, Morris JC, Reisberg B, Schmitt FA, Grundman M, Thomas RG, Ferris SH, and the Alzheimer's Disease Cooperative Study. Validity and Reliability of the Alzheimer's Disease Cooperative Study-Clinical Global Impression of Change. Alzheimer Disease and Associated Disorders. 1997; 11(2):S22-S32).","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Alzheimer's Disease Cooperative Study-Clinical Global Impression of Change Questionnaire","conceptCode":"C103515","definition":"A standardized rating scale developed by Lon S. Schneider in 1997 to evaluate a clinically relevant change in an individual's Alzheimer's Disease symptoms. This instrument consists of an interview that is given to both the patient and their caregiver by a clinician at a baseline visit and then is repeated at the 2, 6, and 12 month visits. Based on the information gather at the 2, 6, and 12 month visits, the clinician rates the patients change from baseline on a 7 increment scale ranging from 'Marked Improvement' to 'Marked Worsening.'","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"81CE4750-3A80-6019-E053-F662850AE483","latestVersionIndicator":"Yes","beginDate":"2019-02-13","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-02-13","modifiedBy":"ONEDATA","dateModified":"2019-02-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5C85-0412-E063-731AD00A56D4","beginDate":"2019-02-13","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"ADHD-RS-IV HOME VERSION","valueDescription":"ADHD Rating Scale-IV Home Version Questionnaire","ValueMeaning":{"publicId":"6642924","version":"1","preferredName":"ADHD Rating Scale-IV Home Version Questionnaire","longName":"6642924","preferredDefinition":"A standardized rating scale developed by DuPaul et al in 1998 based on the DSM-IV criteria, which is used for the diagnosis of ADHD in children and adolescents, and for the assessment of treatment response. This questionnaire requires a subject to rate the frequency and severity of inattentive and hyperactive-impulsive symptoms on a scale of 0 to 3: never or rarely (0), sometimes (1), often (2), or very often (3).","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"ADHD Rating Scale-IV Home Version Questionnaire","conceptCode":"C122371","definition":"A standardized rating scale developed by DuPaul et al in 1998 based on the DSM-IV criteria, which is used for the diagnosis of ADHD in children and adolescents, and for the assessment of treatment response. This questionnaire requires a subject to rate the frequency and severity of inattentive and hyperactive-impulsive symptoms on a scale of 0 to 3: never or rarely (0), sometimes (1), often (2), or very often (3).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"81CE4750-3AA6-6019-E053-F662850AE483","latestVersionIndicator":"Yes","beginDate":"2019-02-13","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-02-13","modifiedBy":"ONEDATA","dateModified":"2019-02-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5C86-0412-E063-731AD00A56D4","beginDate":"2019-02-13","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"AQLQ","valueDescription":"Asthma Quality of Life Questionnaire","ValueMeaning":{"publicId":"6642930","version":"1","preferredName":"Asthma Quality of Life Questionnaire","longName":"6642930","preferredDefinition":"A standardized rating scale developed by Juniper et al in 1992, which is used to measure the physical and emotional impacts on quality of life in patients with asthma. This questionnaire contains 32 items using a 7-point scale, and the items are grouped into four domains: activity limitations, symptoms, emotional function, and exposure to environmental stimuli.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Asthma Quality of Life Questionnaire","conceptCode":"C122372","definition":"A standardized rating scale developed by Juniper et al in 1992, which is used to measure the physical and emotional impacts on quality of life in patients with asthma. This questionnaire contains 32 items using a 7-point scale, and the items are grouped into four domains: activity limitations, symptoms, emotional function, and exposure to environmental stimuli.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"81CE4750-3B18-6019-E053-F662850AE483","latestVersionIndicator":"Yes","beginDate":"2019-02-13","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-02-13","modifiedBy":"ONEDATA","dateModified":"2019-02-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5C87-0412-E063-731AD00A56D4","beginDate":"2019-02-13","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"BEBQ CONCURRENT","valueDescription":"Baby Eating Behaviour Questionnaire Concurrent Version","ValueMeaning":{"publicId":"6642944","version":"1","preferredName":"Baby Eating Behaviour Questionnaire Concurrent Version","longName":"6642944","preferredDefinition":"A standardized 18-item concurrent parent-report questionnaire developed by Llewellyn et al in 2010 as a psychometric measure of infant appetite during the 0-3-month period of exclusive milk-feeding. The instrument, which is derived from the Children's Eating Behaviour Questionnaire, was designed to characterize appetite traits that might confer susceptibility to gain weight.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Baby Eating Behaviour Questionnaire Concurrent Version","conceptCode":"C135735","definition":"A standardized 18-item concurrent parent-report questionnaire developed by Llewellyn et al in 2010 as a psychometric measure of infant appetite during the 0-3-month period of exclusive milk-feeding. The instrument, which is derived from the Children's Eating Behaviour Questionnaire, was designed to characterize appetite traits that might confer susceptibility to gain weight.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"81CE4750-3C22-6019-E053-F662850AE483","latestVersionIndicator":"Yes","beginDate":"2019-02-13","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-02-13","modifiedBy":"ONEDATA","dateModified":"2019-02-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5C88-0412-E063-731AD00A56D4","beginDate":"2019-02-13","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"BEBQ RETROSPECTIVE","valueDescription":"Baby Eating Behaviour Questionnaire Retrospective Version","ValueMeaning":{"publicId":"6642946","version":"1","preferredName":"Baby Eating Behaviour Questionnaire Retrospective Version","longName":"6642946","preferredDefinition":"A standardized 18-item retrospective parent-report questionnaire developed by Llewellyn et al in 2010 as a psychometric measure of infant appetite during the 0-3-month period of exclusive milk-feeding. The instrument, which is derived from the Children's Eating Behaviour Questionnaire, was designed to characterize appetite traits that might confer susceptibility to gain weight.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Baby Eating Behaviour Questionnaire Retrospective Version","conceptCode":"C135736","definition":"A standardized 18-item retrospective parent-report questionnaire developed by Llewellyn et al in 2010 as a psychometric measure of infant appetite during the 0-3-month period of exclusive milk-feeding. The instrument, which is derived from the Children's Eating Behaviour Questionnaire, was designed to characterize appetite traits that might confer susceptibility to gain weight.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"81CE4750-3C48-6019-E053-F662850AE483","latestVersionIndicator":"Yes","beginDate":"2019-02-13","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-02-13","modifiedBy":"ONEDATA","dateModified":"2019-02-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5C89-0412-E063-731AD00A56D4","beginDate":"2019-02-13","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"BLCS","valueDescription":"Bladder Control Scale Questionnaire","ValueMeaning":{"publicId":"6642948","version":"1","preferredName":"Bladder Control Scale Questionnaire","longName":"6642948","preferredDefinition":"A standardized rating scale developed by Turnbull et al in 1992, which measures the level of bladder function and control, as well as the extent to which bladder problems have an impact on everyday activities. The questionnaire contains 4 questions which are scored ranging from 0 (not at all) to 4 (daily).","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Bladder Control Scale Questionnaire","conceptCode":"C113874","definition":"A standardized rating scale developed by Turnbull et al in 1992, which measures the level of bladder function and control, as well as the extent to which bladder problems have an impact on everyday activities. The questionnaire contains 4 questions which are scored ranging from 0 (not at all) to 4 (daily).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"81CE4750-3C6E-6019-E053-F662850AE483","latestVersionIndicator":"Yes","beginDate":"2019-02-13","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-02-13","modifiedBy":"ONEDATA","dateModified":"2019-02-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5C8A-0412-E063-731AD00A56D4","beginDate":"2019-02-13","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"BORG CR10","valueDescription":"Borg Category-Ratio 10 Scale Questionnaire","ValueMeaning":{"publicId":"6642949","version":"1","preferredName":"Borg Category-Ratio 10 Scale Questionnaire","longName":"6642949","preferredDefinition":"A standardized rating scale developed by Gunnar Borg in 1998, which is used primarily in clinical diagnosis to measure perceived exertion or intensities of most kinds of experiences and feelings, such as breathlessness. The questionnaire contains 1 item which is scored ranging from 0 (nothing at all) to infinity.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Borg Category-Ratio 10 Scale Questionnaire","conceptCode":"C113872","definition":"A standardized rating scale developed by Gunnar Borg in 1998, which is used primarily in clinical diagnosis to measure perceived exertion or intensities of most kinds of experiences and feelings, such as breathlessness. The questionnaire contains 1 item which is scored ranging from 0 (nothing at all) to infinity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"81CE4750-3C91-6019-E053-F662850AE483","latestVersionIndicator":"Yes","beginDate":"2019-02-13","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-02-13","modifiedBy":"ONEDATA","dateModified":"2019-02-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5C8B-0412-E063-731AD00A56D4","beginDate":"2019-02-13","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"BWCS","valueDescription":"Bowel Control Scale Questionnaire","ValueMeaning":{"publicId":"6642956","version":"1","preferredName":"Bowel Control Scale Questionnaire","longName":"6642956","preferredDefinition":"A standardized rating scale developed by Turnbull et al in 1992, which measures the level of bowel function and control, as well as the extent to which bowel problems have an impact on everyday activities. The questionnaire contains 5 questions which are scored ranging from 0 (not at all) to 4 (daily).","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Bowel Control Scale Questionnaire","conceptCode":"C113875","definition":"A standardized rating scale developed by Turnbull et al in 1992, which measures the level of bowel function and control, as well as the extent to which bowel problems have an impact on everyday activities. The questionnaire contains 5 questions which are scored ranging from 0 (not at all) to 4 (daily).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"81CE4750-3D46-6019-E053-F662850AE483","latestVersionIndicator":"Yes","beginDate":"2019-02-13","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-02-13","modifiedBy":"ONEDATA","dateModified":"2019-02-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5C8C-0412-E063-731AD00A56D4","beginDate":"2019-02-13","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"BPI","valueDescription":"Brief Pain Inventory Questionnaire","ValueMeaning":{"publicId":"6642950","version":"1","preferredName":"Brief Pain Inventory Questionnaire","longName":"6642950","preferredDefinition":"A standardized survey originally developed and copyrighted by Charles S. Cleeland in 1991 which is used to evaluate the severity of a patient's pain and the impact that their pain has on their daily activities. This longer version is more clinically useful, can be completed by the patient or in an interview format and consists of 32 multi-level questions covering areas such as location, type, and severity of pain as well as the use of pain medications.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Brief Pain Inventory Questionnaire","conceptCode":"C100759","definition":"A standardized survey originally developed and copyrighted by Charles S. Cleeland in 1991 which is used to evaluate the severity of a patient's pain and the impact that their pain has on their daily activities. This longer version is more clinically useful, can be completed by the patient or in an interview format and consists of 32 multi-level questions covering areas such as location, type, and severity of pain as well as the use of pain medications.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"81CE4750-3CB4-6019-E053-F662850AE483","latestVersionIndicator":"Yes","beginDate":"2019-02-13","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-02-13","modifiedBy":"ONEDATA","dateModified":"2019-02-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5C8D-0412-E063-731AD00A56D4","beginDate":"2019-02-13","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"BPI SHORT FORM","valueDescription":"Brief Pain Inventory Short Form Questionnaire","ValueMeaning":{"publicId":"6642951","version":"1","preferredName":"Brief Pain Inventory Short Form Questionnaire","longName":"6642951","preferredDefinition":"A standardized survey originally developed and copyrighted by Charles S. Cleeland in 1991 which is used to evaluate the severity of a patient's pain and the impact that their pain has on their daily activities. This shorter version of the Brief Pain Inventory (BPI) is more useful for clinical trials, can be completed by the patient or in an interview format, and consists of only 9 questions most of which can be answered on a 0-10 rating scale.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Brief Pain Inventory Short Form Questionnaire","conceptCode":"C100760","definition":"A standardized survey originally developed and copyrighted by Charles S. Cleeland in 1991 which is used to evaluate the severity of a patient's pain and the impact that their pain has on their daily activities. This shorter version of the Brief Pain Inventory (BPI) is more useful for clinical trials, can be completed by the patient or in an interview format, and consists of only 9 questions most of which can be answered on a 0-10 rating scale.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"81CE4750-3CD7-6019-E053-F662850AE483","latestVersionIndicator":"Yes","beginDate":"2019-02-13","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-02-13","modifiedBy":"ONEDATA","dateModified":"2019-02-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5C8E-0412-E063-731AD00A56D4","beginDate":"2019-02-13","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"ASEX-FEMALE","valueDescription":"Arizona Sexual Experiences Scale-Female Version Questionnaire","ValueMeaning":{"publicId":"6642932","version":"1","preferredName":"Arizona Sexual Experiences Scale-Female Version Questionnaire","longName":"6642932","preferredDefinition":"A standardized rating scale developed by McGahuey et al in 2000, which is used to measure sexual dysfunction. The female version of the instrument contains 5 items and quantifies sex drive, arousal, vaginal lubrication, ability to reach orgasm, and satisfaction from orgasm.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Arizona Sexual Experiences Scale-Female Version Questionnaire","conceptCode":"C125757","definition":"A standardized rating scale developed by McGahuey et al in 2000, which is used to measure sexual dysfunction. The female version of the instrument contains 5 items and quantifies sex drive, arousal, vaginal lubrication, ability to reach orgasm, and satisfaction from orgasm.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"81CE4750-3B3E-6019-E053-F662850AE483","latestVersionIndicator":"Yes","beginDate":"2019-02-13","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-02-13","modifiedBy":"ONEDATA","dateModified":"2019-02-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5C8F-0412-E063-731AD00A56D4","beginDate":"2019-02-13","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"ASEX-MALE","valueDescription":"Arizona Sexual Experiences Scale-Male Version Questionnaire","ValueMeaning":{"publicId":"6642934","version":"1","preferredName":"Arizona Sexual Experiences Scale-Male Version Questionnaire","longName":"6642934","preferredDefinition":"A standardized rating scale developed by McGahuey et al in 2000, which is used to measure sexual dysfunction. The male version of the instrument contains 5 items and quantifies sex drive, arousal, penile erection, ability to reach orgasm, and satisfaction from orgasm.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Arizona Sexual Experiences Scale-Male Version Questionnaire","conceptCode":"C125758","definition":"A standardized rating scale developed by McGahuey et al in 2000, which is used to measure sexual dysfunction. The male version of the instrument contains 5 items and quantifies sex drive, arousal, penile erection, ability to reach orgasm, and satisfaction from orgasm.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"81CE4750-3B64-6019-E053-F662850AE483","latestVersionIndicator":"Yes","beginDate":"2019-02-13","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-02-13","modifiedBy":"ONEDATA","dateModified":"2019-02-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5C90-0412-E063-731AD00A56D4","beginDate":"2019-02-13","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"CDLQ","valueDescription":"Children's Dermatology Life Quality Index Questionnaire","ValueMeaning":{"publicId":"6642988","version":"1","preferredName":"Children's Dermatology Life Quality Index Questionnaire","longName":"6642988","preferredDefinition":"A standardized rating scale originally developed by Lewis-Jones and Finlay in 1995. This instrument is used to make quality of life assessment in children with skin conditions.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Children's Dermatology Life Quality Index Questionnaire","conceptCode":"C119092","definition":"A standardized rating scale originally developed by Lewis-Jones and Finlay in 1995. This instrument is used to make quality of life assessment in children with skin conditions.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"81CE4750-3FA6-6019-E053-F662850AE483","latestVersionIndicator":"Yes","beginDate":"2019-02-13","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-02-13","modifiedBy":"ONEDATA","dateModified":"2019-02-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5C91-0412-E063-731AD00A56D4","beginDate":"2019-02-13","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"AUDIT-C","valueDescription":"Alcohol Use Disorder Identification Test Alcohol Consumption Questions Questionnaire","ValueMeaning":{"publicId":"6642936","version":"1","preferredName":"Alcohol Use Disorder Identification Test Alcohol Consumption Questions Questionnaire","longName":"6642936","preferredDefinition":"A standardized rating scale developed by the World Health Organization (WHO), which is a modified version of the original Alcohol Use Disorder Identification Test (ADUIT). The questionnaire contains 3 questions, and is used to identify patients who are hazardous drinkers or have active alcohol use disorders.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Alcohol Use Disorder Identification Test Alcohol Consumption Questions Questionnaire","conceptCode":"C119098","definition":"A standardized rating scale developed by the World Health Organization (WHO), which is a modified version of the original Alcohol Use Disorder Identification Test (ADUIT). The questionnaire contains 3 questions, and is used to identify patients who are hazardous drinkers or have active alcohol use disorders.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"81CE4750-3B8A-6019-E053-F662850AE483","latestVersionIndicator":"Yes","beginDate":"2019-02-13","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-02-13","modifiedBy":"ONEDATA","dateModified":"2019-02-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5C92-0412-E063-731AD00A56D4","beginDate":"2019-02-13","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"AUDIT-SR","valueDescription":"Alcohol Use Disorder Identification Test Self-Report Version Questionnaire","ValueMeaning":{"publicId":"6642938","version":"1","preferredName":"Alcohol Use Disorder Identification Test Self-Report Version Questionnaire","longName":"6642938","preferredDefinition":"A standardized rating scale developed by the World Health Organization (WHO) to screen for excessive, hazardous or harmful alcohol consumption. The questionnaire contains 10 questions and evaluates the frequency and amount of alcohol use, alcohol-dependence symptoms and alcohol-related problems.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Alcohol Use Disorder Identification Test Self-Report Version Questionnaire","conceptCode":"C119097","definition":"A standardized rating scale developed by the World Health Organization (WHO) to screen for excessive, hazardous or harmful alcohol consumption. The questionnaire contains 10 questions and evaluates the frequency and amount of alcohol use, alcohol-dependence symptoms and alcohol-related problems.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"81CE4750-3BB0-6019-E053-F662850AE483","latestVersionIndicator":"Yes","beginDate":"2019-02-13","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-02-13","modifiedBy":"ONEDATA","dateModified":"2019-02-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5C93-0412-E063-731AD00A56D4","beginDate":"2019-02-13","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"CCQ 1 WEEK VERSION","valueDescription":"Clinical COPD Questionnaire 1 Week Version","ValueMeaning":{"publicId":"6642984","version":"1","preferredName":"Clinical COPD Questionnaire 1 Week Version","longName":"6642984","preferredDefinition":"A standardized rating scale originally developed by Thys van der Molen et al in 2003, which is a self-administered instrument used to measure clinical status of the airways and health-related quality of life in subjects with COPD. The 1 week version questionnaire contains 10 questions which are divided into 3 areas or domains: symptoms, mental state and functional state.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Clinical COPD Questionnaire 1 Week Version","conceptCode":"C119100","definition":"A standardized rating scale originally developed by Thys van der Molen et al in 2003, which is a self-administered instrument used to measure clinical status of the airways and health-related quality of life in subjects with COPD. The 1 week version questionnaire contains 10 questions which are divided into 3 areas or domains: symptoms, mental state and functional state.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"81CE4750-3F5A-6019-E053-F662850AE483","latestVersionIndicator":"Yes","beginDate":"2019-02-13","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-02-13","modifiedBy":"ONEDATA","dateModified":"2019-02-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5C94-0412-E063-731AD00A56D4","beginDate":"2019-02-13","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"CCQ 24 HOUR VERSION","valueDescription":"Clinical COPD Questionnaire 24 Hour Version","ValueMeaning":{"publicId":"6642986","version":"1","preferredName":"Clinical COPD Questionnaire 24 Hour Version","longName":"6642986","preferredDefinition":"A standardized rating scale originally developed by Thys van der Molen et al in 2003, which is a self-administered instrument used to measure clinical status of the airways and health-related quality of life in subjects with COPD. The 24 hour version questionnaire contains 10 questions which are divided into 3 areas or domains: symptoms, mental state and functional state.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Clinical COPD Questionnaire 24 Hour Version","conceptCode":"C119099","definition":"A standardized rating scale originally developed by Thys van der Molen et al in 2003, which is a self-administered instrument used to measure clinical status of the airways and health-related quality of life in subjects with COPD. The 24 hour version questionnaire contains 10 questions which are divided into 3 areas or domains: symptoms, mental state and functional state.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"81CE4750-3F80-6019-E053-F662850AE483","latestVersionIndicator":"Yes","beginDate":"2019-02-13","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-02-13","modifiedBy":"ONEDATA","dateModified":"2019-02-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5C95-0412-E063-731AD00A56D4","beginDate":"2019-02-13","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"CDR","valueDescription":"Clinical Dementia Rating Questionnaire","ValueMeaning":{"publicId":"6642990","version":"1","preferredName":"Clinical Dementia Rating Questionnaire","longName":"6642990","preferredDefinition":"A standardized rating scale developed by John C. Morris in 1997 to evaluate the severity of an individual's cognitive impairment. This instrument contains 6 areas which include memory, orientation, judgment and problem solving, community affairs, home and hobbies, and personal care. Each item is rated on a scale from 0 to 3 with 0 being none and 3 being severe.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Clinical Dementia Rating Questionnaire","conceptCode":"C102114","definition":"A standardized rating scale developed by John C. Morris in 1997 to evaluate the severity of an individual's cognitive impairment. This instrument contains 6 areas which include memory, orientation, judgment and problem solving, community affairs, home and hobbies, and personal care. Each item is rated on a scale from 0 to 3 with 0 being none and 3 being severe.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"81CE4750-3FCC-6019-E053-F662850AE483","latestVersionIndicator":"Yes","beginDate":"2019-02-13","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-02-13","modifiedBy":"ONEDATA","dateModified":"2019-02-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5C96-0412-E063-731AD00A56D4","beginDate":"2019-02-13","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"CGI","valueDescription":"Clinical Global Impression Generic Modification Version Questionnaire","ValueMeaning":{"publicId":"6642994","version":"1","preferredName":"Clinical Global Impression Generic Modification Version Questionnaire","longName":"6642994","preferredDefinition":"Clinical Global Impression (CGI) generic modification for any disease/condition concept use case (Modified from Guy W: ECDEU Assessment Manual for Psychopharmacology. Rockville, MD: U.S. Department of Health, Education, and Welfare; 1976).","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Clinical Global Impression Generic Modification Version Questionnaire","conceptCode":"C135738","definition":"A modified version of a standardized questionnaire published in 1976 by Guy et al. that was initially created to provide a clinician-determined summary measure of a patient's global functioning prior to and after initiating a study medication. It has been modified for use in any disease/condition concept use case.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"81CE4750-4018-6019-E053-F662850AE483","latestVersionIndicator":"Yes","beginDate":"2019-02-13","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-02-13","modifiedBy":"ONEDATA","dateModified":"2019-02-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5C97-0412-E063-731AD00A56D4","beginDate":"2019-02-13","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"COWS","valueDescription":"Clinical Opiate Withdrawal Scale Questionnaire","ValueMeaning":{"publicId":"6643005","version":"1","preferredName":"Clinical Opiate Withdrawal Scale Questionnaire","longName":"6643005","preferredDefinition":"A standardized rating scale developed by Wesson and Ling in 2003 to evaluate the severity of an individual's opiate withdrawal symptoms. This instrument consists of 11 signs or symptoms which are assessed and rated by a clinician. The severity of each sign or symptom correlates with a numerical value. A total score of 5-12 is 'mild'; 13-24 is 'moderate'; 25-36 is 'moderately severe'; and greater than 36 is 'severe withdrawal.'","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Clinical Opiate Withdrawal Scale Questionnaire","conceptCode":"C102115","definition":"A standardized rating scale developed by Wesson and Ling in 2003 to evaluate the severity of an individual's opiate withdrawal symptoms. This instrument consists of 11 signs or symptoms which are assessed and rated by a clinician. The severity of each sign or symptom correlates with a numerical value. A total score of 5-12 is 'mild'; 13-24 is 'moderate'; 25-36 is 'moderately severe'; and greater than 36 is 'severe withdrawal.'","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"81CE4750-40F9-6019-E053-F662850AE483","latestVersionIndicator":"Yes","beginDate":"2019-02-13","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-02-13","modifiedBy":"ONEDATA","dateModified":"2019-02-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5C98-0412-E063-731AD00A56D4","beginDate":"2019-02-13","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"BSI-18","valueDescription":"Brief Symptom Inventory 18","ValueMeaning":{"publicId":"6642954","version":"1","preferredName":"Brief Symptom Inventory 18","longName":"6642954","preferredDefinition":"The Brief Symptom Inventory 18 (BSI 18) assessment gathers patient-reported data to help measure psychological distress and psychiatric disorders in medical and community populations.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Brief Symptom Inventory 18","conceptCode":"C43524","definition":"The Brief Symptom Inventory 18 (BSI 18) assessment gathers patient-reported data to help measure psychological distress and psychiatric disorders in medical and community populations.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"81CE4750-3D20-6019-E053-F662850AE483","latestVersionIndicator":"Yes","beginDate":"2019-02-13","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-02-13","modifiedBy":"ONEDATA","dateModified":"2019-02-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5C99-0412-E063-731AD00A56D4","beginDate":"2019-02-13","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"C-SSRS ALREADY ENROLLED SUBJECTS","valueDescription":"Columbia-Suicide Severity Rating Scale Already Enrolled Subjects Questionnaire","ValueMeaning":{"publicId":"6642958","version":"1","preferredName":"Columbia-Suicide Severity Rating Scale Already Enrolled Subjects Questionnaire","longName":"6642958","preferredDefinition":"A standardized rating scale developed by Posner et al (version 1/14/09), which is used to determine the presence of suicidal ideation or behavior. The already enrolled subjects version questionnaire contains 24 items across 4 domains; suicidal ideation, intensity of ideation, suicidal behavior and actual attempts.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Columbia-Suicide Severity Rating Scale Already Enrolled Subjects Questionnaire","conceptCode":"C106695","definition":"A standardized rating scale developed by Posner et al (version 1/14/09), which is used to determine the presence of suicidal ideation or behavior. The already enrolled subjects version questionnaire contains 24 items across 4 domains; suicidal ideation, intensity of ideation, suicidal behavior and actual attempts.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"81CE4750-3D6C-6019-E053-F662850AE483","latestVersionIndicator":"Yes","beginDate":"2019-02-13","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-02-13","modifiedBy":"ONEDATA","dateModified":"2019-02-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5C9A-0412-E063-731AD00A56D4","beginDate":"2019-02-13","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"C-SSRS BASELINE","valueDescription":"Columbia-Suicide Severity Rating Scale Baseline Questionnaire","ValueMeaning":{"publicId":"6642960","version":"1","preferredName":"Columbia-Suicide Severity Rating Scale Baseline Questionnaire","longName":"6642960","preferredDefinition":"A standardized survey developed and copyrighted by Kelly Posner and colleagues with The Research Foundation for Mental Hygiene in 2008 which is used to evaluate a patient's suicidal tendencies. The baseline version questionnaire contains four sections with approximately 40 questions and is administered in an interview format. The first three sections pertain to the patient's suicidal ideations and behaviors while the fourth section assess any actual suicide attempts.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Columbia-Suicide Severity Rating Scale Baseline Questionnaire","conceptCode":"C100765","definition":"A standardized survey developed and copyrighted by Kelly Posner and colleagues with The Research Foundation for Mental Hygiene in 2008 which is used to evaluate a patient's suicidal tendencies. The baseline version questionnaire contains four sections with approximately 40 questions and is administered in an interview format. The first three sections pertain to the patient's suicidal ideations and behaviors while the fourth section assess any actual suicide attempts.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"81CE4750-3D92-6019-E053-F662850AE483","latestVersionIndicator":"Yes","beginDate":"2019-02-13","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-02-13","modifiedBy":"ONEDATA","dateModified":"2019-02-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5C9B-0412-E063-731AD00A56D4","beginDate":"2019-02-13","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"C-SSRS BASELINE/SCREENING VERSION","valueDescription":"Columbia-Suicide Severity Rating Scale Baseline/Screening Version Questionnaire","ValueMeaning":{"publicId":"6642962","version":"1","preferredName":"Columbia-Suicide Severity Rating Scale Baseline/Screening Version Questionnaire","longName":"6642962","preferredDefinition":"A standardized rating scale developed by Posner et al (version 1/14/09), which is used to determine the presence of suicidal ideation or behavior. The baseline/screening version questionnaire contains 23 items across 4 domains; suicidal ideation, intensity of ideation, suicidal behavior and actual attempts.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Columbia-Suicide Severity Rating Scale Baseline/Screening Version Questionnaire","conceptCode":"C106696","definition":"A standardized rating scale developed by Posner et al (version 1/14/09), which is used to determine the presence of suicidal ideation or behavior. The baseline/screening version questionnaire contains 23 items across 4 domains; suicidal ideation, intensity of ideation, suicidal behavior and actual attempts.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"81CE4750-3DB8-6019-E053-F662850AE483","latestVersionIndicator":"Yes","beginDate":"2019-02-13","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-02-13","modifiedBy":"ONEDATA","dateModified":"2019-02-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5C9C-0412-E063-731AD00A56D4","beginDate":"2019-02-13","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"C-SSRS BASELINE/SCREENING VERSION PHASE 1 STUDY","valueDescription":"Columbia-Suicide Severity Rating Scale Baseline/Screening Version Phase 1 Study 1/14/09 Questionnaire","ValueMeaning":{"publicId":"6642964","version":"1","preferredName":"Columbia-Suicide Severity Rating Scale Baseline/Screening Version Phase 1 Study 1/14/09 Questionnaire","longName":"6642964","preferredDefinition":"A standardized rating scale developed by Posner et al (version 1/14/09), which is used to determine the presence of suicidal ideation or behavior. The baseline/screening version phase 1 study questionnaire contains 23 items across 4 domains; suicidal ideation, intensity of ideation, suicidal behavior and actual attempts.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Columbia-Suicide Severity Rating Scale Baseline/Screening Version Phase 1 Study 1/14/09 Questionnaire","conceptCode":"C105164","definition":"A standardized rating scale developed by Posner et al (version 1/14/09), which is used to determine the presence of suicidal ideation or behavior. The baseline/screening version phase 1 study questionnaire contains 23 items across 4 domains; suicidal ideation, intensity of ideation, suicidal behavior and actual attempts.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"81CE4750-3DDE-6019-E053-F662850AE483","latestVersionIndicator":"Yes","beginDate":"2019-02-13","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-02-13","modifiedBy":"ONEDATA","dateModified":"2019-02-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5C9D-0412-E063-731AD00A56D4","beginDate":"2019-02-13","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"C-SSRS CHILDREN'S BASELINE","valueDescription":"Columbia-Suicide Severity Rating Scale Children's Baseline Questionnaire","ValueMeaning":{"publicId":"6642966","version":"1","preferredName":"Columbia-Suicide Severity Rating Scale Children's Baseline Questionnaire","longName":"6642966","preferredDefinition":"A standardized rating scale developed by Posner et al (version 6/23/10), which is used to determine the presence of suicidal ideation or behavior. The children's baseline version questionnaire contains 20 items across 4 domains; suicidal ideation, intensity of ideation, suicidal behavior and actual attempts.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Columbia-Suicide Severity Rating Scale Children's Baseline Questionnaire","conceptCode":"C111377","definition":"A standardized rating scale developed by Posner et al (version 6/23/10), which is used to determine the presence of suicidal ideation or behavior. The children's baseline version questionnaire contains 20 items across 4 domains; suicidal ideation, intensity of ideation, suicidal behavior and actual attempts.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"81CE4750-3E04-6019-E053-F662850AE483","latestVersionIndicator":"Yes","beginDate":"2019-02-13","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-02-13","modifiedBy":"ONEDATA","dateModified":"2019-02-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5C9E-0412-E063-731AD00A56D4","beginDate":"2019-02-13","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"C-SSRS CHILDREN'S BASELINE/SCREENING","valueDescription":"Columbia-Suicide Severity Rating Scale Children's Baseline/Screening Questionnaire","ValueMeaning":{"publicId":"6642968","version":"1","preferredName":"Columbia-Suicide Severity Rating Scale Children's Baseline/Screening Questionnaire","longName":"6642968","preferredDefinition":"A standardized rating scale developed by Posner et al (version 6/23/10), which is used to determine the presence of suicidal ideation or behavior. The children's baseline/screening version questionnaire contains 20 items across 4 domains; suicidal ideation (lifetime and past 6 months), intensity of ideation (lifetime and past 6 months), suicidal behavior and actual attempts.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Columbia-Suicide Severity Rating Scale Children's Baseline/Screening Questionnaire","conceptCode":"C111378","definition":"A standardized rating scale developed by Posner et al (version 6/23/10), which is used to determine the presence of suicidal ideation or behavior. The children's baseline/screening version questionnaire contains 20 items across 4 domains; suicidal ideation (lifetime and past 6 months), intensity of ideation (lifetime and past 6 months), suicidal behavior and actual attempts.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"81CE4750-3E2A-6019-E053-F662850AE483","latestVersionIndicator":"Yes","beginDate":"2019-02-13","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-02-13","modifiedBy":"ONEDATA","dateModified":"2019-02-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5C9F-0412-E063-731AD00A56D4","beginDate":"2019-02-13","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"C-SSRS CHILDREN'S SINCE LAST VISIT","valueDescription":"Columbia-Suicide Severity Rating Scale Children's Since Last Visit Questionnaire","ValueMeaning":{"publicId":"6642970","version":"1","preferredName":"Columbia-Suicide Severity Rating Scale Children's Since Last Visit Questionnaire","longName":"6642970","preferredDefinition":"A standardized rating scale developed by Posner et al (version 6/23/10), which is used to determine the presence of suicidal ideation or behavior. The children's since last visit version questionnaire contains 19 items across 4 domains; suicidal ideation, intensity of ideation, suicidal behavior and actual attempts.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Columbia-Suicide Severity Rating Scale Children's Since Last Visit Questionnaire","conceptCode":"C111379","definition":"A standardized rating scale developed by Posner et al (version 6/23/10), which is used to determine the presence of suicidal ideation or behavior. The children's since last visit version questionnaire contains 19 items across 4 domains; suicidal ideation, intensity of ideation, suicidal behavior and actual attempts.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"81CE4750-3E50-6019-E053-F662850AE483","latestVersionIndicator":"Yes","beginDate":"2019-02-13","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-02-13","modifiedBy":"ONEDATA","dateModified":"2019-02-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5CA0-0412-E063-731AD00A56D4","beginDate":"2019-02-13","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"C-SSRS LIFETIME/RECENT VERSION","valueDescription":"Columbia-Suicide Severity Rating Scale Lifetime/Recent Version Questionnaire","ValueMeaning":{"publicId":"6642972","version":"1","preferredName":"Columbia-Suicide Severity Rating Scale Lifetime/Recent Version Questionnaire","longName":"6642972","preferredDefinition":"A standardized rating scale developed by Posner et al (version 1/14/2009), which is used to determine the presence of suicidal ideation or behavior. The lifetime/recent version questionnaire contains 23 items across 4 domains; suicidal ideation (lifetime and past 1 month), intensity of ideation (lifetime and past 1 month), suicidal behavior (lifetime and past 3 months) and actual attempts.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Columbia-Suicide Severity Rating Scale Lifetime/Recent Version Questionnaire","conceptCode":"C117996","definition":"A standardized rating scale developed by Posner et al (version 1/14/2009), which is used to determine the presence of suicidal ideation or behavior. The lifetime/recent version questionnaire contains 23 items across 4 domains; suicidal ideation (lifetime and past 1 month), intensity of ideation (lifetime and past 1 month), suicidal behavior (lifetime and past 3 months) and actual attempts.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"81CE4750-3E76-6019-E053-F662850AE483","latestVersionIndicator":"Yes","beginDate":"2019-02-13","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-02-13","modifiedBy":"ONEDATA","dateModified":"2019-02-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5CA1-0412-E063-731AD00A56D4","beginDate":"2019-02-13","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"C-SSRS PEDIATRIC/COGNITIVELY IMPAIRED LIFETIME/RECENT","valueDescription":"Columbia-Suicide Severity Rating Scale Pediatric/Cognitively Impaired Lifetime/Recent Questionnaire","ValueMeaning":{"publicId":"6642974","version":"1","preferredName":"Columbia-Suicide Severity Rating Scale Pediatric/Cognitively Impaired Lifetime/Recent Questionnaire","longName":"6642974","preferredDefinition":"A standardized rating scale developed by Posner et al (version 6/23/10), which is used to determine the presence of suicidal ideation or behavior in pediatric patients. The pediatric/cognitively impaired lifetime/recent version questionnaire contains 20 items across 4 domains; suicidal ideation, intensity of ideation, suicidal behavior and actual attempts.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Columbia-Suicide Severity Rating Scale Pediatric/Cognitively Impaired Lifetime/Recent Questionnaire","conceptCode":"C113873","definition":"A standardized rating scale developed by Posner et al (version 6/23/10), which is used to determine the presence of suicidal ideation or behavior in pediatric patients. The pediatric/cognitively impaired lifetime/recent version questionnaire contains 20 items across 4 domains; suicidal ideation, intensity of ideation, suicidal behavior and actual attempts.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"81CE4750-3E9C-6019-E053-F662850AE483","latestVersionIndicator":"Yes","beginDate":"2019-02-13","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-02-13","modifiedBy":"ONEDATA","dateModified":"2019-02-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5CA2-0412-E063-731AD00A56D4","beginDate":"2019-02-13","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"C-SSRS PEDIATRIC/COGNITIVELY IMPAIRED-LIFETIME RECENT-CLINICAL","valueDescription":"Columbia-Suicide Severity Rating Scale Pediatric/Cognitively Impaired - Lifetime Recent - Clinical Questionnaire","ValueMeaning":{"publicId":"6642976","version":"1","preferredName":"Columbia-Suicide Severity Rating Scale Pediatric/Cognitively Impaired - Lifetime Recent - Clinical Questionnaire","longName":"6642976","preferredDefinition":"A standardized rating scale developed by Posner et al (version 6/23/2010), which is used to determine the presence of suicidal ideation or behavior. The pediatric/cognitively impaired - lifetime recent - clinical version questionnaire contains 4 domains; suicidal ideation, intensity of ideation, suicidal behavior and actual attempts.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Columbia-Suicide Severity Rating Scale Pediatric/Cognitively Impaired - Lifetime Recent - Clinical Questionnaire","conceptCode":"C123661","definition":"A standardized rating scale developed by Posner et al (version 6/23/2010), which is used to determine the presence of suicidal ideation or behavior. The pediatric/cognitively impaired - lifetime recent - clinical version questionnaire contains 4 domains; suicidal ideation, intensity of ideation, suicidal behavior and actual attempts.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"81CE4750-3EC2-6019-E053-F662850AE483","latestVersionIndicator":"Yes","beginDate":"2019-02-13","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-02-13","modifiedBy":"ONEDATA","dateModified":"2019-02-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5CA3-0412-E063-731AD00A56D4","beginDate":"2019-02-13","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"C-SSRS PEDIATRIC/COGNITIVELY IMPAIRED-SINCE LAST VISIT-CLINICAL","valueDescription":"Columbia-Suicide Severity Rating Scale Pediatric/Cognitively Impaired - Since Last Visit - Clinical Questionnaire","ValueMeaning":{"publicId":"6642978","version":"1","preferredName":"Columbia-Suicide Severity Rating Scale Pediatric/Cognitively Impaired - Since Last Visit - Clinical Questionnaire","longName":"6642978","preferredDefinition":"A standardized rating scale developed by Posner et al (version 6/23/2010), which is used to determine the presence of suicidal ideation or behavior. The pediatric/cognitively impaired - since last visit - clinical version questionnaire contains 4 domains; suicidal ideation, intensity of ideation, suicidal behavior and actual attempts.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Columbia-Suicide Severity Rating Scale Pediatric/Cognitively Impaired - Since Last Visit - Clinical Questionnaire","conceptCode":"C123662","definition":"A standardized rating scale developed by Posner et al (version 6/23/2010), which is used to determine the presence of suicidal ideation or behavior. The pediatric/cognitively impaired - since last visit - clinical version questionnaire contains 4 domains; suicidal ideation, intensity of ideation, suicidal behavior and actual attempts.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"81CE4750-3EE8-6019-E053-F662850AE483","latestVersionIndicator":"Yes","beginDate":"2019-02-13","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-02-13","modifiedBy":"ONEDATA","dateModified":"2019-02-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5CA4-0412-E063-731AD00A56D4","beginDate":"2019-02-13","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"CES","valueDescription":"Combat Exposure Scale Questionnaire","ValueMeaning":{"publicId":"6642992","version":"1","preferredName":"Combat Exposure Scale Questionnaire","longName":"6642992","preferredDefinition":"A standardized 7-item self-report scale that was developed by Keane et al in 1989 to measure combat exposure. The instrument is derived from Figley's combat scale (1980), with additional items included by consensus of a group of clinical psychologists with experience in the assessment and treatment of combat-related PTSD. The items are weighted according to the severity of the combat experience.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Combat Exposure Scale Questionnaire","conceptCode":"C132532","definition":"A standardized 7-item self-report scale that was developed by Keane et al in 1989 to measure combat exposure. The instrument is derived from Figley's combat scale (1980), with additional items included by consensus of a group of clinical psychologists with experience in the assessment and treatment of combat-related PTSD. The items are weighted according to the severity of the combat experience.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"81CE4750-3FF2-6019-E053-F662850AE483","latestVersionIndicator":"Yes","beginDate":"2019-02-13","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-02-13","modifiedBy":"ONEDATA","dateModified":"2019-02-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5CA5-0412-E063-731AD00A56D4","beginDate":"2019-02-13","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"COPD ASSESSMENT TEST","valueDescription":"COPD Assessment Test Questionnaire","ValueMeaning":{"publicId":"6643003","version":"1","preferredName":"COPD Assessment Test Questionnaire","longName":"6643003","preferredDefinition":"A standardized rating scale developed by Jones et al in 2009, which is a self-administered instrument used to measure the health status of patients with COPD. This instrument contains 8 items; each item is scored on a scale from 0 to 5.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"COPD Assessment Test Questionnaire","conceptCode":"C125756","definition":"A standardized rating scale developed by Jones et al in 2009, which is a self-administered instrument used to measure the health status of patients with COPD. This instrument contains 8 items; each item is scored on a scale from 0 to 5.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"81CE4750-40D3-6019-E053-F662850AE483","latestVersionIndicator":"Yes","beginDate":"2019-02-13","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-02-13","modifiedBy":"ONEDATA","dateModified":"2019-02-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5CA6-0412-E063-731AD00A56D4","beginDate":"2019-02-13","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"C-SSRS SCREENING","valueDescription":"Columbia-Suicide Severity Rating Scale Screening Questionnaire","ValueMeaning":{"publicId":"6642980","version":"1","preferredName":"Columbia-Suicide Severity Rating Scale Screening Questionnaire","longName":"6642980","preferredDefinition":"A standardized rating scale developed by Posner et al (version 1/14/09), which is used to determine the presence of suicidal ideation or behavior. The screening version questionnaire contains 23 items across 4 domains; suicidal ideation, intensity of ideation, suicidal behavior and actual attempts.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Columbia-Suicide Severity Rating Scale Screening Questionnaire","conceptCode":"C111380","definition":"A standardized rating scale developed by Posner et al (version 1/14/09), which is used to determine the presence of suicidal ideation or behavior. The screening version questionnaire contains 23 items across 4 domains; suicidal ideation, intensity of ideation, suicidal behavior and actual attempts.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"81CE4750-3F0E-6019-E053-F662850AE483","latestVersionIndicator":"Yes","beginDate":"2019-02-13","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-02-13","modifiedBy":"ONEDATA","dateModified":"2019-02-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5CA7-0412-E063-731AD00A56D4","beginDate":"2019-02-13","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"C-SSRS SINCE LAST VISIT","valueDescription":"Columbia-Suicide Severity Rating Scale Since Last Visit Questionnaire","ValueMeaning":{"publicId":"6642982","version":"1","preferredName":"Columbia-Suicide Severity Rating Scale Since Last Visit Questionnaire","longName":"6642982","preferredDefinition":"A standardized survey developed and copyrighted by Kelly Posner and colleagues with The Research Foundation for Mental Hygiene in 2008 which is used to evaluate a patient's suicidal tendencies at a subsequent visit. The since last visit version questionnaire contains four sections with approximately 40 questions and is administered in an interview format. The first three sections pertain to the patient's suicidal ideations and behaviors while the fourth section assess any actual suicide attempts.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Columbia-Suicide Severity Rating Scale Since Last Visit Questionnaire","conceptCode":"C103516","definition":"A standardized survey developed and copyrighted by Kelly Posner and colleagues with The Research Foundation for Mental Hygiene in 2008 which is used to evaluate a patient's suicidal tendencies at a subsequent visit. The since last visit version questionnaire contains four sections with approximately 40 questions and is administered in an interview format. The first three sections pertain to the patient's suicidal ideations and behaviors while the fourth section assess any actual suicide attempts.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"81CE4750-3F34-6019-E053-F662850AE483","latestVersionIndicator":"Yes","beginDate":"2019-02-13","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-02-13","modifiedBy":"ONEDATA","dateModified":"2019-02-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5CA8-0412-E063-731AD00A56D4","beginDate":"2019-02-13","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"COMM","valueDescription":"Current Opioid Misuse Measure Questionnaire","ValueMeaning":{"publicId":"6643001","version":"1","preferredName":"Current Opioid Misuse Measure Questionnaire","longName":"6643001","preferredDefinition":"A standardized rating scale developed and copyrighted by Inflexxicon, Inc. which is used to aid clinicians in determining if a patient may be improperly using opioids for the treatment of pain. This instrument consists of 17 questions which can be completed by the patient. Each question is rated on a scale of 0-4 with 0 being 'never' and 4 being 'very often'. A score equal to or greater than 9 indicates possible misuse.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Current Opioid Misuse Measure Questionnaire","conceptCode":"C100764","definition":"A standardized rating scale developed and copyrighted by Inflexxicon, Inc. which is used to aid clinicians in determining if a patient may be improperly using opioids for the treatment of pain. This instrument consists of 17 questions which can be completed by the patient. Each question is rated on a scale of 0-4 with 0 being 'never' and 4 being 'very often'. A score equal to or greater than 9 indicates possible misuse.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"81CE4750-40AD-6019-E053-F662850AE483","latestVersionIndicator":"Yes","beginDate":"2019-02-13","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-02-13","modifiedBy":"ONEDATA","dateModified":"2019-02-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5CA9-0412-E063-731AD00A56D4","beginDate":"2019-02-13","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"CHART-SF INTERVIEW VERSION","valueDescription":"Craig Handicap Assessment and Reporting Technique-Short Form Interview Version Questionnaire","ValueMeaning":{"publicId":"6642997","version":"1","preferredName":"Craig Handicap Assessment and Reporting Technique-Short Form Interview Version Questionnaire","longName":"6642997","preferredDefinition":"A standardized rating scale originally developed by Whiteneck et al in 1992 and modified in 2000, which is used to measure the degree to which impairments and disabilities result in handicaps in the years after initial rehabilitation. The questionnaire contains 19 questions and generates 6 subscales: physical independence, cognitive independence, mobility, occupation, social integration and economic self-sufficiency.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Craig Handicap Assessment and Reporting Technique-Short Form Interview Version Questionnaire","conceptCode":"C117995","definition":"A standardized rating scale originally developed by Whiteneck et al in 1992 and modified in 2000, which is used to measure the degree to which impairments and disabilities result in handicaps in the years after initial rehabilitation. The questionnaire contains 19 questions and generates 6 subscales: physical independence, cognitive independence, mobility, occupation, social integration and economic self-sufficiency.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"81CE4750-4061-6019-E053-F662850AE483","latestVersionIndicator":"Yes","beginDate":"2019-02-13","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-02-13","modifiedBy":"ONEDATA","dateModified":"2019-02-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5CAA-0412-E063-731AD00A56D4","beginDate":"2019-02-13","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"DLQI","valueDescription":"Dermatology Life Quality Index Questionnaire","ValueMeaning":{"publicId":"6643015","version":"1","preferredName":"Dermatology Life Quality Index Questionnaire","longName":"6643015","preferredDefinition":"A standardized rating scale originally developed by Finlay and Khan in 1994, which is a dermatology-specific health-related quality of life instrument. This questionnaire contains 10 questions concerning symptoms and feelings, daily activities, leisure, work, and school, personal relationships and treatment. Each question can be answered with: very much, a lot, a little or not at all.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Dermatology Life Quality Index Questionnaire","conceptCode":"C119102","definition":"A standardized rating scale originally developed by Finlay and Khan in 1994, which is a dermatology-specific health-related quality of life instrument. This questionnaire contains 10 questions concerning symptoms and feelings, daily activities, leisure, work, and school, personal relationships and treatment. Each question can be answered with: very much, a lot, a little or not at all.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"81CE4750-41B7-6019-E053-F662850AE483","latestVersionIndicator":"Yes","beginDate":"2019-02-13","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-02-13","modifiedBy":"ONEDATA","dateModified":"2019-02-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5CAB-0412-E063-731AD00A56D4","beginDate":"2019-02-13","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"DAD","valueDescription":"Disability Assessment for Dementia Questionnaire","ValueMeaning":{"publicId":"6643011","version":"1","preferredName":"Disability Assessment for Dementia Questionnaire","longName":"6643011","preferredDefinition":"A standardized questionnaire developed by Gelinas et al in 1998, which is used to measure the changes in functional activities in patients with Alzheimer's disease. The questionnaire contains 40 items across 3 domains; basic activities of daily living, instrumental activities of daily living and leisure activities.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Disability Assessment for Dementia Questionnaire","conceptCode":"C105165","definition":"A standardized questionnaire developed by Gelinas et al in 1998, which is used to measure the changes in functional activities in patients with Alzheimer's disease. The questionnaire contains 40 items across 3 domains; basic activities of daily living, instrumental activities of daily living and leisure activities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"81CE4750-416B-6019-E053-F662850AE483","latestVersionIndicator":"Yes","beginDate":"2019-02-13","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-02-13","modifiedBy":"ONEDATA","dateModified":"2019-02-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5CAC-0412-E063-731AD00A56D4","beginDate":"2019-02-13","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"EPDS","valueDescription":"Edinburgh Postnatal Depression Scale Questionnaire","ValueMeaning":{"publicId":"6643024","version":"1","preferredName":"Edinburgh Postnatal Depression Scale Questionnaire","longName":"6643024","preferredDefinition":"A standardized 10-item self-report scale that was developed by Cox et al 1987 to assist health professionals in identifying possible symptoms of depression in the postnatal period. The instrument utilizes a 4-point symptom rating scale to allow women to grade their experiences over the past seven days.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Edinburgh Postnatal Depression Scale Questionnaire","conceptCode":"C132533","definition":"A standardized 10-item self-report scale that was developed by Cox et al 1987 to assist health professionals in identifying possible symptoms of depression in the postnatal period. The instrument utilizes a 4-point symptom rating scale to allow women to grade their experiences over the past seven days.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"81CE4750-4272-6019-E053-F662850AE483","latestVersionIndicator":"Yes","beginDate":"2019-02-13","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-02-13","modifiedBy":"ONEDATA","dateModified":"2019-02-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5CAD-0412-E063-731AD00A56D4","beginDate":"2019-02-13","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"ESS","valueDescription":"Epworth Sleepiness Scale Questionnaire","ValueMeaning":{"publicId":"6643031","version":"1","preferredName":"Epworth Sleepiness Scale Questionnaire","longName":"6643031","preferredDefinition":"A standardized rating scale used to assess an individual's general level of daytime sleepiness.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Epworth Sleepiness Scale Questionnaire","conceptCode":"C103517","definition":"A standardized rating scale used to assess an individual's general level of daytime sleepiness.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"81CE4750-4327-6019-E053-F662850AE483","latestVersionIndicator":"Yes","beginDate":"2019-02-13","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-02-13","modifiedBy":"ONEDATA","dateModified":"2019-02-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5CAE-0412-E063-731AD00A56D4","beginDate":"2019-02-13","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"PODCI - ADOLESCENT SELF REPORTED","valueDescription":"Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported Version Questionnaire","ValueMeaning":{"publicId":"6643538","version":"1","preferredName":"Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported Version Questionnaire","longName":"6643538","preferredDefinition":"A standardized 83-item self-report questionnaire, developed by the American Academy of Orthopaedic Surgeons and the Pediatric Orthopaedic Society of North America (POSNA) in 1998 to assess the overall health, pain, and ability to participate in normal daily activities in patients 11 to 18 years of age. The instrument includes five scales: upper extremity and physical function, transfer and mobility tasks, sports/physical functioning, pain/comfort, treatment expectations, happiness, and satisfaction with symptoms, as well as a Global Functioning scale that consists of the mean of the values for the first four scales.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported Version Questionnaire","conceptCode":"C135744","definition":"A standardized 83-item self-report questionnaire, developed by the American Academy of Orthopaedic Surgeons and the Pediatric Orthopaedic Society of North America (POSNA) in 1998 to assess the overall health, pain, and ability to participate in normal daily activities in patients 11 to 18 years of age. The instrument includes five scales: upper extremity and physical function, transfer and mobility tasks, sports/physical functioning, pain/comfort, treatment expectations, happiness, and satisfaction with symptoms, as well as a Global Functioning scale that consists of the mean of the values for the first four scales.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"81E08FC2-61FC-6DE6-E053-F662850A1E6E","latestVersionIndicator":"Yes","beginDate":"2019-02-14","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-02-14","modifiedBy":"ONEDATA","dateModified":"2019-02-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5CAF-0412-E063-731AD00A56D4","beginDate":"2019-02-14","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2023-10-20","modifiedBy":"KUMMEROA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"WHODAS 2.0 - 12-ITEM INTERVIEWER","valueDescription":"World Health Organization Disability Assessment Schedule 2.0 12-item Version Interviewer-administered Questionnaire","ValueMeaning":{"publicId":"6643435","version":"1","preferredName":"World Health Organization Disability Assessment Schedule 2.0 12-item Version Interviewer-administered Questionnaire","longName":"6643435","preferredDefinition":"A standardized 12-item interviewer-administered questionnaire that utilizes a 5-point rating scale to provide a brief assessment of an individual's ability to perform activities in six domains of functioning over the 30 days prior to evaluation in order to calculate a global disability score. The questionnaire was developed in 2010 by the World Health Organization (WHO) Classification, Terminology and Standards team, within the framework of the WHO/National Institutes of Health (NIH) Joint Project on Assessment and Classification of Disability.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"World Health Organization Disability Assessment Schedule 2.0 12-item Version Interviewer-administered Questionnaire","conceptCode":"C130322","definition":"A standardized 12-item interviewer-administered questionnaire that utilizes a 5-point rating scale to provide a brief assessment of an individual's ability to perform activities in six domains of functioning over the 30 days prior to evaluation in order to calculate a global disability score. The questionnaire was developed in 2010 by the World Health Organization (WHO) Classification, Terminology and Standards team, within the framework of the WHO/National Institutes of Health (NIH) Joint Project on Assessment and Classification of Disability.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"81DF52B1-9DF8-4DD9-E053-F662850A2BAE","latestVersionIndicator":"Yes","beginDate":"2019-02-14","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-02-14","modifiedBy":"ONEDATA","dateModified":"2019-02-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5CB0-0412-E063-731AD00A56D4","beginDate":"2019-02-14","endDate":null,"createdBy":"TAYLORT","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"NCCN-FACT FBRSI-24 V2","valueDescription":"National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Brain Symptom Index-24 Version 2 Questionnaire","ValueMeaning":{"publicId":"6643812","version":"1","preferredName":"National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Brain Symptom Index-24 Version 2 Questionnaire","longName":"6643812","preferredDefinition":"A standardized 24-item self-report rating scale that utilizes a five-point rating scale and a seven-day time frame to assess the symptoms in advanced brain tumors perceived as most important by patients and clinicians. Originally developed by Cella et al. in 2014, it is a modified version of the Functional Assessment of Cancer Therapy-Brain questionnaire (FACT-Br).","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Brain Symptom Index-24 Version 2 Questionnaire","conceptCode":"C150918","definition":"A standardized 24-item self-report rating scale that utilizes a five-point rating scale and a seven-day time frame to assess the symptoms in advanced brain tumors perceived as most important by patients and clinicians. Originally developed by Cella et al. in 2014, it is a modified version of the Functional Assessment of Cancer Therapy-Brain questionnaire (FACT-Br).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"81E18CEC-E981-621D-E053-F662850AC981","latestVersionIndicator":"Yes","beginDate":"2019-02-14","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-02-14","modifiedBy":"ONEDATA","dateModified":"2019-02-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5CB1-0412-E063-731AD00A56D4","beginDate":"2019-02-14","endDate":null,"createdBy":"TAYLORT","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"WHODAS 2.0 - 12 + 24-ITEM INTERVIEWER","valueDescription":"World Health Organization Disability Assessment Schedule 2.0 12+24-item Version Interviewer-administered Questionnaire","ValueMeaning":{"publicId":"6643437","version":"1","preferredName":"World Health Organization Disability Assessment Schedule 2.0 12+24-item Version Interviewer-administered Questionnaire","longName":"6643437","preferredDefinition":"A standardized interviewer-administered or computer-adaptive testing (CAT) questionnaire that utilizes a 5-point rating scale to assess an individual's ability to perform activities in six domains of functioning over the 30 days prior to evaluation in order to calculate a global disability score. The questionnaire is initially administered as 12 items to screen for problematic domains of functioning. Up to 24 items are then added based on the initial responses. The questionnaire was developed in 2010 by the World Health Organization (WHO) Classification, Terminology and Standards team, within the framework of the WHO/National Institutes of Health (NIH) Joint Project on Assessment and Classification of Disability.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"World Health Organization Disability Assessment Schedule 2.0 12+24-item Version Interviewer-administered Questionnaire","conceptCode":"C130325","definition":"A standardized interviewer-administered or computer-adaptive testing (CAT) questionnaire that utilizes a 5-point rating scale to assess an individual's ability to perform activities in six domains of functioning over the 30 days prior to evaluation in order to calculate a global disability score. The questionnaire is initially administered as 12 items to screen for problematic domains of functioning. Up to 24 items are then added based on the initial responses. The questionnaire was developed in 2010 by the World Health Organization (WHO) Classification, Terminology and Standards team, within the framework of the WHO/National Institutes of Health (NIH) Joint Project on Assessment and Classification of Disability.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"81DF52B1-9E1E-4DD9-E053-F662850A2BAE","latestVersionIndicator":"Yes","beginDate":"2019-02-14","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-02-14","modifiedBy":"ONEDATA","dateModified":"2019-02-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5CB2-0412-E063-731AD00A56D4","beginDate":"2019-02-14","endDate":null,"createdBy":"TAYLORT","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"Q-LES-Q","valueDescription":"Quality Of Life Enjoyment And Satisfaction Questionnaire","ValueMeaning":{"publicId":"6643548","version":"1","preferredName":"Quality Of Life Enjoyment And Satisfaction Questionnaire","longName":"6643548","preferredDefinition":"A standardized self-report questionnaire, available as a 16-item short form for adults and 93-item long form for children, adolescents, and adults, that utilizes a 5-point rating scale to assess the degree of enjoyment and satisfaction experienced by individuals in various areas of daily functioning. The questionnaire was developed by Endicot et al. in 1993 to assess broad functional impairment in research and treatment settings.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Quality Of Life Enjoyment And Satisfaction Questionnaire","conceptCode":"C130317","definition":"A standardized self-report questionnaire, available as a 16-item short form for adults and 93-item long form for children, adolescents, and adults, that utilizes a 5-point rating scale to assess the degree of enjoyment and satisfaction experienced by individuals in various areas of daily functioning. The questionnaire was developed by Endicot et al. in 1993 to assess broad functional impairment in research and treatment settings.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"81E08FC2-62DA-6DE6-E053-F662850A1E6E","latestVersionIndicator":"Yes","beginDate":"2019-02-14","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-02-14","modifiedBy":"ONEDATA","dateModified":"2019-02-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5CB3-0412-E063-731AD00A56D4","beginDate":"2019-02-14","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"PODCI - PEDIATRIC PARENT REPORTED","valueDescription":"Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported Version Questionnaire","ValueMeaning":{"publicId":"6643542","version":"1","preferredName":"Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported Version Questionnaire","longName":"6643542","preferredDefinition":"A standardized 86-item parent-report questionnaire, developed by the American Academy of Orthopaedic Surgeons and the Pediatric Orthopaedic Society of North America (POSNA) in 1998 to assess the overall health, pain, and ability to participate in normal daily activities in patients 10 years of age or younger. The instrument includes five scales: upper extremity and physical function, transfer and mobility tasks, sports/physical functioning, pain/comfort, treatment expectations, happiness, and satisfaction with symptoms, as well as a Global Functioning scale that consists of the mean of the values for the first four scales.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported Version Questionnaire","conceptCode":"C135742","definition":"A standardized 86-item parent-report questionnaire, developed by the American Academy of Orthopaedic Surgeons and the Pediatric Orthopaedic Society of North America (POSNA) in 1998 to assess the overall health, pain, and ability to participate in normal daily activities in patients 10 years of age or younger. The instrument includes five scales: upper extremity and physical function, transfer and mobility tasks, sports/physical functioning, pain/comfort, treatment expectations, happiness, and satisfaction with symptoms, as well as a Global Functioning scale that consists of the mean of the values for the first four scales.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"81E08FC2-6248-6DE6-E053-F662850A1E6E","latestVersionIndicator":"Yes","beginDate":"2019-02-14","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-02-14","modifiedBy":"ONEDATA","dateModified":"2019-02-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5CB4-0412-E063-731AD00A56D4","beginDate":"2019-02-14","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2023-10-20","modifiedBy":"KUMMEROA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"Q-LES-Q-SF","valueDescription":"Quality of Life Enjoyment and Satisfaction Questionnaire-Short Form","ValueMeaning":{"publicId":"6643547","version":"1","preferredName":"Quality of Life Enjoyment and Satisfaction Questionnaire-Short Form","longName":"6643547","preferredDefinition":"A standardized 16-item self-report questionnaire that utilizes a 5-point rating scale to assess the degree of enjoyment and satisfaction experienced by adults in various areas of daily functioning. The questionnaire was developed by Endicot et al. in 1993 to assess broad functional impairment in research and treatment settings. \r\n","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Quality of Life Enjoyment and Satisfaction Questionnaire-Short Form","conceptCode":"C130318","definition":"A standardized 16-item self-report questionnaire that utilizes a 5-point rating scale to assess the degree of enjoyment and satisfaction experienced by adults in various areas of daily functioning. The questionnaire was developed by Endicot et al. in 1993 to assess broad functional impairment in research and treatment settings.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"81E08FC2-62B7-6DE6-E053-F662850A1E6E","latestVersionIndicator":"Yes","beginDate":"2019-02-14","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-02-14","modifiedBy":"HARTLEYG","dateModified":"2019-02-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5CB5-0412-E063-731AD00A56D4","beginDate":"2019-02-14","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"QIDS-SR","valueDescription":"Quick Inventory of Depressive Symptomatology Self-Report Version Questionnaire","ValueMeaning":{"publicId":"6643550","version":"1","preferredName":"Quick Inventory of Depressive Symptomatology Self-Report Version Questionnaire","longName":"6643550","preferredDefinition":"A standardized 16-item self-report questionnaire, derived from the 30-item Inventory of Depressive Symptomatology (IDS), that utilizes a 5-point rating scale for the assessment of the severity of depressive symptoms over the seven day period prior to evaluation. The original questionnaire, created by Rush et al. in 1986, includes the nine diagnostic DSM-IV symptom domains that are used to characterize a major depressive episode, as well as items to address melancholic and atypical features. The shortened, 16-item version was initially developed by Rush et al. in 2000 by selecting only items from the original scale that assessed DSM-IV criterion diagnostic symptoms.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Quick Inventory of Depressive Symptomatology Self-Report Version Questionnaire","conceptCode":"C130316","definition":"A standardized 16-item self-report questionnaire, derived from the 30-item Inventory of Depressive Symptomatology (IDS), that utilizes a 5-point rating scale for the assessment of the severity of depressive symptoms over the seven day period prior to evaluation. The original questionnaire, created by Rush et al. in 1986, includes the nine diagnostic DSM-IV symptom domains that are used to characterize a major depressive episode, as well as items to address melancholic and atypical features. The shortened, 16-item version was initially developed by Rush et al. in 2000 by selecting only items from the original scale that assessed DSM-IV criterion diagnostic symptoms.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"81E08FC2-6300-6DE6-E053-F662850A1E6E","latestVersionIndicator":"Yes","beginDate":"2019-02-14","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-02-14","modifiedBy":"ONEDATA","dateModified":"2019-02-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5CB6-0412-E063-731AD00A56D4","beginDate":"2019-02-14","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"RAND-36 V1.0","valueDescription":"RAND 36-Item Health Survey 1.0 Questionnaire","ValueMeaning":{"publicId":"6643578","version":"1","preferredName":"RAND 36-Item Health Survey 1.0 Questionnaire","longName":"6643578","preferredDefinition":"A standardized rating scale developed by Hays et al in 1993 and the RAND corporation as part of the Medical Outcome Study, which is a generic measurement of health-related quality of life. This questionnaire contains 36 questions and generates 8 subscales: physical functioning, bodily pain, role limitations due to physical health problems, role limitations due to personal or emotional problems, general mental health, social functioning, energy/fatigue, and general health perceptions.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"RAND 36-Item Health Survey 1.0 Questionnaire","conceptCode":"C113879","definition":"A standardized rating scale developed by Hays et al in 1993 and the RAND corporation as part of the Medical Outcome Study, which is a generic measurement of health-related quality of life. This questionnaire contains 36 questions and generates 8 subscales: physical functioning, bodily pain, role limitations due to physical health problems, role limitations due to personal or emotional problems, general mental health, social functioning, energy/fatigue, and general health perceptions.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"81E08FC2-6514-6DE6-E053-F662850A1E6E","latestVersionIndicator":"Yes","beginDate":"2019-02-14","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-02-14","modifiedBy":"ONEDATA","dateModified":"2019-02-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5CB7-0412-E063-731AD00A56D4","beginDate":"2019-02-14","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"SGRQ-C","valueDescription":"St. George's Respiratory Questionnaire for Chronic Obstructive Pulmonary Disease Patients","ValueMeaning":{"publicId":"6643596","version":"1","preferredName":"St. George's Respiratory Questionnaire for Chronic Obstructive Pulmonary Disease Patients","longName":"6643596","preferredDefinition":"St. George's Respiratory Questionnaire for COPD Patients (SGRQ-C) (Jones PW, Quirk FH, Baveystock CM, and Littlejohns PA. Self-complete measure of health status for chronic airflow limitation. The St. George's Respiratory Questionnaire. Am Rev Respir Dis. 1992 Jun; 145(6):1321-7).","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"St. George's Respiratory Questionnaire for Chronic Obstructive Pulmonary Disease Patients","conceptCode":"C106890","definition":"A standardized rating scale developed by Jones et al in 1992, which is a shorter version derived from the original SGRQ, and used to measure health impairment and perceived well-being (quality of life) in patients with asthma and chronic obstructive pulmonary disease (COPD). It has also been used in patients with bronchiectasis, post tuberculosis, kyphoscoliosis and sarcoidosis. The questionnaire contains 2 parts of 14 questions. Part 1 comprises questions 1 to 7 and addresses the frequency of a subject's respiratory symptoms. Part 2 has questions 8 to 14 and addresses the patient's current state.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"81E08FC2-666A-6DE6-E053-F662850A1E6E","latestVersionIndicator":"Yes","beginDate":"2019-02-14","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-02-14","modifiedBy":"ONEDATA","dateModified":"2019-02-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5CB8-0412-E063-731AD00A56D4","beginDate":"2019-02-14","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"SHORT-FORM MPQ-2","valueDescription":"Short-Form McGill Pain Questionnaire-2","ValueMeaning":{"publicId":"6643472","version":"1","preferredName":"Short-Form McGill Pain Questionnaire-2","longName":"6643472","preferredDefinition":"A standardized rating scale developed to evaluate the type and severity of a patients neuropathic or non-neuropathic pain. This revised version contains 22 symptoms associated with neuropathic and non-neuropathic pain which can be completed by the patient. Each symptom is rated on a scale of 0-10 with 0 being no pain and 10 being the worst possible pain. This questionnaire was copyrighted by Ronald Melzack and the Initiative on Methods, Measurement, and Pain Assessment in Clinical Trials (IMMPACT) in 2009 as well as published in the journal pain (Dworkin R.H., Development and initial validation of an expanded and revised version of the Short-form McGill Pain Questionnaire-2 (SF-MPQ-2). Pain, 2009 Jul;144(1-2):35-42).","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Short-Form McGill Pain Questionnaire-2","conceptCode":"C100776","definition":"A standardized rating scale developed to evaluate the type and severity of a patients neuropathic or non-neuropathic pain. This revised version contains 22 symptoms associated with neuropathic and non-neuropathic pain which can be completed by the patient. Each symptom is rated on a scale of 0-10 with 0 being no pain and 10 being the worst possible pain. This questionnaire was copyrighted by Ronald Melzack and the Initiative on Methods, Measurement, and Pain Assessment in Clinical Trials (IMMPACT) in 2009 as well as published in the journal pain (Dworkin R.H., Development and initial validation of an expanded and revised version of the Short-form McGill Pain Questionnaire-2 (SF-MPQ-2). Pain, 2009 Jul;144(1-2):35-42).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"81DFACE8-A0CA-5C5C-E053-F662850AD99A","latestVersionIndicator":"Yes","beginDate":"2019-02-14","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-02-14","modifiedBy":"ONEDATA","dateModified":"2019-02-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5CB9-0412-E063-731AD00A56D4","beginDate":"2019-02-14","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"SIQ-JR","valueDescription":"Suicidal Ideation Questionnaire-Junior","ValueMeaning":{"publicId":"6643806","version":"1","preferredName":"Suicidal Ideation Questionnaire-Junior","longName":"6643806","preferredDefinition":"A standardized 15-item self-report questionnaire developed by William M. Reynolds in 1987 that utilizes a seven-point rating scale to assess the frequency of suicidal thoughts in adolescents grades 7 to 9.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Suicidal Ideation Questionnaire-Junior","conceptCode":"C150921","definition":"A standardized 15-item self-report questionnaire developed by William M. Reynolds in 1987 that utilizes a seven-point rating scale to assess the frequency of suicidal thoughts in adolescents grades 7 to 9.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"81E18CEC-E90F-621D-E053-F662850AC981","latestVersionIndicator":"Yes","beginDate":"2019-02-14","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-02-14","modifiedBy":"ONEDATA","dateModified":"2019-02-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5CBA-0412-E063-731AD00A56D4","beginDate":"2019-02-14","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"SOAPP-R","valueDescription":"Screener and Opioid Assessment for Patients with Pain Revised Questionnaire","ValueMeaning":{"publicId":"6643474","version":"1","preferredName":"Screener and Opioid Assessment for Patients with Pain Revised Questionnaire","longName":"6643474","preferredDefinition":"A standardized rating scale developed and copyrighted by Inflexxicon, Inc. which is used to aid clinicians in screening a patient's potential for long-term opioid use in the treatment of pain. This revised version consists of 24 questions which can be completed by the patient. Each question is rated on a scale of 0-4 with 0 being 'never' and 4 being 'very often'. A score equal to or greater than 18 indicates that the patient has a high risk of misusing opioids.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Screener and Opioid Assessment for Patients with Pain Revised Questionnaire","conceptCode":"C100777","definition":"A standardized rating scale developed and copyrighted by Inflexxicon, Inc. which is used to aid clinicians in screening a patient's potential for long-term opioid use in the treatment of pain. This revised version consists of 24 questions which can be completed by the patient. Each question is rated on a scale of 0-4 with 0 being 'never' and 4 being 'very often'. A score equal to or greater than 18 indicates that the patient has a high risk of misusing opioids.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"81DFACE8-A0F0-5C5C-E053-F662850AD99A","latestVersionIndicator":"Yes","beginDate":"2019-02-14","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-02-14","modifiedBy":"ONEDATA","dateModified":"2019-02-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5CBB-0412-E063-731AD00A56D4","beginDate":"2019-02-14","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"VFQ-25 INTERVIEWER ADMINISTERED","valueDescription":"Visual Functioning Questionnaire 25-Interviewer Administered Format Version 2000","ValueMeaning":{"publicId":"6643441","version":"1","preferredName":"Visual Functioning Questionnaire 25-Interviewer Administered Format Version 2000","longName":"6643441","preferredDefinition":"A standardized rating scale developed by RAND and sponsored by the National Eye Institute (NEI) to assess the dimensions of self-reported vision-targeted health status that are most important for individuals with chronic eye disease. It also measures the influence of visual disability and symptoms on emotional well-being, mental health, social and daily visual functioning. This questionnaire is in the Interviewer Administered Format and contains 25 multiple choice questions across 3 domains; general health and vision, difficulty with activates, and response to vision problems. It also includes an appendix of additional 13 questions researchers can use to expand the scales up to 38 total items.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Visual Functioning Questionnaire 25-Interviewer Administered Format Version 2000","conceptCode":"C112527","definition":"A standardized rating scale developed by RAND and sponsored by the National Eye Institute (NEI) to assess the dimensions of self-reported vision-targeted health status that are most important for individuals with chronic eye disease. It also measures the influence of visual disability and symptoms on emotional well-being, mental health, social and daily visual functioning. This questionnaire is in the Interviewer Administered Format and contains 25 multiple choice questions across 3 domains; general health and vision, difficulty with activates, and response to vision problems. It also includes an appendix of additional 13 questions researchers can use to expand the scales up to 38 total items.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"81DF52B1-9E6A-4DD9-E053-F662850A2BAE","latestVersionIndicator":"Yes","beginDate":"2019-02-14","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-02-14","modifiedBy":"ONEDATA","dateModified":"2019-02-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5CBC-0412-E063-731AD00A56D4","beginDate":"2019-02-14","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"VFQ-25 SELF ADMINISTERED","valueDescription":"Visual Functioning Questionnaire 25-Self Administered Format Version 2000","ValueMeaning":{"publicId":"6643439","version":"1","preferredName":"Visual Functioning Questionnaire 25-Self Administered Format Version 2000","longName":"6643439","preferredDefinition":"A standardized rating scale developed by RAND and sponsored by the National Eye Institute (NEI) to assess the dimensions of self-reported vision-targeted health status that are most important for individuals with chronic eye disease. It also measures the influence of visual disability and symptoms on emotional well-being, mental health, social and daily visual functioning. This questionnaire is in the Self or Patient Administered Format and contains 25 multiple choice questions across 3 domains; general health and vision, difficulty with activates, and response to vision problems. It also includes an appendix of additional 13 questions researchers can use to expand the scales up to 38 total items.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Visual Functioning Questionnaire 25-Self Administered Format Version 2000","conceptCode":"C112528","definition":"A standardized rating scale developed by RAND and sponsored by the National Eye Institute (NEI) to assess the dimensions of self-reported vision-targeted health status that are most important for individuals with chronic eye disease. It also measures the influence of visual disability and symptoms on emotional well-being, mental health, social and daily visual functioning. This questionnaire is in the Self or Patient Administered Format and contains 25 multiple choice questions across 3 domains; general health and vision, difficulty with activates, and response to vision problems. It also includes an appendix of additional 13 questions researchers can use to expand the scales up to 38 total items.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"81DF52B1-9E44-4DD9-E053-F662850A2BAE","latestVersionIndicator":"Yes","beginDate":"2019-02-14","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-02-14","modifiedBy":"ONEDATA","dateModified":"2019-02-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5CBD-0412-E063-731AD00A56D4","beginDate":"2019-02-14","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"WHODAS 2.0 - 12-ITEM PROXY","valueDescription":"World Health Organization Disability Assessment Schedule 2.0 12-item Version Proxy-administered Questionnaire","ValueMeaning":{"publicId":"6643433","version":"1","preferredName":"World Health Organization Disability Assessment Schedule 2.0 12-item Version Proxy-administered Questionnaire","longName":"6643433","preferredDefinition":"A standardized 12-item questionnaire, administered by a friend, relative, or caretaker, that utilizes a 5-point rating scale to provide a brief assessment of an individual's ability to perform activities in six domains of functioning over the 30 days prior to evaluation in order to calculate a global disability score. The questionnaire was developed in 2010 by the World Health Organization (WHO) Classification, Terminology and Standards team, within the framework of the WHO/National Institutes of Health (NIH) Joint Project on Assessment and Classification of Disability.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"World Health Organization Disability Assessment Schedule 2.0 12-item Version Proxy-administered Questionnaire","conceptCode":"C130323","definition":"A standardized 12-item questionnaire, administered by a friend, relative, or caretaker, that utilizes a 5-point rating scale to provide a brief assessment of an individual's ability to perform activities in six domains of functioning over the 30 days prior to evaluation in order to calculate a global disability score. The questionnaire was developed in 2010 by the World Health Organization (WHO) Classification, Terminology and Standards team, within the framework of the WHO/National Institutes of Health (NIH) Joint Project on Assessment and Classification of Disability.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"81DF52B1-9DD2-4DD9-E053-F662850A2BAE","latestVersionIndicator":"Yes","beginDate":"2019-02-14","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-02-14","modifiedBy":"ONEDATA","dateModified":"2019-02-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5CBE-0412-E063-731AD00A56D4","beginDate":"2019-02-14","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"WHODAS 2.0 - 12-ITEM SELF","valueDescription":"World Health Organization Disability Assessment Schedule 2.0 12-item Version Self-administered Questionnaire","ValueMeaning":{"publicId":"6643431","version":"1","preferredName":"World Health Organization Disability Assessment Schedule 2.0 12-item Version Self-administered Questionnaire","longName":"6643431","preferredDefinition":"A standardized 12-item self-report questionnaire that utilizes a 5-point rating scale to provide a brief assessment of an individual's ability to perform activities in six domains of functioning over the 30 days prior to evaluation in order to calculate a global disability score. The questionnaire was developed in 2010 by the World Health Organization (WHO) Classification, Terminology and Standards team, within the framework of the WHO/National Institutes of Health (NIH) Joint Project on Assessment and Classification of Disability.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"World Health Organization Disability Assessment Schedule 2.0 12-item Version Self-administered Questionnaire","conceptCode":"C130324","definition":"A standardized 12-item self-report questionnaire that utilizes a 5-point rating scale to provide a brief assessment of an individual's ability to perform activities in six domains of functioning over the 30 days prior to evaluation in order to calculate a global disability score. The questionnaire was developed in 2010 by the World Health Organization (WHO) Classification, Terminology and Standards team, within the framework of the WHO/National Institutes of Health (NIH) Joint Project on Assessment and Classification of Disability.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"81DF52B1-9DAC-4DD9-E053-F662850A2BAE","latestVersionIndicator":"Yes","beginDate":"2019-02-14","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-02-14","modifiedBy":"ONEDATA","dateModified":"2019-02-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5CBF-0412-E063-731AD00A56D4","beginDate":"2019-02-14","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"WHODAS 2.0 - 36-ITEM INTERVIEWER","valueDescription":"World Health Organization Disability Assessment Schedule 2.0 36-item Version Interviewer-administered Questionnaire","ValueMeaning":{"publicId":"6643429","version":"1","preferredName":"World Health Organization Disability Assessment Schedule 2.0 36-item Version Interviewer-administered Questionnaire","longName":"6643429","preferredDefinition":"A standardized 36-item interviewer-administered questionnaire that utilizes a 5-point rating scale to assess an individual's ability to perform activities in six domains of functioning over the 30 days prior to evaluation in order to calculate a global disability score. The questionnaire was developed in 2010 by the World Health Organization (WHO) Classification, Terminology and Standards team, within the framework of the WHO/National Institutes of Health (NIH) Joint Project on Assessment and Classification of Disability.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"World Health Organization Disability Assessment Schedule 2.0 36-item Version Interviewer-administered Questionnaire","conceptCode":"C130319","definition":"A standardized 36-item interviewer-administered questionnaire that utilizes a 5-point rating scale to assess an individual's ability to perform activities in six domains of functioning over the 30 days prior to evaluation in order to calculate a global disability score. The questionnaire was developed in 2010 by the World Health Organization (WHO) Classification, Terminology and Standards team, within the framework of the WHO/National Institutes of Health (NIH) Joint Project on Assessment and Classification of Disability.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"81DF52B1-9D86-4DD9-E053-F662850A2BAE","latestVersionIndicator":"Yes","beginDate":"2019-02-14","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-02-14","modifiedBy":"ONEDATA","dateModified":"2019-02-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5CC0-0412-E063-731AD00A56D4","beginDate":"2019-02-14","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"WHODAS 2.0 - 36-ITEM PROXY","valueDescription":"World Health Organization Disability Assessment Schedule 2.0 36-item Version Proxy-administered Questionnaire","ValueMeaning":{"publicId":"6643427","version":"1","preferredName":"World Health Organization Disability Assessment Schedule 2.0 36-item Version Proxy-administered Questionnaire","longName":"6643427","preferredDefinition":"A standardized 36-item questionnaire, administered by a friend, relative, or caretaker, that utilizes a 5-point rating scale to assess an individual's ability to perform activities in six domains of functioning over the 30 days prior to evaluation in order to calculate a global disability score. The questionnaire was developed in 2010 by the World Health Organization (WHO) Classification, Terminology and Standards team, within the framework of the WHO/National Institutes of Health (NIH) Joint Project on Assessment and Classification of Disability.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"World Health Organization Disability Assessment Schedule 2.0 36-item Version Proxy-administered Questionnaire","conceptCode":"C130320","definition":"A standardized 36-item questionnaire, administered by a friend, relative, or caretaker, that utilizes a 5-point rating scale to assess an individual's ability to perform activities in six domains of functioning over the 30 days prior to evaluation in order to calculate a global disability score. The questionnaire was developed in 2010 by the World Health Organization (WHO) Classification, Terminology and Standards team, within the framework of the WHO/National Institutes of Health (NIH) Joint Project on Assessment and Classification of Disability.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"81DF52B1-9D60-4DD9-E053-F662850A2BAE","latestVersionIndicator":"Yes","beginDate":"2019-02-14","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-02-14","modifiedBy":"ONEDATA","dateModified":"2019-02-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5CC1-0412-E063-731AD00A56D4","beginDate":"2019-02-14","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"WPAI-SHP V2.0","valueDescription":"Work Productivity and Activity Impairment Specific Health Problems Version 2.0 Questionnaire","ValueMeaning":{"publicId":"6643415","version":"1","preferredName":"Work Productivity and Activity Impairment Specific Health Problems Version 2.0 Questionnaire","longName":"6643415","preferredDefinition":"The second version of a standardized survey originally developed by Margaret C. Reilly in 1993 which is used to evaluate the extent to which a patient's specific health problems effect their ability to work and perform daily activities. This instrument consist of 6 questions which can be completed by the patient or in an interview format.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Work Productivity and Activity Impairment Specific Health Problems Version 2.0 Questionnaire","conceptCode":"C100779","definition":"The second version of a standardized survey originally developed by Margaret C. Reilly in 1993 which is used to evaluate the extent to which a patient's specific health problems effect their ability to work and perform daily activities. This instrument consist of 6 questions which can be completed by the patient or in an interview format.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"81DF52B1-9C7C-4DD9-E053-F662850A2BAE","latestVersionIndicator":"Yes","beginDate":"2019-02-14","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-02-14","modifiedBy":"ONEDATA","dateModified":"2019-02-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5CC2-0412-E063-731AD00A56D4","beginDate":"2019-02-14","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2023-10-20","modifiedBy":"KUMMEROA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"NCCN-FACT FHNSI-22 V2","valueDescription":"National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Head & Neck Symptom Index-22 Version 2 Questionnaire","ValueMeaning":{"publicId":"6643810","version":"1","preferredName":"National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Head & Neck Symptom Index-22 Version 2 Questionnaire","longName":"6643810","preferredDefinition":"A standardized 22-item self-report rating scale to assess quality of life for patients diagnosed with head and neck cancers. Originally developed by Cella et al. in 2013, it is a modified version of the Functional Assessment of Cancer Therapy-Head and Neck questionnaire (FACT-HN) and is broken down into disease-related symptoms, treatment side effects, and general function and well-being.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Head & Neck Symptom Index-22 Version 2 Questionnaire","conceptCode":"C150919","definition":"A standardized 22-item self-report rating scale to assess quality of life for patients diagnosed with head and neck cancers. Originally developed by Cella et al. in 2013, it is a modified version of the Functional Assessment of Cancer Therapy-Head and Neck questionnaire (FACT-HN) and is broken down into disease-related symptoms, treatment side effects, and general function and well-being.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"81E18CEC-E95B-621D-E053-F662850AC981","latestVersionIndicator":"Yes","beginDate":"2019-02-14","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-02-14","modifiedBy":"ONEDATA","dateModified":"2019-02-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5CC3-0412-E063-731AD00A56D4","beginDate":"2019-02-14","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"NCCN-FACT FKSI-19 V2","valueDescription":"National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Kidney Symptom Index-19 Version 2 Questionnaire","ValueMeaning":{"publicId":"6643556","version":"1","preferredName":"National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Kidney Symptom Index-19 Version 2 Questionnaire","longName":"6643556","preferredDefinition":"A standardized 19-item rating scale for symptoms of advanced kidney cancer that is comprised of disease-related, treatment side effects, and general function and well-being subscales. Originally developed by Rao et al. in 2006, it is a modified version of the National Comprehensive Cancer Network (NCCN) 15-item Functional Assessment of Cancer Therapy - Kidney Symptom Index (FKSI-15) that incorporates additional symptoms rated as highest priority by patients and clinicians from the Functional Assessment of Cancer Therapy-Kidney Symptom Index-Disease-Related Symptoms (FKSI-DRS).","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Kidney Symptom Index-19 Version 2 Questionnaire","conceptCode":"C129106","definition":"A standardized 19-item rating scale for symptoms of advanced kidney cancer that is comprised of disease-related, treatment side effects, and general function and well-being subscales. Originally developed by Rao et al. in 2006, it is a modified version of the National Comprehensive Cancer Network (NCCN) 15-item Functional Assessment of Cancer Therapy - Kidney Symptom Index (FKSI-15) that incorporates additional symptoms rated as highest priority by patients and clinicians from the Functional Assessment of Cancer Therapy-Kidney Symptom Index-Disease-Related Symptoms (FKSI-DRS).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"81E08FC2-6372-6DE6-E053-F662850A1E6E","latestVersionIndicator":"Yes","beginDate":"2019-02-14","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-02-14","modifiedBy":"ONEDATA","dateModified":"2019-02-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5CC4-0412-E063-731AD00A56D4","beginDate":"2019-02-14","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"NCCN-FACT FOSI-18 V2","valueDescription":"National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Ovarian Symptom Index-18 Version 2 Questionnaire","ValueMeaning":{"publicId":"6643552","version":"1","preferredName":"National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Ovarian Symptom Index-18 Version 2 Questionnaire","longName":"6643552","preferredDefinition":"A standardized 18-item rating scale for the assessment of symptom response to treatment for advanced ovarian cancer, including subscales that are specific for disease-related symptoms, treatment-related symptoms, and general function/well-being. Originally developed by Cella, et al. in 1997, it is derived from the ovarian cancer-specific subscale of the Functional Assessment of Cancer Therapy (FACT-O).","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Ovarian Symptom Index-18 Version 2 Questionnaire","conceptCode":"C129110","definition":"A standardized 18-item rating scale for the assessment of symptom response to treatment for advanced ovarian cancer, including subscales that are specific for disease-related symptoms, treatment-related symptoms, and general function/well-being. Originally developed by Cella, et al. in 1997, it is derived from the ovarian cancer-specific subscale of the Functional Assessment of Cancer Therapy (FACT-O).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"81E08FC2-6326-6DE6-E053-F662850A1E6E","latestVersionIndicator":"Yes","beginDate":"2019-02-14","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-02-14","modifiedBy":"ONEDATA","dateModified":"2019-02-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5CC5-0412-E063-731AD00A56D4","beginDate":"2019-02-14","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"NCCN-FACT FPSI-17 V2","valueDescription":"National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Prostate Symptom Index 17 Version 2 Questionnaire","ValueMeaning":{"publicId":"6643560","version":"1","preferredName":"National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Prostate Symptom Index 17 Version 2 Questionnaire","longName":"6643560","preferredDefinition":"A standardized rating scale modified from FACT-G and FACT-P and developed by Victorson et al in 2011, based on the recommendations of the National Comprehensive Cancer Network (NCCN). This instrument contains 17 items, and is used to examine the effectiveness of noncurative treatments in patients with advanced prostate cancer.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Prostate Symptom Index 17 Version 2 Questionnaire","conceptCode":"C127370","definition":"A standardized rating scale modified from FACT-G and FACT-P and developed by Victorson et al in 2011, based on the recommendations of the National Comprehensive Cancer Network (NCCN). This instrument contains 17 items, and is used to examine the effectiveness of noncurative treatments in patients with advanced prostate cancer.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"81E08FC2-63BE-6DE6-E053-F662850A1E6E","latestVersionIndicator":"Yes","beginDate":"2019-02-14","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-02-14","modifiedBy":"ONEDATA","dateModified":"2019-02-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5CC6-0412-E063-731AD00A56D4","beginDate":"2019-02-14","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"NSCLC-SAQ V1.0","valueDescription":"Non-Small Cell Lung Cancer Symptom Assessment Questionnaire v1.0","ValueMeaning":{"publicId":"6643804","version":"1","preferredName":"Non-Small Cell Lung Cancer Symptom Assessment Questionnaire v1.0","longName":"6643804","preferredDefinition":"A standardized 7-item patient-reported outcome instrument, created by McCarrier et al. in 2016, that utilizes a 7-day recall period and a five-point verbal rating scale to assess symptoms of non-small cell lung cancer.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Non-Small Cell Lung Cancer Symptom Assessment Questionnaire v1.0","conceptCode":"C155327","definition":"A standardized 7-item patient-reported outcome instrument, created by McCarrier et al. in 2016, that utilizes a 7-day recall period and a five-point verbal rating scale to assess symptoms of non-small cell lung cancer.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"81E18CEC-E8E9-621D-E053-F662850AC981","latestVersionIndicator":"Yes","beginDate":"2019-02-14","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-02-14","modifiedBy":"ONEDATA","dateModified":"2019-02-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5CC7-0412-E063-731AD00A56D4","beginDate":"2019-02-14","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"OAB-Q","valueDescription":"The Overactive Bladder Questionnaire","ValueMeaning":{"publicId":"6643483","version":"1","preferredName":"The Overactive Bladder Questionnaire","longName":"6643483","preferredDefinition":"A standardized survey developed and published by K. Coyne and colleagues in 2002 in the journal Quality of Life Research which is used to evaluate the all symptoms associated with overactive bladder. This instrument contains 33 items pertaining to bladder symptoms occurring during the past week that can be self-administered. Each item is rated on a scale of 1-6 with 1 representing none or not at all and 6 representing a great deal or all the time.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"The Overactive Bladder Questionnaire","conceptCode":"C103523","definition":"A standardized survey developed and published by K. Coyne and colleagues in 2002 in the journal Quality of Life Research which is used to evaluate the all symptoms associated with overactive bladder. This instrument contains 33 items pertaining to bladder symptoms occurring during the past week that can be self-administered. Each item is rated on a scale of 1-6 with 1 representing none or not at all and 6 representing a great deal or all the time.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"81DFACE8-A1AB-5C5C-E053-F662850AD99A","latestVersionIndicator":"Yes","beginDate":"2019-02-14","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-02-14","modifiedBy":"ONEDATA","dateModified":"2019-02-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5CC8-0412-E063-731AD00A56D4","beginDate":"2019-02-14","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"GOSE","valueDescription":"Extended Glasgow Outcome Scale Questionnaire","ValueMeaning":{"publicId":"6643100","version":"1","preferredName":"Extended Glasgow Outcome Scale Questionnaire","longName":"6643100","preferredDefinition":"A standardized rating scale originally developed by Jennett and Bondin in 1975 and later modified by Wilson et al in 1998, which is used to assess outcome after, and level of function in major life areas with head injury and non-traumatic acute brain insults. The questionnaire contains 23 items and generates 7 subscales: consciousness, independence in the home, independence outside the home, work, social and leisure activities, family and friendships, and epilepsy.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Extended Glasgow Outcome Scale Questionnaire","conceptCode":"C115797","definition":"A standardized rating scale originally developed by Jennett and Bondin in 1975 and later modified by Wilson et al in 1998, which is used to assess outcome after, and level of function in major life areas with head injury and non-traumatic acute brain insults. The questionnaire contains 23 items and generates 7 subscales: consciousness, independence in the home, independence outside the home, work, social and leisure activities, family and friendships, and epilepsy.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"81CE4750-4896-6019-E053-F662850AE483","latestVersionIndicator":"Yes","beginDate":"2019-02-13","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-02-13","modifiedBy":"ONEDATA","dateModified":"2019-02-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5CC9-0412-E063-731AD00A56D4","beginDate":"2019-02-13","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"FPSR","valueDescription":"Faces Pain Scale Revised Questionnaire","ValueMeaning":{"publicId":"6643091","version":"1","preferredName":"Faces Pain Scale Revised Questionnaire","longName":"6643091","preferredDefinition":"A standardized rating scale developed and copyrighted by the International Association for the Study of Pain (IASP) in 2001 but is available for non-commercial clinical, educational and research use in the journal Pain (Hicks CL, von Baeyer CL, Spafford P, van Korlaar I, Goodenough B. The Faces Pain Scale - Revised: Toward a common metric in pediatric pain measurement. Pain 2001;93:173-183). This instrument is used to evaluate the severity of pain in an individual who is unable to use a numerical scale alone such as a child. The scale consists of six facial expression representing varying levels of pain which correspond to a number between 0 and 10 where the 0 face represents 'no pain' and the 10 face represents 'very much pain'.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Faces Pain Scale Revised Questionnaire","conceptCode":"C100766","definition":"A standardized rating scale developed and copyrighted by the International Association for the Study of Pain (IASP) in 2001 but is available for non-commercial clinical, educational and research use in the journal Pain (Hicks CL, von Baeyer CL, Spafford P, van Korlaar I, Goodenough B. The Faces Pain Scale - Revised: Toward a common metric in pediatric pain measurement. Pain 2001;93:173-183). This instrument is used to evaluate the severity of pain in an individual who is unable to use a numerical scale alone such as a child. The scale consists of six facial expression representing varying levels of pain which correspond to a number between 0 and 10 where the 0 face represents 'no pain' and the 10 face represents 'very much pain'.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"81CE4750-47BB-6019-E053-F662850AE483","latestVersionIndicator":"Yes","beginDate":"2019-02-13","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-02-13","modifiedBy":"ONEDATA","dateModified":"2019-02-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5CCA-0412-E063-731AD00A56D4","beginDate":"2019-02-13","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"MNSI","valueDescription":"Michigan Neuropathy Screening Instrument Questionnaire","ValueMeaning":{"publicId":"6643464","version":"1","preferredName":"Michigan Neuropathy Screening Instrument Questionnaire","longName":"6643464","preferredDefinition":"A standardized survey developed and copyrighted by the University of Michigan's Diabetes Research and Training Center and is based on Peter Dyck's Neuropathy Screening Profile (Dyck PJ, Karnes J, O'Brien PC, Swanson CJ, Neuropathy Symptom Profile in health, motor neuron disease, diabetic neuropathy, and amyloidosis. Neurology, 1986, 36:1300-1308) which is used to screen for neuropathy particularly in individuals with diabetes. This instrument consists of two parts, the first part is a patient history and can be completed by the patient while the second part is physical exam completed by a health professional.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Michigan Neuropathy Screening Instrument Questionnaire","conceptCode":"C100771","definition":"A standardized survey developed and copyrighted by the University of Michigan's Diabetes Research and Training Center and is based on Peter Dyck's Neuropathy Screening Profile (Dyck PJ, Karnes J, O'Brien PC, Swanson CJ, Neuropathy Symptom Profile in health, motor neuron disease, diabetic neuropathy, and amyloidosis. Neurology, 1986, 36:1300-1308) which is used to screen for neuropathy particularly in individuals with diabetes. This instrument consists of two parts, the first part is a patient history and can be completed by the patient while the second part is physical exam completed by a health professional.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"81DFACE8-A032-5C5C-E053-F662850AD99A","latestVersionIndicator":"Yes","beginDate":"2019-02-14","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-02-14","modifiedBy":"ONEDATA","dateModified":"2019-02-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5CCB-0412-E063-731AD00A56D4","beginDate":"2019-02-14","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"OAB-Q SHORT FORM","valueDescription":"The Overactive Bladder Questionnaire Short Form","ValueMeaning":{"publicId":"6643614","version":"1","preferredName":"The Overactive Bladder Questionnaire Short Form","longName":"6643614","preferredDefinition":"A standardized survey developed by K. Coyne and colleagues in 2004 and presented at the Joint Meeting of the International Continence Society and the International Urogynecological Association which is used to evaluate the symptoms associated with overactive bladder. This self-administered, shorter version of the Overactive Bladder Questionnaire (OAB-q) contains 19 items pertaining to bladder symptoms occurring during the past four weeks. Each item is rated on a scale of 1-6 with 1 representing none or not at all and 6 representing a great deal or all the time.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"The Overactive Bladder Questionnaire Short Form","conceptCode":"C103524","definition":"A standardized survey developed by K. Coyne and colleagues in 2004 and presented at the Joint Meeting of the International Continence Society and the International Urogynecological Association which is used to evaluate the symptoms associated with overactive bladder. This self-administered, shorter version of the Overactive Bladder Questionnaire (OAB-q) contains 19 items pertaining to bladder symptoms occurring during the past four weeks. Each item is rated on a scale of 1-6 with 1 representing none or not at all and 6 representing a great deal or all the time.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"81E08FC2-67E0-6DE6-E053-F662850A1E6E","latestVersionIndicator":"Yes","beginDate":"2019-02-14","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-02-14","modifiedBy":"ONEDATA","dateModified":"2019-02-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5CCC-0412-E063-731AD00A56D4","beginDate":"2019-02-14","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"PDQUALIF","valueDescription":"Parkinson's Disease Quality of Life Scale Questionnaire","ValueMeaning":{"publicId":"6643466","version":"1","preferredName":"Parkinson's Disease Quality of Life Scale Questionnaire","longName":"6643466","preferredDefinition":"A standardized rating scale originally developed and copyrighted by Mickie Welsh and The Parkinson Study Group in 1996 then released for publication in the journal Movement Disorders in 2003 which is used to assist the clinician in evaluating the degree to which the patient's Parkinson's disease symptoms interfere with their quality of life. This instrument contains 33 questions covering 7 areas including social/role function, self-image/sexuality, sleep, outlook on life, physical function, independence, and urinary function and can be completed by the patient. For each question, the patient must choose from five different responses.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Parkinson's Disease Quality of Life Scale Questionnaire","conceptCode":"C100773","definition":"A standardized rating scale originally developed and copyrighted by Mickie Welsh and The Parkinson Study Group in 1996 then released for publication in the journal Movement Disorders in 2003 which is used to assist the clinician in evaluating the degree to which the patient's Parkinson's disease symptoms interfere with their quality of life. This instrument contains 33 questions covering 7 areas including social/role function, self-image/sexuality, sleep, outlook on life, physical function, independence, and urinary function and can be completed by the patient. For each question, the patient must choose from five different responses.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"81DFACE8-A058-5C5C-E053-F662850AD99A","latestVersionIndicator":"Yes","beginDate":"2019-02-14","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-02-14","modifiedBy":"ONEDATA","dateModified":"2019-02-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5CCD-0412-E063-731AD00A56D4","beginDate":"2019-02-14","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"RDQ","valueDescription":"Roland Morris Disability Questionnaire","ValueMeaning":{"publicId":"6643468","version":"1","preferredName":"Roland Morris Disability Questionnaire","longName":"6643468","preferredDefinition":"A standardized survey developed by M.O. Roland and R.W. Morris in 1983 used to assess the level of disability experienced by a patient with back pain. This original version consists of 24 statements and can be completed by the patient. Each statement receives either a 0 if it is not applicable to patient on the day the questionnaire is administered or a 1 if it is applicable.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Roland Morris Disability Questionnaire","conceptCode":"C100774","definition":"A standardized survey developed by M.O. Roland and R.W. Morris in 1983 used to assess the level of disability experienced by a patient with back pain. This original version consists of 24 statements and can be completed by the patient. Each statement receives either a 0 if it is not applicable to patient on the day the questionnaire is administered or a 1 if it is applicable.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"81DFACE8-A07E-5C5C-E053-F662850AD99A","latestVersionIndicator":"Yes","beginDate":"2019-02-14","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-02-14","modifiedBy":"ONEDATA","dateModified":"2019-02-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5CCE-0412-E063-731AD00A56D4","beginDate":"2019-02-14","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"PCL-5","valueDescription":"The PTSD Checklist for DSM-5 Questionnaire","ValueMeaning":{"publicId":"6643544","version":"1","preferredName":"The PTSD Checklist for DSM-5 Questionnaire","longName":"6643544","preferredDefinition":"A standardized 20-item self-report measure, published in 2013, that is used to assess the 20 Diagnostic and Statistical Manual of Mental Disorders (DSM-5) symptoms of post-traumatic stress disorder (PTSD), using a 5-point Likert-type intensity scale, ranging from zero (not at all) to four (extremely).","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"The PTSD Checklist for DSM-5 Questionnaire","conceptCode":"C135741","definition":"A standardized 20-item self-report measure, published in 2013, that is used to assess the 20 Diagnostic and Statistical Manual of Mental Disorders (DSM-5) symptoms of post-traumatic stress disorder (PTSD), using a 5-point Likert-type intensity scale, ranging from zero (not at all) to four (extremely).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"81E08FC2-626E-6DE6-E053-F662850A1E6E","latestVersionIndicator":"Yes","beginDate":"2019-02-14","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-02-14","modifiedBy":"ONEDATA","dateModified":"2019-02-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5CCF-0412-E063-731AD00A56D4","beginDate":"2019-02-14","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"SF36 V2.0 ACUTE","valueDescription":"Short Form 36 Health Survey Acute, US Version 2.0 Questionnaire","ValueMeaning":{"publicId":"6643478","version":"1","preferredName":"Short Form 36 Health Survey Acute, US Version 2.0 Questionnaire","longName":"6643478","preferredDefinition":"A standardized, multipurpose, general health survey developed by John E. Ware and copyrighted by Quality Metric Inc. and the Medical Outcomes Trust in 1996 and 2000, which is used to assess the patient's functional health and overall well-being. This second version contains 36 questions that refer to the patient's symptoms or status within the past week and can be completed by the patient. For each question the patient must choose from five different responses.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Short Form 36 Health Survey Acute, US Version 2.0 Questionnaire","conceptCode":"C102121","definition":"A standardized, multipurpose, general health survey developed by John E. Ware and copyrighted by Quality Metric Inc. and the Medical Outcomes Trust in 1996 and 2000, which is used to assess the patient's functional health and overall well-being. This second version contains 36 questions that refer to the patient's symptoms or status within the past week and can be completed by the patient. For each question the patient must choose from five different responses.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"81DFACE8-A13C-5C5C-E053-F662850AD99A","latestVersionIndicator":"Yes","beginDate":"2019-02-14","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-02-14","modifiedBy":"ONEDATA","dateModified":"2019-02-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5CD0-0412-E063-731AD00A56D4","beginDate":"2019-02-14","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"SF36 V1.0 STANDARD","valueDescription":"Short Form 36 Health Survey Standard, US Version 1.0 Questionnaire","ValueMeaning":{"publicId":"6643470","version":"1","preferredName":"Short Form 36 Health Survey Standard, US Version 1.0 Questionnaire","longName":"6643470","preferredDefinition":"A standardized, multipurpose, general health survey developed by John E. Ware and copyrighted by Medical Outcomes Trust and Quality Metric Inc. in 1988 and 2002 which is used to assess the patient's functional health and overall well-being. This instrument contains 36 questions to be completed by the patient. For each question the patient must choose from five different responses.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Short Form 36 Health Survey Standard, US Version 1.0 Questionnaire","conceptCode":"C100775","definition":"A standardized, multipurpose, general health survey developed by John E. Ware and copyrighted by Medical Outcomes Trust and Quality Metric Inc. in 1988 and 2002 which is used to assess the patient's functional health and overall well-being. This instrument contains 36 questions to be completed by the patient. For each question the patient must choose from five different responses.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"81DFACE8-A0A4-5C5C-E053-F662850AD99A","latestVersionIndicator":"Yes","beginDate":"2019-02-14","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-02-14","modifiedBy":"ONEDATA","dateModified":"2019-02-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5CD1-0412-E063-731AD00A56D4","beginDate":"2019-02-14","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"SF36 V2.0 STANDARD","valueDescription":"Short Form 36 Health Survey Standard, US Version 2.0 Questionnaire","ValueMeaning":{"publicId":"6643479","version":"1","preferredName":"Short Form 36 Health Survey Standard, US Version 2.0 Questionnaire","longName":"6643479","preferredDefinition":"A standardized, multipurpose, general health survey developed by John E. Ware and copyrighted by Quality Metric Inc. and the Medical Outcomes Trust in 1996 and 2000 which is used to assess the patient's functional health and overall well-being. This second version contains 36 questions that refer to the patient's symptoms or status within the past four weeks and can be completed by the patient. For each question the patient must choose from five different responses.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Short Form 36 Health Survey Standard, US Version 2.0 Questionnaire","conceptCode":"C102122","definition":"A standardized, multipurpose, general health survey developed by John E. Ware and copyrighted by Quality Metric Inc. and the Medical Outcomes Trust in 1996 and 2000 which is used to assess the patient's functional health and overall well-being. This second version contains 36 questions that refer to the patient's symptoms or status within the past four weeks and can be completed by the patient. For each question the patient must choose from five different responses.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"81DFACE8-A15F-5C5C-E053-F662850AD99A","latestVersionIndicator":"Yes","beginDate":"2019-02-14","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-02-14","modifiedBy":"ONEDATA","dateModified":"2019-02-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5CD2-0412-E063-731AD00A56D4","beginDate":"2019-02-14","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"PEDS-FACIT-F","valueDescription":"Pediatric Functional Assessment of Chronic Illness Therapy-Fatigue Questionnaire","ValueMeaning":{"publicId":"6643814","version":"1","preferredName":"Pediatric Functional Assessment of Chronic Illness Therapy-Fatigue Questionnaire","longName":"6643814","preferredDefinition":"A standardized 11-item self-report questionnaire, part of the Functional Assessment of Chronic Illness Therapy (FACIT) Measurement System developed by Cella et al. in 1987, that utilizes a five-point Likert rating scale to evaluate fatigue over the past 7 days in children.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pediatric Functional Assessment of Chronic Illness Therapy-Fatigue Questionnaire","conceptCode":"C147586","definition":"A standardized 11-item self-report questionnaire, part of the Functional Assessment of Chronic Illness Therapy (FACIT) Measurement System developed by Cella et al. in 1987, that utilizes a five-point Likert rating scale to evaluate fatigue over the past 7 days in children.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"81E18CEC-E9A7-621D-E053-F662850AC981","latestVersionIndicator":"Yes","beginDate":"2019-02-14","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-02-14","modifiedBy":"ONEDATA","dateModified":"2019-02-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5CD3-0412-E063-731AD00A56D4","beginDate":"2019-02-14","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"PHQ-15","valueDescription":"Patient Health Questionnaire - 15 Item","ValueMeaning":{"publicId":"6643609","version":"1","preferredName":"Patient Health Questionnaire - 15 Item","longName":"6643609","preferredDefinition":"A standardized survey developed and published by Kurt Kroenke, Robert Spitzer and Janet Williams in 2002 in the journal Psychosomatic Medicine which is used to assess the severity of an individual's somatic symptoms. This self-administered instrument contains 15 items pertaining to topics such as stomach pain, headaches, dizziness, and trouble sleeping. Each item is rated on a scale of 0-2 with 0 being 'not bothered at all' and 2 being 'bothered a lot.'","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Patient Health Questionnaire - 15 Item","conceptCode":"C103527","definition":"A standardized survey developed and published by Kurt Kroenke, Robert Spitzer and Janet Williams in 2002 in the journal Psychosomatic Medicine which is used to assess the severity of an individual's somatic symptoms. This self-administered instrument contains 15 items pertaining to topics such as stomach pain, headaches, dizziness, and trouble sleeping. Each item is rated on a scale of 0-2 with 0 being 'not bothered at all' and 2 being 'bothered a lot.'","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"81E08FC2-6771-6DE6-E053-F662850A1E6E","latestVersionIndicator":"Yes","beginDate":"2019-02-14","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-02-14","modifiedBy":"ONEDATA","dateModified":"2019-02-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5CD4-0412-E063-731AD00A56D4","beginDate":"2019-02-14","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"YMRS","valueDescription":"Young Mania Rating Scale Questionnaire","ValueMeaning":{"publicId":"6643481","version":"1","preferredName":"Young Mania Rating Scale Questionnaire","longName":"6643481","preferredDefinition":"A standardized rating scale developed by R. C. Young and colleagues in 1978 to assess the severity of an individual's mania. This instrument contains 11 items or symptoms associated with mania which is administered by a clinician. Each item has 5 response options but the weight of each response differs with each item.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Young Mania Rating Scale Questionnaire","conceptCode":"C102124","definition":"A standardized rating scale developed by R. C. Young and colleagues in 1978 to assess the severity of an individual's mania. This instrument contains 11 items or symptoms associated with mania which is administered by a clinician. Each item has 5 response options but the weight of each response differs with each item.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"81DFACE8-A185-5C5C-E053-F662850AD99A","latestVersionIndicator":"Yes","beginDate":"2019-02-14","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-02-14","modifiedBy":"ONEDATA","dateModified":"2019-02-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5CD5-0412-E063-731AD00A56D4","beginDate":"2019-02-14","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"PHQ-9","valueDescription":"Patient Health Questionnaire - 9 Item","ValueMeaning":{"publicId":"6643610","version":"1","preferredName":"Patient Health Questionnaire - 9 Item","longName":"6643610","preferredDefinition":"A 9-item scale using each of the 9 DSM-IV criteria with self-reported frequency of \"0\" (not at all) to \"3\" (nearly every day). One of the most widely used instruments to assess depression, PHQ-9 scores of 5, 10, 15, and 20 represent mild, moderate, moderately severe, and severe depression, respectively.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Patient Health Questionnaire - 9 Item","conceptCode":"C103526","definition":"A 9-item scale using each of the 9 DSM-IV criteria with self-reported frequency of \"0\" (not at all) to \"3\" (nearly every day). One of the most widely used instruments to assess depression, PHQ-9 scores of 5, 10, 15, and 20 represent mild, moderate, moderately severe, and severe depression, respectively.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"81E08FC2-6794-6DE6-E053-F662850A1E6E","latestVersionIndicator":"Yes","beginDate":"2019-02-14","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-02-14","modifiedBy":"ONEDATA","dateModified":"2019-02-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5CD6-0412-E063-731AD00A56D4","beginDate":"2019-02-14","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"PODCI - ADOLESCENT PARENT REPORTED","valueDescription":"Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported Version Questionnaire","ValueMeaning":{"publicId":"6643540","version":"1","preferredName":"Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported Version Questionnaire","longName":"6643540","preferredDefinition":"A standardized 86-item parent-report questionnaire, developed by the American Academy of Orthopaedic Surgeons and the Pediatric Orthopaedic Society of North America (POSNA) in 1998 to assess the overall health, pain, and ability to participate in normal daily activities in patients 11 to 18 years of age. The instrument includes five scales: upper extremity and physical function, transfer and mobility tasks, sports/physical functioning, pain/comfort, treatment expectations, happiness, and satisfaction with symptoms, as well as a Global Functioning scale that consists of the mean of the values for the first four scales.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported Version Questionnaire","conceptCode":"C135743","definition":"A standardized 86-item parent-report questionnaire, developed by the American Academy of Orthopaedic Surgeons and the Pediatric Orthopaedic Society of North America (POSNA) in 1998 to assess the overall health, pain, and ability to participate in normal daily activities in patients 11 to 18 years of age. The instrument includes five scales: upper extremity and physical function, transfer and mobility tasks, sports/physical functioning, pain/comfort, treatment expectations, happiness, and satisfaction with symptoms, as well as a Global Functioning scale that consists of the mean of the values for the first four scales.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"81E08FC2-6222-6DE6-E053-F662850A1E6E","latestVersionIndicator":"Yes","beginDate":"2019-02-14","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-02-14","modifiedBy":"ONEDATA","dateModified":"2019-02-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5CD7-0412-E063-731AD00A56D4","beginDate":"2019-02-14","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2023-10-20","modifiedBy":"KUMMEROA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"T1-DDS","valueDescription":"Diabetes Distress Scale for Adults with Type 1 Diabetes Questionnaire","ValueMeaning":{"publicId":"6859293","version":"1","preferredName":"Diabetes Distress Scale for Adults with Type 1 Diabetes Questionnaire","longName":"6859293","preferredDefinition":"Diabetes Distress Scale for Adults with Type 1 Diabetes (T1-DDS) (Fisher L, Polonsky WH, Hessler DM, Masharani U, Blumer I, Peters AL, Strycker LA, Bowyer V. Understanding the sources of diabetes distress in adults with type 1 diabetes. J Diabetes Complications 2015; 29(4): 572-7).","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Diabetes Distress Scale for Adults with Type 1 Diabetes Questionnaire","conceptCode":"C161655","definition":"A standardized 28-item self-report questionnaire first published by Fisher et al. in 2015 that utilizes a six-point response scale to assess seven major sources of diabetes distress for adults with Type 1 Diabetes: powerlessness, management distress, hypoglycemia distress, negative social perceptions, eating distress, physician distress, and friends/family distress.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"90A8A11D-7C4D-22DD-E053-F662850ACAD2","latestVersionIndicator":"Yes","beginDate":"2019-08-21","endDate":null,"createdBy":"COOPERM","dateCreated":"2019-08-21","modifiedBy":"ONEDATA","dateModified":"2019-08-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5CD8-0412-E063-731AD00A56D4","beginDate":"2019-08-21","endDate":null,"createdBy":"COOPERM","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"EORTC QLQ-C30 V3.0","valueDescription":"European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Core 30 Version 3.0","ValueMeaning":{"publicId":"6859295","version":"1","preferredName":"European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Core 30 Version 3.0","longName":"6859295","preferredDefinition":"European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Core 30 Version 3.0 (EORTC QLQ-C30 V3.0) (Copyright 1995 EORTC Quality of Life Group. All rights reserved. Version 3.0).","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire - Core 30 Version 3.0","conceptCode":"C161654","definition":"A standardized 30-item self-administered quality of life questionnaire, developed by the European Organization for the Research and Treatment of Cancer Quality of Life Group in 1995 as an update to the European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire - Core 36 (EORTC QLQ-C36), which was originally developed in 1987 and then modified to become EORTC QLQ-C30 in 1993. EORTC QLQ-C30 V3.0 utilizes a four-point response scale to assess functional, symptom, and global health status/quality of life scales, as well as five additional single symptoms and perceived financial impact, and a seven-point response scale to assess overall health and quality of life.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"90A8A11D-7C73-22DD-E053-F662850ACAD2","latestVersionIndicator":"Yes","beginDate":"2019-08-21","endDate":null,"createdBy":"COOPERM","dateCreated":"2019-08-21","modifiedBy":"ONEDATA","dateModified":"2019-08-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5CD9-0412-E063-731AD00A56D4","beginDate":"2019-08-21","endDate":null,"createdBy":"COOPERM","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"EORTC QLQ-C15-PAL V1.0","valueDescription":"European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Paliative Care Version 1.0","ValueMeaning":{"publicId":"6859297","version":"1","preferredName":"European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Paliative Care Version 1.0","longName":"6859297","preferredDefinition":"European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Paliative Care Version 1.0 (EORTC QLQ-C15-PAL V1.0) (Copyright 1995 and 2005 EORTC Quality of Life Group. All rights reserved. Version 1.0).","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire - Paliative Care Version 1.0","conceptCode":"C161653","definition":"A standardized 15-item questionnaire, developed in 2006 by the European Organization for Research and Treatment of Cancer as an abbreviated version of the cancer-specific quality of life questionnaire European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire - Core 30 (EORTC QLQ-C30), that utilizes a four-point response scale to assess the symptoms and problems for which patients are frequently treated in palliative care, and a seven-point response scale to assess overall quality of life.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"90A8A11D-7C99-22DD-E053-F662850ACAD2","latestVersionIndicator":"Yes","beginDate":"2019-08-21","endDate":null,"createdBy":"COOPERM","dateCreated":"2019-08-21","modifiedBy":"ONEDATA","dateModified":"2019-08-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5CDA-0412-E063-731AD00A56D4","beginDate":"2019-08-21","endDate":null,"createdBy":"COOPERM","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"PHQ-2","valueDescription":"Patient Health Questionnaire-2","ValueMeaning":{"publicId":"6775597","version":"1","preferredName":"Patient Health Questionnaire-2","longName":"6775597","preferredDefinition":"A 2-item scale used to screen for depression and anhedonia over the past 2 weeks. It is comprised of the first 2 items of the Patient Health Questionnaire-9.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Patient Health Questionnaire-2","conceptCode":"C123386","definition":"A 2-item scale used to screen for depression and anhedonia over the past 2 weeks. It is comprised of the first 2 items of the Patient Health Questionnaire-9.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8A9CE42F-C5FA-0B4E-E053-F662850A8740","latestVersionIndicator":"Yes","beginDate":"2019-06-06","endDate":null,"createdBy":"COOPERM","dateCreated":"2019-06-06","modifiedBy":"ONEDATA","dateModified":"2019-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5CDB-0412-E063-731AD00A56D4","beginDate":"2019-06-06","endDate":null,"createdBy":"COOPERM","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"EORTC QLQ-CR29 V2.1","valueDescription":"European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Colorectal Cancer Module Version 2.1","ValueMeaning":{"publicId":"7240407","version":"1","preferredName":"European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Colorectal Cancer Module Version 2.1","longName":"7240407","preferredDefinition":"European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Colorectal Version 2.1 (EORTC QLQ-CR29 V2.1) (QLQ-CR29 Copyright 2006 EORTC Quality of Life Group. All rights reserved. (Validated module). Version 2.1).","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire - Colorectal Cancer Module Version 2.1","conceptCode":"C170644","definition":"An updated modular supplement to the European Organization for the Research and Treatment of Cancer Core Quality of Life Questionnaire (EORTC QLQ-C30) that was developed in 2007 and is used to assess quality of life in patients with colorectal cancer. The patient-report questionnaire utilizes a four point rating scale to assess symptoms or problems experienced over the last week.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A2B843B6-3806-080B-E053-F662850AB10C","latestVersionIndicator":"Yes","beginDate":"2020-04-07","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-04-07","modifiedBy":"ONEDATA","dateModified":"2020-04-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5CDC-0412-E063-731AD00A56D4","beginDate":"2020-04-07","endDate":null,"createdBy":"TAYLORT","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"BSFS","valueDescription":"Bristol Stool Scale","ValueMeaning":{"publicId":"7240410","version":"1","preferredName":"Bristol Stool Scale","longName":"7240410","preferredDefinition":"A medical scale designed to classify human feces into seven categories by form.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Bristol Stool Scale","conceptCode":"C125393","definition":"A medical scale designed to classify human feces into seven categories by form.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A2B843B6-384F-080B-E053-F662850AB10C","latestVersionIndicator":"Yes","beginDate":"2020-04-07","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-04-07","modifiedBy":"ONEDATA","dateModified":"2020-04-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5CDD-0412-E063-731AD00A56D4","beginDate":"2020-04-07","endDate":null,"createdBy":"TAYLORT","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"WPAI-GH V2.0","valueDescription":"Work Productivity and Activity Impairment General Health V2.0 Questionnaire","ValueMeaning":{"publicId":"7240411","version":"1","preferredName":"Work Productivity and Activity Impairment General Health V2.0 Questionnaire","longName":"7240411","preferredDefinition":"The second version of a standardized survey originally developed by Margaret C. Reilly in 1993 which is used to evaluate the extent to which a patient's general health problems effects their ability to work and perform daily activities. This instrument consists of 6 questions which can be completed by the patient or in an interview format.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Work Productivity and Activity Impairment General Health V2.0 Questionnaire","conceptCode":"C123285","definition":"The second version of a standardized survey originally developed by Margaret C. Reilly in 1993 which is used to evaluate the extent to which a patient's general health problems effects their ability to work and perform daily activities. This instrument consists of 6 questions which can be completed by the patient or in an interview format.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A2B843B6-3872-080B-E053-F662850AB10C","latestVersionIndicator":"Yes","beginDate":"2020-04-07","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-04-07","modifiedBy":"ONEDATA","dateModified":"2020-04-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5CDE-0412-E063-731AD00A56D4","beginDate":"2020-04-07","endDate":null,"createdBy":"TAYLORT","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"FACT-COG V3","valueDescription":"FACT-Cognitive Function","ValueMeaning":{"publicId":"7240412","version":"1","preferredName":"FACT-Cognitive Function","longName":"7240412","preferredDefinition":"The FACT-Cognitive Function questionnaire is a 37 item measure developed by Dr. David Cella to evaluate knowledge and information processing.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"FACT-Cognitive Function","conceptCode":"C103850","definition":"The FACT-Cognitive Function questionnaire is a 37 item measure developed by Dr. David Cella to evaluate knowledge and information processing.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A2B843B6-3895-080B-E053-F662850AB10C","latestVersionIndicator":"Yes","beginDate":"2020-04-07","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-04-07","modifiedBy":"ONEDATA","dateModified":"2020-04-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5CDF-0412-E063-731AD00A56D4","beginDate":"2020-04-07","endDate":null,"createdBy":"TAYLORT","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"PARTNER-DDS","valueDescription":"Diabetes Distress Scale for Partners of Adults with Type 1 Diabetes Questionnaire","ValueMeaning":{"publicId":"7240414","version":"1","preferredName":"Diabetes Distress Scale for Partners of Adults with Type 1 Diabetes Questionnaire","longName":"7240414","preferredDefinition":"A 21-item self-administered questionnaire, published by Hessler et al. in 2016, that utilizes a five-point rating scale to assess diabetes distress in partners of adults with type 1 diabetes; the instrument includes four subscales that address key dimensions of partner-related distress, including \"my partner's diabetes management\", \"how best to help\", \"diabetes and me\", and hypoglycemia.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Diabetes Distress Scale for Partners of Adults with Type 1 Diabetes Questionnaire","conceptCode":"C163817","definition":"A 21-item self-administered questionnaire, published by Hessler et al. in 2016, that utilizes a five-point rating scale to assess diabetes distress in partners of adults with type 1 diabetes; the instrument includes four subscales that address key dimensions of partner-related distress, including \"my partner's diabetes management\", \"how best to help\", \"diabetes and me\", and hypoglycemia.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A2B843B6-38BB-080B-E053-F662850AB10C","latestVersionIndicator":"Yes","beginDate":"2020-04-07","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-04-07","modifiedBy":"ONEDATA","dateModified":"2020-04-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5CE0-0412-E063-731AD00A56D4","beginDate":"2020-04-07","endDate":null,"createdBy":"TAYLORT","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"PARENT-DDS","valueDescription":"Diabetes Distress Scale for Parents of Teens with Type 1 Diabetes Questionnaire","ValueMeaning":{"publicId":"7240416","version":"1","preferredName":"Diabetes Distress Scale for Parents of Teens with Type 1 Diabetes Questionnaire","longName":"7240416","preferredDefinition":"A 20-item self-administered questionnaire, published by Hessler et al. in 2016, that utilizes a five-point rating scale to assess diabetes distress in parents of teens with type 1 diabetes; the instrument includes four subscales that address key dimensions of parent-related distress, including personal distress, teen management distress, parent/teen relationship distress and healthcare team distress.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Diabetes Distress Scale for Parents of Teens with Type 1 Diabetes Questionnaire","conceptCode":"C163816","definition":"A 20-item self-administered questionnaire, published by Hessler et al. in 2016, that utilizes a five-point rating scale to assess diabetes distress in parents of teens with type 1 diabetes; the instrument includes four subscales that address key dimensions of parent-related distress, including personal distress, teen management distress, parent/teen relationship distress and healthcare team distress.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A2B843B6-38E1-080B-E053-F662850AB10C","latestVersionIndicator":"Yes","beginDate":"2020-04-07","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-04-07","modifiedBy":"ONEDATA","dateModified":"2020-04-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5CE1-0412-E063-731AD00A56D4","beginDate":"2020-04-07","endDate":null,"createdBy":"TAYLORT","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"HCS","valueDescription":"Hypoglycemic Confidence Scale Questionnaire","ValueMeaning":{"publicId":"7240418","version":"1","preferredName":"Hypoglycemic Confidence Scale Questionnaire","longName":"7240418","preferredDefinition":"A nine-item self-administered questionnaire, published by Polonsky et al. in 2017, that utilizes a four-point rating scale to assess the degree to which patients with diabetes feel secure regarding their ability to stay safe from hypoglycemia-related problems.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hypoglycemic Confidence Scale Questionnaire","conceptCode":"C163815","definition":"A nine-item self-administered questionnaire, published by Polonsky et al. in 2017, that utilizes a four-point rating scale to assess the degree to which patients with diabetes feel secure regarding their ability to stay safe from hypoglycemia-related problems.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A2B843B6-3907-080B-E053-F662850AB10C","latestVersionIndicator":"Yes","beginDate":"2020-04-07","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-04-07","modifiedBy":"ONEDATA","dateModified":"2020-04-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5CE2-0412-E063-731AD00A56D4","beginDate":"2020-04-07","endDate":null,"createdBy":"TAYLORT","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"GMSS VERSION TYPE 1 DIABETES","valueDescription":"The Glucose Monitoring Satisfaction Survey Version: Type 1 Diabetes Questionnaire","ValueMeaning":{"publicId":"7240420","version":"1","preferredName":"The Glucose Monitoring Satisfaction Survey Version: Type 1 Diabetes Questionnaire","longName":"7240420","preferredDefinition":"A 15-item self-administered questionnaire, published by Polonsky et al. in 2015, that utilizes a five-point rating scale to assess patient treatment satisfaction with glucose monitoring devices for type 1 diabetes; the instrument includes four subscales that address openness, emotional burden, behavioral burden, and trust.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"The Glucose Monitoring Satisfaction Survey Version: Type 1 Diabetes Questionnaire","conceptCode":"C163814","definition":"A 15-item self-administered questionnaire, published by Polonsky et al. in 2015, that utilizes a five-point rating scale to assess patient treatment satisfaction with glucose monitoring devices for type 1 diabetes; the instrument includes four subscales that address openness, emotional burden, behavioral burden, and trust.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A2B843B6-392D-080B-E053-F662850AB10C","latestVersionIndicator":"Yes","beginDate":"2020-04-07","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-04-07","modifiedBy":"ONEDATA","dateModified":"2020-04-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5CE3-0412-E063-731AD00A56D4","beginDate":"2020-04-07","endDate":null,"createdBy":"TAYLORT","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"GAD-7 V2","valueDescription":"Generalized Anxiety Disorder - 7 Version 2 Questionnaire","ValueMeaning":{"publicId":"7240422","version":"1","preferredName":"Generalized Anxiety Disorder - 7 Version 2 Questionnaire","longName":"7240422","preferredDefinition":"A revised version of the Generalized Anxiety Disorder - 7 Questionnaire, which is a seven-item, self-administered assessment tool published by Spitzer et al. in 2006 that utilizes a four-point rating scale to screen for and measure the severity of generalized anxiety disorder. The revised questionnaire has alternative wording in two of the rating scale options, and does not include the supplementary question at the end of the questionnaire.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Generalized Anxiety Disorder - 7 Version 2 Questionnaire","conceptCode":"C163813","definition":"A revised version of the Generalized Anxiety Disorder - 7 Questionnaire, which is a seven-item, self-administered assessment tool published by Spitzer et al. in 2006 that utilizes a four-point rating scale to screen for and measure the severity of generalized anxiety disorder. The revised questionnaire has alternative wording in two of the rating scale options, and does not include the supplementary question at the end of the questionnaire.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A2B843B6-3953-080B-E053-F662850AB10C","latestVersionIndicator":"Yes","beginDate":"2020-04-07","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-04-07","modifiedBy":"ONEDATA","dateModified":"2020-04-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5CE4-0412-E063-731AD00A56D4","beginDate":"2020-04-07","endDate":null,"createdBy":"TAYLORT","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"ANSD V1.0","valueDescription":"Asthma Nighttime Symptom Diary V1.0 Questionnaire","ValueMeaning":{"publicId":"7240424","version":"1","preferredName":"Asthma Nighttime Symptom Diary V1.0 Questionnaire","longName":"7240424","preferredDefinition":"A six-item self-administered questionnaire, developed by Gater et al. in 2016, that utilizes a ten-point rating scale to assess a patient's experience with core asthma symptoms during the preceding night, including difficulty breathing, wheezing, shortness of breath, chest tightness, chest pain, and cough.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Asthma Nighttime Symptom Diary V1.0 Questionnaire","conceptCode":"C163812","definition":"A six-item self-administered questionnaire, developed by Gater et al. in 2016, that utilizes a ten-point rating scale to assess a patient's experience with core asthma symptoms during the preceding night, including difficulty breathing, wheezing, shortness of breath, chest tightness, chest pain, and cough.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A2B843B6-3979-080B-E053-F662850AB10C","latestVersionIndicator":"Yes","beginDate":"2020-04-07","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-04-07","modifiedBy":"ONEDATA","dateModified":"2020-04-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5CE5-0412-E063-731AD00A56D4","beginDate":"2020-04-07","endDate":null,"createdBy":"TAYLORT","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"ADSD V1.0","valueDescription":"Asthma Daytime Symptom Diary V1.0 Questionnaire","ValueMeaning":{"publicId":"7240426","version":"1","preferredName":"Asthma Daytime Symptom Diary V1.0 Questionnaire","longName":"7240426","preferredDefinition":"A six-item self-administered questionnaire, developed by Gater et al. in 2016, that utilizes a ten-point rating scale to assess a patient's experience with core asthma symptoms during the preceding day, including difficulty breathing, wheezing, shortness of breath, chest tightness, chest pain, and cough.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Asthma Daytime Symptom Diary V1.0 Questionnaire","conceptCode":"C163811","definition":"A six-item self-administered questionnaire, developed by Gater et al. in 2016, that utilizes a ten-point rating scale to assess a patient's experience with core asthma symptoms during the preceding day, including difficulty breathing, wheezing, shortness of breath, chest tightness, chest pain, and cough.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A2B843B6-399F-080B-E053-F662850AB10C","latestVersionIndicator":"Yes","beginDate":"2020-04-07","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-04-07","modifiedBy":"ONEDATA","dateModified":"2020-04-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5CE6-0412-E063-731AD00A56D4","beginDate":"2020-04-07","endDate":null,"createdBy":"TAYLORT","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"BIS-11","valueDescription":"Barratt Impulsiveness Scale 1995 Version Questionnaire","ValueMeaning":{"publicId":"7351334","version":"1","preferredName":"Barratt Impulsiveness Scale 1995 Version Questionnaire","longName":"7351334","preferredDefinition":"Barratt Impulsiveness Scale 1995 Version (BIS-11) (Patton JH, Stanford MS, and Barratt ES (1995). Factor structure of the Barratt impulsiveness scale. Journal of Clinical Psychology, 51, 768-774. Copyright International Society for Research on Impulsivity and it's licensor's. All Rights Reserved).","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Barratt Impulsiveness Scale 1995 Version Questionnaire","conceptCode":"C172402","definition":"A standardized 30-item questionnaire developed by Patton et al. 1995 that utilizes a four-point rating scale to assess impulsiveness. The items describe common impulsive and non-impulsive behaviors and preferences.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AA548C76-3660-7E6C-E053-4EBD850A73A3","latestVersionIndicator":"Yes","beginDate":"2020-07-13","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-07-13","modifiedBy":"ONEDATA","dateModified":"2020-07-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5CE7-0412-E063-731AD00A56D4","beginDate":"2020-07-13","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"EORTC QLQ-LC13","valueDescription":"EORTC Quality of Life Questionnaire - Lung Cancer Module","ValueMeaning":{"publicId":"7351335","version":"1","preferredName":"EORTC Quality of Life Questionnaire - Lung Cancer Module","longName":"7351335","preferredDefinition":"A modular supplement to the EORTC Core Quality of Life Questionnaire (QLQ-C30) for use in lung cancer clinical trials.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"EORTC Quality of Life Questionnaire - Lung Cancer Module","conceptCode":"C168555","definition":"A modular supplement to the EORTC Core Quality of Life Questionnaire (QLQ-C30) for use in lung cancer clinical trials.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AA548C76-3683-7E6C-E053-4EBD850A73A3","latestVersionIndicator":"Yes","beginDate":"2020-07-13","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-07-13","modifiedBy":"ONEDATA","dateModified":"2020-07-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5CE8-0412-E063-731AD00A56D4","beginDate":"2020-07-13","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"IBDQ","valueDescription":"Quality of Life in Inflammatory Bowel Disease Questionnaire","ValueMeaning":{"publicId":"7448884","version":"1","preferredName":"Quality of Life in Inflammatory Bowel Disease Questionnaire","longName":"7448884","preferredDefinition":"Quality of Life in Inflammatory Bowel Disease Questionnaire (IBDQ) (Copyright 1989, McMaster University, Hamilton, Ontario, Canada. The Inflammatory Bowel Disease Questionnaire, authored by Dr. Jan Irvine et. al., was made under license from McMaster University, Hamilton, Canada (Copyright 1989, McMaster University). The IBDQ is provided under license from McMaster University and may not be copied, distributed or used in any way without the prior written consent of McMaster University. Contact the McMaster Industry Liaison Office at: milo at mcmaster.ca for licensing details).","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Quality of Life in Inflammatory Bowel Disease Questionnaire","conceptCode":"C174070","definition":"A standardized 32-item self-report or clinician-administered questionnaire, developed by Irvine et al. 1989, that utilizes a seven-point Likert scale and a two week recall of bowel, systemic, emotional, and social functioning to assess quality of life in patients with inflammatory bowel diseases.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B065B6BE-FA7F-5CD1-E053-4EBD850A9AA1","latestVersionIndicator":"Yes","beginDate":"2020-09-29","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-09-29","modifiedBy":"ONEDATA","dateModified":"2020-09-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5CE9-0412-E063-731AD00A56D4","beginDate":"2020-09-29","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"SF12 V2.0 ACUTE","valueDescription":"Short Form 12 Health Survey Acute, US Version 2.0 Questionnaire","ValueMeaning":{"publicId":"7448886","version":"1","preferredName":"Short Form 12 Health Survey Acute, US Version 2.0 Questionnaire","longName":"7448886","preferredDefinition":"The Short Form 12 Health Survey, Acute, US Version 2.0 (SF12 v2.0 ACUTE) (copyright 1994, 2002 Medical Outcomes Trust and QualityMetric Incorporated. All rights reserved). These materials discuss and/or include one or more of the SF Health Surveys, which are owned exclusively by Optum, Inc. No part of the SF Health Surveys may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of Optum and payment of any applicable fees. Copyright Optum, Inc. All rights reserved.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Short Form 12 Health Survey Acute, US Version 2.0 Questionnaire","conceptCode":"C174069","definition":"A standardized 12-item self-report questionnaire, originally adapted from the Medical Outcomes Study 36-Item Short-Form Health Survey (SF-36) in 1996 and revised in 2002, that utilizes a one week recall of eight domains of physical and psychosocial functioning to assess the impact of health on an individual's everyday life.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B065B6BE-FAA5-5CD1-E053-4EBD850A9AA1","latestVersionIndicator":"Yes","beginDate":"2020-09-29","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-09-29","modifiedBy":"ONEDATA","dateModified":"2020-09-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5CEA-0412-E063-731AD00A56D4","beginDate":"2020-09-29","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"SF8 V1.0 ACUTE","valueDescription":"Short Form 8 Health Survey Acute, US Version 1.0 Questionnaire","ValueMeaning":{"publicId":"7448898","version":"1","preferredName":"Short Form 8 Health Survey Acute, US Version 1.0 Questionnaire","longName":"7448898","preferredDefinition":"The Short Form 8 Health Survey, Acute, US Version 1.0 (SF8 v1.0 ACUTE) (copyright 1999, 2001 QualityMetric Incorporated. All rights reserved). These materials discuss and/or include one or more of the SF Health Surveys, which are owned exclusively by Optum, Inc. No part of the SF Health Surveys may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of Optum and payment of any applicable fees. Copyright Optum, Inc. All rights reserved.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Short Form 8 Health Survey Acute, US Version 1.0 Questionnaire","conceptCode":"C174063","definition":"A standardized eight-item short version of the Medical Outcomes Study 36-Item Short-Form Health Survey (SF-36) that utilizes a five-point rating scale and a one week recall to assess health-related quality of life. The measured dimensions include general health, physical functioning, role-physical, bodily pain, vitality, social functioning, mental health, and role-emotional.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B065B6BE-FB89-5CD1-E053-4EBD850A9AA1","latestVersionIndicator":"Yes","beginDate":"2020-09-29","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-09-29","modifiedBy":"ONEDATA","dateModified":"2020-09-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5CEB-0412-E063-731AD00A56D4","beginDate":"2020-09-29","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"SF8 V1.0 STANDARD","valueDescription":"Short Form 8 Health Survey Standard, US Version 1.0 Questionnaire","ValueMeaning":{"publicId":"7448900","version":"1","preferredName":"Short Form 8 Health Survey Standard, US Version 1.0 Questionnaire","longName":"7448900","preferredDefinition":"The Short Form 8 Health Survey, Standard, US Version 1.0 (SF8 v1.0 STANDARD) (copyright 1998, 1999 QualityMetric Incorporated. All rights reserved). These materials discuss and/or include one or more of the SF Health Surveys, which are owned exclusively by Optum, Inc. No part of the SF Health Surveys may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of Optum and payment of any applicable fees. Copyright Optum, Inc. All rights reserved.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Short Form 8 Health Survey Standard, US Version 1.0 Questionnaire","conceptCode":"C174062","definition":"A standardized eight-item short version of the Medical Outcomes Study 36-Item Short-Form Health Survey (SF-36) that utilizes a five-point rating scale and a four week recall to assess health-related quality of life. The measured dimensions include general health, physical functioning, role-physical, bodily pain, vitality, social functioning, mental health, and role-emotional.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B065B6BE-FBAF-5CD1-E053-4EBD850A9AA1","latestVersionIndicator":"Yes","beginDate":"2020-09-29","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-09-29","modifiedBy":"ONEDATA","dateModified":"2020-09-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5CEC-0412-E063-731AD00A56D4","beginDate":"2020-09-29","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"SF12 V2.0 STANDARD","valueDescription":"Short Form 12 Health Survey Standard, US Version 2.0 Questionnaire","ValueMeaning":{"publicId":"7448888","version":"1","preferredName":"Short Form 12 Health Survey Standard, US Version 2.0 Questionnaire","longName":"7448888","preferredDefinition":"The Short Form 12 Health Survey, Standard, US Version 2.0 (SF12 v2.0 STANDARD) (copyright 1994, 2002 Medical Outcomes Trust and QualityMetric Incorporated. All rights reserved). These materials discuss and/or include one or more of the SF Health Surveys, which are owned exclusively by Optum, Inc. No part of the SF Health Surveys may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of Optum and payment of any applicable fees. Copyright Optum, Inc. All rights reserved.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Short Form 12 Health Survey Standard, US Version 2.0 Questionnaire","conceptCode":"C174068","definition":"A standardized 12-item self-report questionnaire, originally adapted from the Medical Outcomes Study 36-Item Short-Form Health Survey (SF-36) in 1996 and revised in 2002, that utilizes a four week recall of eight domains of physical and psychosocial functioning to assess the impact of health on an individual's everyday life.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B065B6BE-FACB-5CD1-E053-4EBD850A9AA1","latestVersionIndicator":"Yes","beginDate":"2020-09-29","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-09-29","modifiedBy":"ONEDATA","dateModified":"2020-09-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5CED-0412-E063-731AD00A56D4","beginDate":"2020-09-29","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"SF12 V1.0 ACUTE","valueDescription":"Short Form 12 Health Survey Acute, US Version 1.0 Questionnaire","ValueMeaning":{"publicId":"7448890","version":"1","preferredName":"Short Form 12 Health Survey Acute, US Version 1.0 Questionnaire","longName":"7448890","preferredDefinition":"The Short Form 12 Health Survey, Acute, US Version 1.0 (SF12 v1.0 ACUTE) (copyright 1994, 2002 by Medical Outcomes Trust and QualityMetric Incorporated. All rights reserved). These materials discuss and/or include one or more of the SF Health Surveys, which are owned exclusively by Optum, Inc. No part of the SF Health Surveys may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of Optum and payment of any applicable fees. Copyright Optum, Inc. All rights reserved.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Short Form 12 Health Survey Acute, US Version 1.0 Questionnaire","conceptCode":"C174067","definition":"A standardized 12-item self-report questionnaire, adapted from the Medical Outcomes Study 36-Item Short-Form Health Survey (SF-36) in 1996, that utilizes a one week recall of eight domains of physical and psychosocial functioning to assess the impact of health on an individual's everyday life.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B065B6BE-FAF1-5CD1-E053-4EBD850A9AA1","latestVersionIndicator":"Yes","beginDate":"2020-09-29","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-09-29","modifiedBy":"ONEDATA","dateModified":"2020-09-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5CEE-0412-E063-731AD00A56D4","beginDate":"2020-09-29","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"SF12 V1.0 STANDARD","valueDescription":"Short Form 12 Health Survey Standard, US Version 1.0 Questionnaire","ValueMeaning":{"publicId":"7448892","version":"1","preferredName":"Short Form 12 Health Survey Standard, US Version 1.0 Questionnaire","longName":"7448892","preferredDefinition":"The Short Form 12 Health Survey, Standard, US Version 1.0 (SF12 v1.0 STANDARD) (copyright 1994, 2002 by Medical Outcomes Trust and QualityMetric Incorporated. All rights reserved). These materials discuss and/or include one or more of the SF Health Surveys, which are owned exclusively by Optum, Inc. No part of the SF Health Surveys may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of Optum and payment of any applicable fees. Copyright Optum, Inc. All rights reserved.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Short Form 12 Health Survey Standard, US Version 1.0 Questionnaire","conceptCode":"C174066","definition":"A standardized 12-item self-report questionnaire, adapted from the Medical Outcomes Study 36-Item Short-Form Health Survey (SF-36) in 1996, that utilizes a four week recall of eight domains of physical and psychosocial functioning to assess the impact of health on an individual's everyday life.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B065B6BE-FB17-5CD1-E053-4EBD850A9AA1","latestVersionIndicator":"Yes","beginDate":"2020-09-29","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-09-29","modifiedBy":"ONEDATA","dateModified":"2020-09-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5CEF-0412-E063-731AD00A56D4","beginDate":"2020-09-29","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"SF10 V1.0 CHILDREN ACUTE","valueDescription":"Short Form 10 Health Survey for Children Acute, US Version 1.0 Questionnaire","ValueMeaning":{"publicId":"7448894","version":"1","preferredName":"Short Form 10 Health Survey for Children Acute, US Version 1.0 Questionnaire","longName":"7448894","preferredDefinition":"The Short Form 10 Health Survey for Children, Acute, US Version 1.0 (SF10 v1.0 CHILDREN ACUTE) (copyright 2001, 2005, 2011 QualityMetric Incorporated. All rights reserved). These materials discuss and/or include one or more of the SF Health Surveys, which are owned exclusively by Optum, Inc. No part of the SF Health Surveys may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of Optum and payment of any applicable fees. Copyright Optum, Inc. All rights reserved.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Short Form 10 Health Survey for Children Acute, US Version 1.0 Questionnaire","conceptCode":"C174065","definition":"A standardized 10-item parent-report survey, adapted from the Child Health Questionnaire in 2003, that utilizes a one week recall of eight domains of physical and psychosocial functioning to assess health-related quality of life in the pediatric population.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B065B6BE-FB3D-5CD1-E053-4EBD850A9AA1","latestVersionIndicator":"Yes","beginDate":"2020-09-29","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-09-29","modifiedBy":"ONEDATA","dateModified":"2020-09-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5CF0-0412-E063-731AD00A56D4","beginDate":"2020-09-29","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"SF10 V1.0 CHILDREN STANDARD","valueDescription":"Short Form 10 Health Survey for Children Standard, US Version 1.0 Questionnaire","ValueMeaning":{"publicId":"7448896","version":"1","preferredName":"Short Form 10 Health Survey for Children Standard, US Version 1.0 Questionnaire","longName":"7448896","preferredDefinition":"The Short Form 10 Health Survey for Children, Standard, US Version 1.0 (SF10 v1.0 CHILDREN STANDARD) (copyright 2001, 2005 QualityMetric Incorporated. All rights reserved). These materials discuss and/or include one or more of the SF Health Surveys, which are owned exclusively by Optum, Inc. No part of the SF Health Surveys may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of Optum and payment of any applicable fees. Copyright Optum, Inc. All rights reserved.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Short Form 10 Health Survey for Children Standard, US Version 1.0 Questionnaire","conceptCode":"C174064","definition":"A standardized 10-item parent-report survey, adapted from the Child Health Questionnaire in 2003, that utilizes a four week recall of eight domains of physical and psychosocial functioning to assess health-related quality of life in the pediatric population.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B065B6BE-FB63-5CD1-E053-4EBD850A9AA1","latestVersionIndicator":"Yes","beginDate":"2020-09-29","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-09-29","modifiedBy":"ONEDATA","dateModified":"2020-09-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5CF1-0412-E063-731AD00A56D4","beginDate":"2020-09-29","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"PRO-CTCAE V1.0","valueDescription":"Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 Version Date 4/26/2020 Questionnaire","ValueMeaning":{"publicId":"7742353","version":"1","preferredName":"Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 Version Date 4/26/2020 Questionnaire","longName":"7742353","preferredDefinition":"Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 Version Date 4/26/2020 (PRO-CTCAE V1.0 VERSION DATE 4/26/2020). The PRO-CTCAE trademark items and information herein were developed by the Division of Cancer Control and Population Sciences in the NATIONAL CANCER INSTITUTE at the NATIONAL INSTITUTES OF HEALTH, in Bethesda, Maryland, U.S.A. Use of the PRO-CTCAE is subject to NCI's \"Terms of Use\". PRO-CTCAE Measurement System content should be downloaded using the \"Instrument & Form Builder\". https://healthcaredelivery.cancer.gov/prot-ctcae/. (Basch E, Reeve BB, Mitchell SA, Clauser SB, Minasian LM, Dueck AC, Mendoza TR, Hay J, Atkinson TM, Abernethy AP, Bruner DW, Cleeland CS, Sloan JA, Chilukuri R, Baumgartner P, Denicoff A, St Germain D, O'Mara AM, Chen A, Kelaghan J, Bennett AV, Sit L, Rogak L, Barz A, Paul DB, Schrag D. Development of the National Cancer Institute's patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE). J Natl Cancer Inst 2014 Sept 29;106(9)).","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 Questionnaire","conceptCode":"C179975","definition":"The first version of a database containing 124 questions that represent 78 symptomatic adverse events taken from the Common Terminology Criteria for Adverse Events.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C72FE571-EB94-3CA0-E053-4EBD850A9CA0","latestVersionIndicator":"Yes","beginDate":"2021-07-15","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-07-15","modifiedBy":"ONEDATA","dateModified":"2021-07-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5CF2-0412-E063-731AD00A56D4","beginDate":"2021-07-15","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-10-20","modifiedBy":"KUMMEROA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"FACT-BP V4","valueDescription":"Functional Assessment of Cancer Therapy-Bone Pain Version 4 Questionnaire","ValueMeaning":{"publicId":"7742355","version":"1","preferredName":"Functional Assessment of Cancer Therapy-Bone Pain Version 4 Questionnaire","longName":"7742355","preferredDefinition":"Functional Assessment of Cancer Therapy-Bone Pain Version 4 (FACT-BP V4) (Copyright 1987, 1997 David Cella, Ph.D. All Rights Reserved; Questionnaires and all related subscales, translations, and adaptations ('FACIT System') are owned and copyrighted by David Cella, Ph.D. The ownership and copyright of the FACIT System resides strictly with Dr. Cella. Dr. Cella has granted FACIT.org the right to license usage of the FACIT System to other parties). These materials discuss and/or include the Functional Assessment of Cancer Therapy-Bone Pain Version 4 (FACT-BP V4), which is owned exclusively by David Cella, Ph.D. No part of the FACT-BP V4 may be reproduced, distributed, or transmitted in any form or by any means, including photocopying recording, or other electronic or mechanical methods, without the prior written permission of David Cella, Ph.D. and payment of any applicable fees. Copyright David Cella 1987, 1997. All rights reserved.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Functional Assessment of Cancer Therapy-Bone Pain Version 4 Questionnaire","conceptCode":"C179974","definition":"The fourth version of a standardized 16-item questionnaire originally developed by Broom et al. in 2009 that utilizes a five point rating scale to assess the general functioning, physical, and pain aspects of quality of life in cancer patients with bone metastases; it supplements the core quality of life questionnaire, Functional Assessment of Cancer Therapy General Questionnaire (FACT-G).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C72FE571-EBBA-3CA0-E053-4EBD850A9CA0","latestVersionIndicator":"Yes","beginDate":"2021-07-15","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-07-15","modifiedBy":"ONEDATA","dateModified":"2021-07-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5CF3-0412-E063-731AD00A56D4","beginDate":"2021-07-15","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"FAACT V4","valueDescription":"Functional Assessment of Anorexia/Cachexia Treatment Version 4 Questionnaire","ValueMeaning":{"publicId":"7742357","version":"1","preferredName":"Functional Assessment of Anorexia/Cachexia Treatment Version 4 Questionnaire","longName":"7742357","preferredDefinition":"Functional Assessment of Anorexia/Cachexia Treatment Version 4 (FAACT V4) (Copyright 1987, 1997 David Cella, Ph.D. All Rights Reserved; Questionnaires and all related subscales, translations, and adaptations ('FACIT System') are owned and copyrighted by David Cella, Ph.D. The ownership and copyright of the FACIT System resides strictly with Dr. Cella. Dr. Cella has granted FACIT.org the right to license usage of the FACIT System to other parties).","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Functional Assessment of Anorexia/Cachexia Treatment Version 4 Questionnaire","conceptCode":"C179973","definition":"The fourth version of a standardized 39-item quality of life questionnaire owned and copyrighted by David Cella et al. that combines the FACT-G general quality of life questionnaire and a subscale complement that specifically addresses anorexia/cachexia-related concerns in patients with cancer, AIDS, and some chronic diseases.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C72FE571-EBE0-3CA0-E053-4EBD850A9CA0","latestVersionIndicator":"Yes","beginDate":"2021-07-15","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-07-15","modifiedBy":"ONEDATA","dateModified":"2021-07-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5CF4-0412-E063-731AD00A56D4","beginDate":"2021-07-15","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"SF6D V2.0 STANDARD","valueDescription":"SF-6Dv2 Health Utility Survey Standard, English Version 2.0 Questionnaire","ValueMeaning":{"publicId":"8158295","version":"1","preferredName":"SF-6Dv2 Health Utility Survey Standard, English Version 2.0 Questionnaire","longName":"8158295","preferredDefinition":"SF-6Dv2 Health Utility Survey Standard, English Version 2.0 (SF6D V2.0 STANDARD) (copyright 2021 QualityMetric Incorporated, LLC. All rights reserved). These materials discuss and/or include one or more of the SF Health Surveys, which are owned exclusively by QualityMetric Incorporated, LLC. No part of the SF Health Surveys may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of QualityMetric and payment of any applicable fees. Copyright QualityMetric Incorporated, LLC. All rights reserved.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"SF-6Dv2 Health Utility Survey Standard, English Version 2.0 Questionnaire","conceptCode":"C185762","definition":"A standardized stand-alone six-item patient report questionnaire derived from the SF-6D that assesses a range of symptoms, experiences, and health outcomes in six health domains over the past four weeks in order to capture changes across physical and mental health conditions and produce a single health utility score.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DC89574F-0BA1-6563-E053-4EBD850A587B","latestVersionIndicator":"Yes","beginDate":"2022-04-13","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-04-13","modifiedBy":"ONEDATA","dateModified":"2022-04-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5CF5-0412-E063-731AD00A56D4","beginDate":"2022-04-13","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"SF6D V2.0 ACUTE","valueDescription":"SF-6Dv2 Health Utility Survey Acute, English Version 2.0 Questionnaire","ValueMeaning":{"publicId":"8158297","version":"1","preferredName":"SF-6Dv2 Health Utility Survey Acute, English Version 2.0 Questionnaire","longName":"8158297","preferredDefinition":"SF-6Dv2 Health Utility Survey Acute, English Version 2.0 (SF6D V2.0 ACUTE) (copyright 2021 QualityMetric Incorporated, LLC. All rights reserved). These materials discuss and/or include one or more of the SF Health Surveys, which are owned exclusively by QualityMetric Incorporated, LLC. No part of the SF Health Surveys may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of QualityMetric and payment of any applicable fees. Copyright QualityMetric Incorporated, LLC. All rights reserved.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"SF-6Dv2 Health Utility Survey Acute, English Version 2.0 Questionnaire","conceptCode":"C185761","definition":"A standardized stand-alone six-item patient report questionnaire derived from the SF-6D that assesses a range of symptoms, experiences, and health outcomes in six health domains over the past week in order to capture changes across physical and mental health conditions and produce a single health utility score.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DC89574F-0BC7-6563-E053-4EBD850A587B","latestVersionIndicator":"Yes","beginDate":"2022-04-13","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-04-13","modifiedBy":"ONEDATA","dateModified":"2022-04-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5CF6-0412-E063-731AD00A56D4","beginDate":"2022-04-13","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"EORTC QLQ-OH15","valueDescription":"European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire - Oral Health","ValueMeaning":{"publicId":"8002812","version":"1","preferredName":"European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire - Oral Health","longName":"8002812","preferredDefinition":"European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Oral Health (EORTC QLQ-OH15) (QLQ-OH15 Copyright 2016 EORTC Quality of Life Group. All rights reserved. (Validated module)). No part of the EORTC QLQ-OH15 may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of the EORTC Quality of Life Group and payment of any applicable fees. Copyright EORTC Quality of Life Group 2016. All rights reserved.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire - Oral Health","conceptCode":"C183583","definition":"A standardized 15-item questionnaire module developed by the European Organisation for Research and Treatment of Cancer (EORTC) in 2016 that is designed to supplement the EORTC QLQ-C30 core questionnaire in assessing oral health problems in cancer patients.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D5648426-6951-3E89-E053-4EBD850A33BC","latestVersionIndicator":"Yes","beginDate":"2022-01-12","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-01-12","modifiedBy":"ONEDATA","dateModified":"2022-01-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5CF7-0412-E063-731AD00A56D4","beginDate":"2022-01-12","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"EORTC QLQ-LMC21","valueDescription":"European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire - Colorectal Liver Metastases","ValueMeaning":{"publicId":"8002814","version":"1","preferredName":"European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire - Colorectal Liver Metastases","longName":"8002814","preferredDefinition":"European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Colorectal Liver Metastases (EORTC QLQ-LMC21) (QLQ-LMC21 Copyright 2002 EORTC Quality of Life Group. All rights reserved. (Validated module)). No part of the EORTC QLQ-LMC21 may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of the EORTC Quality of Life Group and payment of any applicable fees. Copyright EORTC Quality of Life Group 2002. All rights reserved.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire - Colorectal Liver Metastases","conceptCode":"C183582","definition":"A standardized 21-item questionnaire module developed by the European Organisation for Research and Treatment of Cancer (EORTC) in 2003 that is designed to supplement the EORTC QLQ-C30 core questionnaire in assessing quality of life in patients with liver metastases from colorectal cancer.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D5648426-6977-3E89-E053-4EBD850A33BC","latestVersionIndicator":"Yes","beginDate":"2022-01-12","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-01-12","modifiedBy":"ONEDATA","dateModified":"2022-01-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5CF8-0412-E063-731AD00A56D4","beginDate":"2022-01-12","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"EORTC QLQ-FA12","valueDescription":"European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire - Cancer Related Fatigue","ValueMeaning":{"publicId":"8002816","version":"1","preferredName":"European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire - Cancer Related Fatigue","longName":"8002816","preferredDefinition":"European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Cancer Related Fatigue (EORTC QLQ-FA12) (QLQ-FA12 Copyright 2016 EORTC Quality of Life Group. All rights reserved. (Validated module)). No part of the EORTC QLQ-FA12 may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of the EORTC Quality of Life Group and payment of any applicable fees. Copyright EORTC Quality of Life Group 2016. All rights reserved.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire - Cancer Related Fatigue","conceptCode":"C183581","definition":"A standardized 12-item questionnaire module developed by the European Organisation for Research and Treatment of Cancer (EORTC) in 2016 that is designed to supplement the EORTC QLQ-C30 core questionnaire in assessing cancer-related fatigue.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D5648426-699D-3E89-E053-4EBD850A33BC","latestVersionIndicator":"Yes","beginDate":"2022-01-12","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-01-12","modifiedBy":"ONEDATA","dateModified":"2022-01-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5CF9-0412-E063-731AD00A56D4","beginDate":"2022-01-12","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"EORTC QLQ-EN24","valueDescription":"European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire - Endometrial","ValueMeaning":{"publicId":"8002818","version":"1","preferredName":"European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire - Endometrial","longName":"8002818","preferredDefinition":"European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Endometrial (EORTC QLQ-EN24) (QLQ-EN24 Copyright 2010 EORTC Quality of Life Group. All rights reserved. (Validated module)). No part of the EORTC QLQ-EN24 may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of the EORTC Quality of Life Group and payment of any applicable fees. Copyright EORTC Quality of Life Group 2010. All rights reserved.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire - Endometrial","conceptCode":"C183580","definition":"A standardized 24-item questionnaire module developed by the European Organisation for Research and Treatment of Cancer (EORTC) in 2010 that is designed to supplement the EORTC QLQ-C30 core questionnaire in assessing quality of life in patients with endometrial cancer.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D5648426-69C3-3E89-E053-4EBD850A33BC","latestVersionIndicator":"Yes","beginDate":"2022-01-12","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-01-12","modifiedBy":"ONEDATA","dateModified":"2022-01-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5CFA-0412-E063-731AD00A56D4","beginDate":"2022-01-12","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"EORTC QLQ-ELD14","valueDescription":"European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire - Elderly Cancer Patients","ValueMeaning":{"publicId":"8002820","version":"1","preferredName":"European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire - Elderly Cancer Patients","longName":"8002820","preferredDefinition":"European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Elderly Cancer Patients (EORTC QLQ-ELD14) (QLQ-ELD14 Copyright 2001 EORTC Quality of Life Group. All rights reserved. (Validated module)). No part of the EORTC QLQ-ELD14 may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of the EORTC Quality of Life Group and payment of any applicable fees. Copyright EORTC Quality of Life Group 2001. All rights reserved.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire - Elderly Cancer Patients","conceptCode":"C183579","definition":"A standardized 14-item questionnaire module developed by the European Organisation for Research and Treatment of Cancer (EORTC) in 2013 that is designed to supplement the EORTC QLQ-C30 core questionnaire in assessing quality of life in cancer patients aged 70 and above with a strong focus on psychosocial issues. This questionnaire is revised from the QLQ-ELD15, which was developed by the EORTC in 2010.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D5648426-69E9-3E89-E053-4EBD850A33BC","latestVersionIndicator":"Yes","beginDate":"2022-01-12","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-01-12","modifiedBy":"ONEDATA","dateModified":"2022-01-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5CFB-0412-E063-731AD00A56D4","beginDate":"2022-01-12","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"EORTC QLQ-CX24","valueDescription":"European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire - Cervical","ValueMeaning":{"publicId":"8002822","version":"1","preferredName":"European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire - Cervical","longName":"8002822","preferredDefinition":"European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Cervical (EORTC QLQ-CX24) (QLQ-CX24 Copyright 2003 EORTC Quality of Life Group. All rights reserved. (Validated module)). No part of the EORTC QLQ-CX24 may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of the EORTC Quality of Life Group and payment of any applicable fees. Copyright EORTC Quality of Life Group 2003. All rights reserved.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire - Cervical","conceptCode":"C183578","definition":"A standardized 24-item questionnaire module developed by the European Organisation for Research and Treatment of Cancer (EORTC) in 2006 that is designed to supplement the EORTC QLQ-C30 core questionnaire in assessing quality of life in patients with cervical cancer.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D5648426-6A0F-3E89-E053-4EBD850A33BC","latestVersionIndicator":"Yes","beginDate":"2022-01-12","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-01-12","modifiedBy":"ONEDATA","dateModified":"2022-01-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5CFC-0412-E063-731AD00A56D4","beginDate":"2022-01-12","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"EORTC QLQ-BM22","valueDescription":"European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire - Bone Metastases","ValueMeaning":{"publicId":"8002824","version":"1","preferredName":"European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire - Bone Metastases","longName":"8002824","preferredDefinition":"European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Bone Metastases (EORTC QLQ-BM22) (QLQ-BM22 Copyright 2008 EORTC Quality of Life Group. All rights reserved. (Validated module)). No part of the EORTC QLQ-BM22 may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of the EORTC Quality of Life Group and payment of any applicable fees. Copyright EORTC Quality of Life Group 2008. All rights reserved.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire - Bone Metastases","conceptCode":"C183577","definition":"A standardized 22-item questionnaire module developed by the European Organisation for Research and Treatment of Cancer (EORTC) in 2008 that is designed to supplement the EORTC QLQ-C30 core questionnaire in assessing quality of life in patients with bone metastases.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D5648426-6A35-3E89-E053-4EBD850A33BC","latestVersionIndicator":"Yes","beginDate":"2022-01-12","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-01-12","modifiedBy":"ONEDATA","dateModified":"2022-01-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5CFD-0412-E063-731AD00A56D4","beginDate":"2022-01-12","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"FACIT-SEARCHABLE ITEM LIBRARY ADULT","valueDescription":"Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult Version Questionnaire","ValueMeaning":{"publicId":"8002826","version":"1","preferredName":"Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult Version Questionnaire","longName":"8002826","preferredDefinition":"Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult (FACIT-SEARCHABLE ITEM LIBRARY ADULT) (These materials discuss and/or include the FACIT Measurement System, which is owned exclusively by Dr. David Cella. No part of the FACIT Measurement System may be reproduced, distributed, or transmitted in any form or by any means, including photocopying recording, or other electronic or mechanical methods, without the prior written permission of Dr. David Cella and payment of any applicable fees. Copyright Dr. David Cella. All rights reserved).","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult Version Questionnaire","conceptCode":"C183576","definition":"A collection of over 700 items from over 100 Functional Assessment of Chronic Illness Therapy (FACIT) questionnaires that was compiled in 2018 and is used to create custom assessment tools that target a wide range of health-related quality of life issues.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D5648426-6A5B-3E89-E053-4EBD850A33BC","latestVersionIndicator":"Yes","beginDate":"2022-01-12","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-01-12","modifiedBy":"ONEDATA","dateModified":"2022-01-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5CFE-0412-E063-731AD00A56D4","beginDate":"2022-01-12","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"DIBSS-C V1.0","valueDescription":"Diary for Irritable Bowel Syndrome Symptoms-Constipation Version 1.0 Questionnaire","ValueMeaning":{"publicId":"8002828","version":"1","preferredName":"Diary for Irritable Bowel Syndrome Symptoms-Constipation Version 1.0 Questionnaire","longName":"8002828","preferredDefinition":"Diary for Irritable Bowel Syndrome Symptoms-Constipation v1.0 (DIBSS-C V1.0) (Copyright 2018 by the Critical Path Institute. All rights reserved. Fehnel S, Ervin C, McLeod L, Carson RT, Reasner DS, Hanlon J, Eremenco S, Coons SJ. Psychometric Evaluation of the Diary for Irritable Bowel Syndrome Symptoms-Constipation (DIBSS-C). Poster presented at ISPOR Europe 2018; November 10-14, 2018. Barcelona, Spain. Fehnel SE, Ervin CM, Carson RT, Rigoni G, Lackner JM, Coons SJ. Development of the Diary for Irritable Bowel Syndrome Symptoms to Assess Treatment Benefit in Clinical Trials: Foundational Qualitative Research. Value in Health 2017;20(4):618-626. Patient-Reported Outcome (PRO) Consortium Diary for Irritable Bowel Syndrome Symptoms-Constipation (DIBSS-C) v1.0 User Manual). No part of the DIBSS-C V1.0 may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of the Critical Path Institute and payment of any applicable fees. Copyright Critical Path Institute, 2018. All rights reserved.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Diary for Irritable Bowel Syndrome Symptoms-Constipation Version 1.0 Questionnaire","conceptCode":"C183575","definition":"The first version of a standardized questionnaire developed by Fehnel et al. 2017 that assesses severity of the core bowel movement and abdominal signs and symptoms associated with Irritable Bowel Syndrome-Constipation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D5648426-6A81-3E89-E053-4EBD850A33BC","latestVersionIndicator":"Yes","beginDate":"2022-01-12","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-01-12","modifiedBy":"ONEDATA","dateModified":"2022-01-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5CFF-0412-E063-731AD00A56D4","beginDate":"2022-01-12","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"EORTC QLQ-BR23 V1.0","valueDescription":"Quality of Life Questionnaire BR-23","ValueMeaning":{"publicId":"8002829","version":"1","preferredName":"Quality of Life Questionnaire BR-23","longName":"8002829","preferredDefinition":"A questionnaire developed by the European Organisation for Research and Treatment of Cancer (EORTC) consisting of 23 questions designed to assess the quality of life of breast cancer patients participating in international clinical trials.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Quality of Life Questionnaire BR-23","conceptCode":"C148236","definition":"A questionnaire developed by the European Organisation for Research and Treatment of Cancer (EORTC) consisting of 23 questions designed to assess the quality of life of breast cancer patients participating in international clinical trials.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D5648426-6AA4-3E89-E053-4EBD850A33BC","latestVersionIndicator":"Yes","beginDate":"2022-01-12","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-01-12","modifiedBy":"ONEDATA","dateModified":"2022-01-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5D00-0412-E063-731AD00A56D4","beginDate":"2022-01-12","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"EORTC QLQ-BRECON23","valueDescription":"European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire - Breast Reconstruction","ValueMeaning":{"publicId":"8002782","version":"1","preferredName":"European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire - Breast Reconstruction","longName":"8002782","preferredDefinition":"European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Breast Reconstruction (EORTC QLQ-BRECON23) (QLQ-BRECON23 Copyright 2017 EORTC Quality of Life Group. All rights reserved. (Validated module)). No part of the EORTC QLQ-BRECON23 may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of the EORTC Quality of Life Group and payment of any applicable fees. Copyright EORTC Quality of Life Group 2017. All rights reserved.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire - Breast Reconstruction","conceptCode":"C183598","definition":"A standardized 23-item questionnaire module developed in 2017 to supplement the European Organisation for Research and Treatment of Cancer (EORTC) QLQ-C30 core questionnaire in assessing the quality of life in patients after breast reconstruction.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D5648426-6717-3E89-E053-4EBD850A33BC","latestVersionIndicator":"Yes","beginDate":"2022-01-12","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-01-12","modifiedBy":"ONEDATA","dateModified":"2022-01-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5D01-0412-E063-731AD00A56D4","beginDate":"2022-01-12","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"EORTC QLQ-BR45 PHASE IV MODULE","valueDescription":"European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire - Breast Cancer Phase IV Module Version","ValueMeaning":{"publicId":"8002784","version":"1","preferredName":"European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire - Breast Cancer Phase IV Module Version","longName":"8002784","preferredDefinition":"European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Breast Cancer Phase IV Module (EORTC QLQ-BR45 PHASE IV MODULE) (QLQ-BR45 Copyright 2018 EORTC Quality of Life Group. All rights reserved. (Phase IV module)). No part of the EORTC QLQ-BR45 PHASE IV MODULE may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of the EORTC Quality of Life Group and payment of any applicable fees. Copyright EORTC Quality of Life Group 2018. All rights reserved.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire - Breast Cancer Phase IV Module Version","conceptCode":"C183597","definition":"A standardized 45-item questionnaire module developed in 2020 to supplement the European Organisation for Research and Treatment of Cancer (EORTC) QLQ-C30 core questionnaire as an update of the EORTC QLQ-BR23 in assessing the quality of life in patients with breast cancer.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D5648426-673D-3E89-E053-4EBD850A33BC","latestVersionIndicator":"Yes","beginDate":"2022-01-12","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-01-12","modifiedBy":"ONEDATA","dateModified":"2022-01-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5D02-0412-E063-731AD00A56D4","beginDate":"2022-01-12","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"EORTC QLQ-ANL27","valueDescription":"European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire - Anal Cancer","ValueMeaning":{"publicId":"8002786","version":"1","preferredName":"European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire - Anal Cancer","longName":"8002786","preferredDefinition":"European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Anal Cancer (EORTC QLQ-ANL27) (QLQ-ANL27 Copyright 2016 EORTC Quality of Life Group. All rights reserved). No part of the EORTC QLQ-ANL27 may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of the EORTC Quality of Life Group and payment of any applicable fees. Copyright EORTC Quality of Life Group 2016. All rights reserved.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire - Anal Cancer","conceptCode":"C183596","definition":"A standardized 27-item questionnaire module developed in 2018 to supplement the European Organisation for Research and Treatment of Cancer (EORTC) QLQ-C30 core questionnaire in assessing the quality of life in patients with anal cancer. It consists of four health-related quality of life domains: pain, bowel, and sexual and stoma care problems, and five single items: frequent urination, keeping clean, proximity to toilet, lower limb oedema, and planning activities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D5648426-6763-3E89-E053-4EBD850A33BC","latestVersionIndicator":"Yes","beginDate":"2022-01-12","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-01-12","modifiedBy":"ONEDATA","dateModified":"2022-01-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5D03-0412-E063-731AD00A56D4","beginDate":"2022-01-12","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"EORTC QLQ-CLL17","valueDescription":"European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire - Chronic lymphocytic leukemia","ValueMeaning":{"publicId":"8002788","version":"1","preferredName":"European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire - Chronic lymphocytic leukemia","longName":"8002788","preferredDefinition":"European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Chronic Lymphocytic Leukaemia (EORTC QLQ-CLL17) (QLQ-CLL17 Copyright 2015 EORTC Quality of Life Group. All rights reserved). No part of the EORTC QLQ-CLL17 may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of the EORTC Quality of Life Group and payment of any applicable fees. Copyright EORTC Quality of Life Group 2015. All rights reserved.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire - Chronic lymphocytic leukemia","conceptCode":"C183595","definition":"A standardized 17-item questionnaire module developed by the European Organisation for Research and Treatment of Cancer (EORTC) in 2017 that is designed to supplement the EORTC QLQ-C30 core questionnaire in assessing the quality of life in patients with chronic lymphocytic leukemia.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D5648426-6789-3E89-E053-4EBD850A33BC","latestVersionIndicator":"Yes","beginDate":"2022-01-12","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-01-12","modifiedBy":"ONEDATA","dateModified":"2022-01-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5D04-0412-E063-731AD00A56D4","beginDate":"2022-01-12","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"EORTC QLQ-NMIBC24","valueDescription":"European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire - Non-Muscle-Invasive Bladder Cancer","ValueMeaning":{"publicId":"8002790","version":"1","preferredName":"European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire - Non-Muscle-Invasive Bladder Cancer","longName":"8002790","preferredDefinition":"European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Non-Muscle-Invasive Bladder Cancer (EORTC QLQ-NMIBC24) (QLQ-NMIBC24 Copyright 1994 EORTC Quality of Life Group. All rights reserved). No part of the EORTC QLQ-NMIBC24 may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of the EORTC Quality of Life Group and payment of any applicable fees. Copyright EORTC Quality of Life Group 1994. All rights reserved.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire - Non-Muscle-Invasive Bladder Cancer","conceptCode":"C183594","definition":"A standardized 24-item questionnaire module developed by the European Organisation for Research and Treatment of Cancer (EORTC) in 2014 that is designed to supplement the EORTC QLQ-C30 core questionnaire in assessing the quality of life in patients with non-muscle-invasive bladder cancer (NMIBC).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D5648426-67AF-3E89-E053-4EBD850A33BC","latestVersionIndicator":"Yes","beginDate":"2022-01-12","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-01-12","modifiedBy":"ONEDATA","dateModified":"2022-01-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5D05-0412-E063-731AD00A56D4","beginDate":"2022-01-12","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"EORTC QLQ-PAN26 PHASE III MODULE","valueDescription":"European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire - Pancreatic Cancer Phase III Module Version","ValueMeaning":{"publicId":"8002792","version":"1","preferredName":"European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire - Pancreatic Cancer Phase III Module Version","longName":"8002792","preferredDefinition":"European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Pancreatic Cancer Phase III Module (EORTC QLQ-PAN26 PHASE III MODULE) (QLQ-C30-PAN26 Copyright 1999 EORTC Quality of Life Group. All rights reserved. (Phase III module)). No part of the EORTC QLQ-PAN26 PHASE III MODULE may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of the EORTC Quality of Life Group and payment of any applicable fees. Copyright EORTC Quality of Life Group 1999. All rights reserved.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire - Pancreatic Cancer Phase III Module Version","conceptCode":"C183593","definition":"A standardized 26-item questionnaire module developed by the European Organisation for Research and Treatment of Cancer (EORTC) in 1999 that is designed to supplement the EORTC QLQ-C30 core questionnaire in assessing the quality of life in patients with pancreatic cancer.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D5648426-67D5-3E89-E053-4EBD850A33BC","latestVersionIndicator":"Yes","beginDate":"2022-01-12","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-01-12","modifiedBy":"ONEDATA","dateModified":"2022-01-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5D06-0412-E063-731AD00A56D4","beginDate":"2022-01-12","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"EORTC QLQ-BIL21","valueDescription":"European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire - Cholangiocarcinoma and Gallbladder Cancer","ValueMeaning":{"publicId":"8002794","version":"1","preferredName":"European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire - Cholangiocarcinoma and Gallbladder Cancer","longName":"8002794","preferredDefinition":"European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Cholangiocarcinoma and Gallbladder Cancer (EORTC QLQ-BIL21) (QLQ-BIL21 Copyright 2011 EORTC Quality of Life Group. All rights reserved. (Validated module)). No part of the EORTC QLQ-BIL21 may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of the EORTC Quality of Life Group and payment of any applicable fees. Copyright EORTC Quality of Life Group 2011. All rights reserved.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire - Cholangiocarcinoma and Gallbladder Cancer","conceptCode":"C183592","definition":"A standardized 21-item questionnaire module developed by the European Organisation for Research and Treatment of Cancer (EORTC) in 2011 that is designed to supplement the EORTC QLQ-C30 core questionnaire in assessing the quality of life in patients with cholangiocarcinoma and cancer of the gallbladder.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D5648426-67FB-3E89-E053-4EBD850A33BC","latestVersionIndicator":"Yes","beginDate":"2022-01-12","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-01-12","modifiedBy":"ONEDATA","dateModified":"2022-01-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5D07-0412-E063-731AD00A56D4","beginDate":"2022-01-12","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"EORTC QLQ-PR25","valueDescription":"European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire - Prostate","ValueMeaning":{"publicId":"8002796","version":"1","preferredName":"European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire - Prostate","longName":"8002796","preferredDefinition":"European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Prostate (EORTC QLQ-PR25) (QLQ-PR25 Copyright 1999 EORTC Quality of Life Group. All rights reserved. (Validated module)). No part of the EORTC QLQ-PR25 may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of the EORTC Quality of Life Group and payment of any applicable fees. Copyright EORTC Quality of Life Group 1999. All rights reserved.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire - Prostate","conceptCode":"C183591","definition":"A standardized 25-item questionnaire module developed by the European Organisation for Research and Treatment of Cancer (EORTC) in 2008 that is designed to supplement the EORTC QLQ-C30 core questionnaire in assessing the quality of life of prostate cancer patients.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D5648426-6821-3E89-E053-4EBD850A33BC","latestVersionIndicator":"Yes","beginDate":"2022-01-12","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-01-12","modifiedBy":"ONEDATA","dateModified":"2022-01-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5D08-0412-E063-731AD00A56D4","beginDate":"2022-01-12","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"EORTC QLQ-OV28","valueDescription":"European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire - Ovarian","ValueMeaning":{"publicId":"8002798","version":"1","preferredName":"European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire - Ovarian","longName":"8002798","preferredDefinition":"European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Ovarian (EORTC QLQ-OV28) (QLQ-OV28 Copyright 1997 EORTC Quality of Life Group. All rights reserved. (Validated module)). No part of the EORTC QLQ-OV28 may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of the EORTC Quality of Life Group and payment of any applicable fees. Copyright EORTC Quality of Life Group 1997. All rights reserved.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire - Ovarian","conceptCode":"C183590","definition":"A standardized 28-item questionnaire module developed by the European Organisation for Research and Treatment of Cancer (EORTC) in 2003 that is designed to supplement the EORTC QLQ-C30 core questionnaire in assessing the quality of life of women with ovarian cancer.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D5648426-6847-3E89-E053-4EBD850A33BC","latestVersionIndicator":"Yes","beginDate":"2022-01-12","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-01-12","modifiedBy":"ONEDATA","dateModified":"2022-01-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5D09-0412-E063-731AD00A56D4","beginDate":"2022-01-12","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"EORTC QLQ-OG25 PHASE IV MODULE","valueDescription":"European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire - Esophago-Gastric Phase IV Module Version","ValueMeaning":{"publicId":"8002800","version":"1","preferredName":"European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire - Esophago-Gastric Phase IV Module Version","longName":"8002800","preferredDefinition":"European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Oesophago-Gastric Phase IV Module (EORTC QLQ-OG25 PHASE IV MODULE) (QLQ-OG25 Copyright 2007 EORTC Quality of Life Group. All rights reserved. (Phase IV module)). No part of the EORTC QLQ-OG25 may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of the EORTC Quality of Life Group and payment of any applicable fees. Copyright EORTC Quality of Life Group 2007. All rights reserved.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire - Esophago-Gastric Phase IV Module Version","conceptCode":"C183589","definition":"A standardized 25-item questionnaire module developed by the European Organisation for Research and Treatment of Cancer (EORTC) in 2007 that is designed to supplement the EORTC QLQ-C30 core questionnaire in assessing quality of life in patients with tumors of the esophagus, esophago-gastric junction, or stomach. This module is derived from the QLQ-OES18 (esophageal) and QLQ-STO22 (stomach) modules.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D5648426-686D-3E89-E053-4EBD850A33BC","latestVersionIndicator":"Yes","beginDate":"2022-01-12","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-01-12","modifiedBy":"ONEDATA","dateModified":"2022-01-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5D0A-0412-E063-731AD00A56D4","beginDate":"2022-01-12","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"EORTC QLQ-OES18","valueDescription":"European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire - Esophageal","ValueMeaning":{"publicId":"8002802","version":"1","preferredName":"European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire - Esophageal","longName":"8002802","preferredDefinition":"European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Oesophageal (EORTC QLQ-OES18) (QLQ-OES18 Copyright 1999 EORTC Quality of Life Group. All rights reserved. (Validated module)). No part of the EORTC QLQ-OES18 may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of the EORTC Quality of Life Group and payment of any applicable fees. Copyright EORTC Quality of Life Group 1999. All rights reserved.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire - Esophageal","conceptCode":"C183588","definition":"A standardized 18-item questionnaire module developed by the European Organisation for Research and Treatment of Cancer (EORTC) in 2003 that is designed to supplement the EORTC QLQ-C30 core questionnaire in assessing quality of life in patients with esophageal cancer. This module was updated from the EORTC QLQ-OE24 that was developed in 1996.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D5648426-6893-3E89-E053-4EBD850A33BC","latestVersionIndicator":"Yes","beginDate":"2022-01-12","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-01-12","modifiedBy":"ONEDATA","dateModified":"2022-01-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5D0B-0412-E063-731AD00A56D4","beginDate":"2022-01-12","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"EORTC QLQ-INFO25","valueDescription":"European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire - Information","ValueMeaning":{"publicId":"8002804","version":"1","preferredName":"European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire - Information","longName":"8002804","preferredDefinition":"European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Information (EORTC QLQ-INFO25) (QLQ-C30-INFO25 Copyright 2004 EORTC Quality of Life Group. All rights reserved. (Validated module)). No part of the EORTC QLQ-INFO25 may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of the EORTC Quality of Life Group and payment of any applicable fees. Copyright EORTC Quality of Life Group 2004. All rights reserved.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire - Information","conceptCode":"C183587","definition":"A standardized 25-item questionnaire module developed by the European Organisation for Research and Treatment of Cancer (EORTC) in 2010 that is designed to supplement the EORTC QLQ-C30 core questionnaire in assessing the level of information received by cancer patients.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D5648426-68B9-3E89-E053-4EBD850A33BC","latestVersionIndicator":"Yes","beginDate":"2022-01-12","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-01-12","modifiedBy":"ONEDATA","dateModified":"2022-01-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5D0C-0412-E063-731AD00A56D4","beginDate":"2022-01-12","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"EORTC QLQ-HCC18","valueDescription":"European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire - Hepatocellular Carcinoma","ValueMeaning":{"publicId":"8002806","version":"1","preferredName":"European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire - Hepatocellular Carcinoma","longName":"8002806","preferredDefinition":"European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Hepatocellular Carcinoma (EORTC QLQ-HCC18) (QLQ-HCC18 Copyright 2002 EORTC Quality of Life Group. All rights reserved. (Validated module)). No part of the EORTC QLQ-HCC18 may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of the EORTC Quality of Life Group and payment of any applicable fees. Copyright EORTC Quality of Life Group 2002. All rights reserved.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire - Hepatocellular Carcinoma","conceptCode":"C183586","definition":"A standardized 18-item questionnaire module developed by the European Organisation for Research and Treatment of Cancer (EORTC) in 2004 that is designed to supplement the EORTC QLQ-C30 core questionnaire in assessing quality of life in patients with hepatocellular carcinoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D5648426-68DF-3E89-E053-4EBD850A33BC","latestVersionIndicator":"Yes","beginDate":"2022-01-12","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-01-12","modifiedBy":"ONEDATA","dateModified":"2022-01-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5D0D-0412-E063-731AD00A56D4","beginDate":"2022-01-12","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"EORTC QLQ-GINET21 DATE 20TH FEBRUARY 2006","valueDescription":"European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire - Neuroendocrine Carcinoid, Date 20th February 2006 Version","ValueMeaning":{"publicId":"8002808","version":"1","preferredName":"European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire - Neuroendocrine Carcinoid, Date 20th February 2006 Version","longName":"8002808","preferredDefinition":"European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Neuroendocrine Carcinoid, Date 20th February 2006 Version (EORTC QLQ-GINET21 DATE 20TH FEBRUARY 2006) (QLQ-G.I.NET21 Copyright 2004 EORTC Quality of Life Group. All rights reserved. Date: 20th February 2006. (Validated module)). No part of the EORTC QLQ-GINET21 may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of the EORTC Quality of Life Group and payment of any applicable fees. Copyright EORTC Quality of Life Group 2004. All rights reserved.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire - Neuroendocrine Carcinoid, Date 20th February 2006 Version","conceptCode":"C183585","definition":"The version of a standardized 21-item questionnaire module developed by the European Organisation for Research and Treatment of Cancer (EORTC) in 2006 that is designed to supplement the EORTC QLQ-C30 core questionnaire in assessing quality of life in the gut, pancreas, and liver neuroendocrine tumors, and is dated February 20, 2006.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D5648426-6905-3E89-E053-4EBD850A33BC","latestVersionIndicator":"Yes","beginDate":"2022-01-12","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-01-12","modifiedBy":"ONEDATA","dateModified":"2022-01-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5D0E-0412-E063-731AD00A56D4","beginDate":"2022-01-12","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"EORTC QLQ-STO22","valueDescription":"European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire - Gastric","ValueMeaning":{"publicId":"8002810","version":"1","preferredName":"European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire - Gastric","longName":"8002810","preferredDefinition":"European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Gastric (EORTC QLQ-STO22) (QLQ-STO22 Copyright 1999 EORTC Quality of Life Group. All rights reserved. (Validated module)). No part of the EORTC QLQ-STO22 may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of the EORTC Quality of Life Group and payment of any applicable fees. Copyright EORTC Quality of Life Group 1999. All rights reserved.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire - Gastric","conceptCode":"C183584","definition":"A standardized 22-item questionnaire module developed by the European Organisation for Research and Treatment of Cancer (EORTC) in 2001 that is designed to supplement the EORTC QLQ-C30 core questionnaire in assessing health-related quality of life in patients with gastric cancer.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D5648426-692B-3E89-E053-4EBD850A33BC","latestVersionIndicator":"Yes","beginDate":"2022-01-12","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-01-12","modifiedBy":"ONEDATA","dateModified":"2022-01-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5D0F-0412-E063-731AD00A56D4","beginDate":"2022-01-12","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"EORTC QLQ-H&N35 V1","valueDescription":"Quality of Life Questionnaire - Head & Neck 35","ValueMeaning":{"publicId":"8002830","version":"1","preferredName":"Quality of Life Questionnaire - Head & Neck 35","longName":"8002830","preferredDefinition":"A questionnaire developed by the European Organisation for Research and Treatment of Cancer (EORTC) consisting of 35 questions designed to assess quality of life in head and neck cancer patients.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Quality of Life Questionnaire - Head & Neck 35","conceptCode":"C136497","definition":"A questionnaire developed by the European Organisation for Research and Treatment of Cancer (EORTC) consisting of 35 questions designed to assess quality of life in head and neck cancer patients.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D5648426-6AC9-3E89-E053-4EBD850A33BC","latestVersionIndicator":"Yes","beginDate":"2022-01-12","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-01-12","modifiedBy":"ONEDATA","dateModified":"2022-01-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5D10-0412-E063-731AD00A56D4","beginDate":"2022-01-12","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"EORTC QLQ-CIPN20","valueDescription":"Quality of Life Questionnaire - Chemotherapy-Induced Peripheral Neuropathy 20","ValueMeaning":{"publicId":"8002831","version":"1","preferredName":"Quality of Life Questionnaire - Chemotherapy-Induced Peripheral Neuropathy 20","longName":"8002831","preferredDefinition":"A questionnaire developed by the European Organisation for Research and Treatment of Cancer (EORTC) consisting of 20 questions designed to assess quality of life related to symptoms and functional limitations in patients with Chemotherapy-Induced Peripheral Neuropathy (CIPN).","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Quality of Life Questionnaire - Chemotherapy-Induced Peripheral Neuropathy 20","conceptCode":"C125719","definition":"A questionnaire developed by the European Organisation for Research and Treatment of Cancer (EORTC) consisting of 20 questions designed to assess quality of life related to symptoms and functional limitations in patients with Chemotherapy-Induced Peripheral Neuropathy (CIPN).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D5648426-6AEE-3E89-E053-4EBD850A33BC","latestVersionIndicator":"Yes","beginDate":"2022-01-12","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-01-12","modifiedBy":"ONEDATA","dateModified":"2022-01-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5D11-0412-E063-731AD00A56D4","beginDate":"2022-01-12","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"EORTC QLQ-MY20","valueDescription":"Quality of Life Questionnaire-Multiple Myeloma 20","ValueMeaning":{"publicId":"8002832","version":"1","preferredName":"Quality of Life Questionnaire-Multiple Myeloma 20","longName":"8002832","preferredDefinition":"A questionnaire developed by the European Organisation for Research and Treatment of Cancer (EORTC) consisting of 20 questions designed to assess quality of life in multiple myeloma patients.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Quality of Life Questionnaire-Multiple Myeloma 20","conceptCode":"C122694","definition":"A questionnaire developed by the European Organisation for Research and Treatment of Cancer (EORTC) consisting of 20 questions designed to assess quality of life in multiple myeloma patients.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D5648426-6B13-3E89-E053-4EBD850A33BC","latestVersionIndicator":"Yes","beginDate":"2022-01-12","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-01-12","modifiedBy":"ONEDATA","dateModified":"2022-01-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5D12-0412-E063-731AD00A56D4","beginDate":"2022-01-12","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"EORTC QLQ-BN20","valueDescription":"Quality of Life Questionnaire-Brain Neoplasm 20","ValueMeaning":{"publicId":"8002833","version":"1","preferredName":"Quality of Life Questionnaire-Brain Neoplasm 20","longName":"8002833","preferredDefinition":"A questionnaire developed by the European Organisation for Research and Treatment of Cancer (EORTC) consisting of 20 questions designed to assess quality of life in brain cancer patients.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Quality of Life Questionnaire-Brain Neoplasm 20","conceptCode":"C121794","definition":"A questionnaire developed by the European Organisation for Research and Treatment of Cancer (EORTC) consisting of 20 questions designed to assess quality of life in brain cancer patients.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D5648426-6B38-3E89-E053-4EBD850A33BC","latestVersionIndicator":"Yes","beginDate":"2022-01-12","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-01-12","modifiedBy":"ONEDATA","dateModified":"2022-01-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5D13-0412-E063-731AD00A56D4","beginDate":"2022-01-12","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"IPSS","valueDescription":"International Prostate Symptom Score","ValueMeaning":{"publicId":"8002834","version":"1","preferredName":"International Prostate Symptom Score","longName":"8002834","preferredDefinition":"A screening tool used to screen for, diagnose, track, and manage the symptoms of benign prostatic hyperplasia.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"International Prostate Symptom Score","conceptCode":"C113446","definition":"A screening tool used to screen for, diagnose, track, and manage the symptoms of benign prostatic hyperplasia.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D5648426-6B5B-3E89-E053-4EBD850A33BC","latestVersionIndicator":"Yes","beginDate":"2022-01-12","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-01-12","modifiedBy":"ONEDATA","dateModified":"2022-01-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5D14-0412-E063-731AD00A56D4","beginDate":"2022-01-12","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-10-20","modifiedBy":"ONEDATA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"SSS","valueDescription":null,"ValueMeaning":{"publicId":"11010729","version":"1","preferredName":"Stanford Sleepiness Scale Questionnaire","longName":"11010729v1.00","preferredDefinition":"No value exists.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stanford Sleepiness Scale Questionnaire","conceptCode":"C187511","definition":"No value exists.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E5C13785-BE31-251F-E053-731AD00AE228","latestVersionIndicator":"Yes","beginDate":"2022-08-08","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-08-08","modifiedBy":"KUMMEROA","dateModified":"2022-08-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5D15-0412-E063-731AD00A56D4","beginDate":"2022-08-08","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-10-20","modifiedBy":"KUMMEROA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"BECK DEPRESSION INVENTORY-II","valueDescription":null,"ValueMeaning":{"publicId":"11010730","version":"1","preferredName":"Beck Depression Inventory-Second Edition Questionnaire","longName":"11010730v1.00","preferredDefinition":"No value exists.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Beck Depression Inventory-Second Edition Questionnaire","conceptCode":"C187512","definition":"No value exists.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E5C13785-BE32-251F-E053-731AD00AE228","latestVersionIndicator":"Yes","beginDate":"2022-08-08","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-08-08","modifiedBy":"KUMMEROA","dateModified":"2022-08-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5D16-0412-E063-731AD00A56D4","beginDate":"2022-08-08","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-10-20","modifiedBy":"KUMMEROA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"SCOPA-AUT","valueDescription":null,"ValueMeaning":{"publicId":"11010731","version":"1","preferredName":"Scales for Outcomes in Parkinson's Disease - Autonomic Dysfunction Questionnaire","longName":"11010731v1.00","preferredDefinition":"No value exists.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Scales for Outcomes in Parkinson's Disease - Autonomic Dysfunction Questionnaire","conceptCode":"C187513","definition":"No value exists.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E5C13785-BE33-251F-E053-731AD00AE228","latestVersionIndicator":"Yes","beginDate":"2022-08-08","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-08-08","modifiedBy":"KUMMEROA","dateModified":"2022-08-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5D17-0412-E063-731AD00A56D4","beginDate":"2022-08-08","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-10-20","modifiedBy":"KUMMEROA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"PDQ-39","valueDescription":null,"ValueMeaning":{"publicId":"11010732","version":"1","preferredName":"Parkinson's Disease Questionnaire-39","longName":"11010732v1.00","preferredDefinition":"No value exists.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Parkinson's Disease Questionnaire-39","conceptCode":"C187514","definition":"No value exists.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E5C13785-BE34-251F-E053-731AD00AE228","latestVersionIndicator":"Yes","beginDate":"2022-08-08","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-08-08","modifiedBy":"KUMMEROA","dateModified":"2022-08-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5D18-0412-E063-731AD00A56D4","beginDate":"2022-08-08","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-10-20","modifiedBy":"KUMMEROA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"LCSS","valueDescription":null,"ValueMeaning":{"publicId":"11010733","version":"1","preferredName":"Lung Cancer Symptom Scale Questionnaire","longName":"11010733v1.00","preferredDefinition":"No value exists.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Lung Cancer Symptom Scale Questionnaire","conceptCode":"C187515","definition":"No value exists.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E5C140D9-0CB0-2601-E053-731AD00A8479","latestVersionIndicator":"Yes","beginDate":"2022-08-08","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-08-08","modifiedBy":"KUMMEROA","dateModified":"2022-08-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5D19-0412-E063-731AD00A56D4","beginDate":"2022-08-08","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-10-20","modifiedBy":"KUMMEROA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"ABC","valueDescription":null,"ValueMeaning":{"publicId":"11010734","version":"1","preferredName":"Activities-Specific Balance Confidence Scale Questionnaire","longName":"11010734v1.00","preferredDefinition":"No value exists.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Activities-Specific Balance Confidence Scale Questionnaire","conceptCode":"C187516","definition":"No value exists.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E5C140D9-0CB1-2601-E053-731AD00A8479","latestVersionIndicator":"Yes","beginDate":"2022-08-08","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-08-08","modifiedBy":"KUMMEROA","dateModified":"2022-08-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5D1A-0412-E063-731AD00A56D4","beginDate":"2022-08-08","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-10-20","modifiedBy":"KUMMEROA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"RBDSQ","valueDescription":null,"ValueMeaning":{"publicId":"11010735","version":"1","preferredName":"REM Sleep Behavior Disorder Screening Questionnaire","longName":"11010735v1.00","preferredDefinition":"No value exists.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"REM Sleep Behavior Disorder Screening Questionnaire","conceptCode":"C187517","definition":"No value exists.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E5C140D9-0CB2-2601-E053-731AD00A8479","latestVersionIndicator":"Yes","beginDate":"2022-08-08","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-08-08","modifiedBy":"KUMMEROA","dateModified":"2022-08-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5D1B-0412-E063-731AD00A56D4","beginDate":"2022-08-08","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-10-20","modifiedBy":"KUMMEROA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"BFI","valueDescription":null,"ValueMeaning":{"publicId":"11010736","version":"1","preferredName":"Brief Fatigue Inventory","longName":"11010736v1.00","preferredDefinition":"A 9-item questionnaire, developed by Cleeland and Mendoza, designed to assess the severity of fatigue and the impact of fatigue on daily functioning in cancer patients.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Brief Fatigue Inventory","conceptCode":"C74297","definition":"A 9-item questionnaire, developed by Cleeland and Mendoza, designed to assess the severity of fatigue and the impact of fatigue on daily functioning in cancer patients.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E5C140D9-0CB3-2601-E053-731AD00A8479","latestVersionIndicator":"Yes","beginDate":"2022-08-08","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-08-08","modifiedBy":"KUMMEROA","dateModified":"2022-08-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5D1C-0412-E063-731AD00A56D4","beginDate":"2022-08-08","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-10-20","modifiedBy":"KUMMEROA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"PHQ-8","valueDescription":null,"ValueMeaning":{"publicId":"12921643","version":"1","preferredName":"The Patient Health Questionnaire - 8 Item","longName":"12921643v1.00","preferredDefinition":"A standardized self-report questionnaire, derived from the Patient Health Questionnaire-9 items and published in 2002, that includes nine items from the diagnostic criteria for MDD in the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV) and is used to measure depression severity.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"The Patient Health Questionnaire - 8 Item","conceptCode":"C191043","definition":"A standardized self-report questionnaire, derived from the Patient Health Questionnaire-9 items and published in 2002, that includes nine items from the diagnostic criteria for MDD in the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV) and is used to measure depression severity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F54FBCE9-6C5E-428A-E053-731AD00A815B","latestVersionIndicator":"Yes","beginDate":"2023-02-22","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-02-22","modifiedBy":"KUMMEROA","dateModified":"2023-02-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5D1D-0412-E063-731AD00A56D4","beginDate":"2023-02-22","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-10-20","modifiedBy":"KUMMEROA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"VHI","valueDescription":null,"ValueMeaning":{"publicId":"12921644","version":"1","preferredName":"Voice Handicap Index","longName":"12921644v1.00","preferredDefinition":"A self-assessment to evaluate the perceived psychosocial consequences of a patient's voice disorder in terms of emotional, physical, and functional factors.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Voice Handicap Index","conceptCode":"C92446","definition":"A self-assessment to evaluate the perceived psychosocial consequences of a patient's voice disorder in terms of emotional, physical, and functional factors.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F54FBCE9-6C5F-428A-E053-731AD00A815B","latestVersionIndicator":"Yes","beginDate":"2023-02-22","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-02-22","modifiedBy":"KUMMEROA","dateModified":"2023-02-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5D1E-0412-E063-731AD00A56D4","beginDate":"2023-02-22","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-10-20","modifiedBy":"KUMMEROA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"KDQOL-36 V1","valueDescription":null,"ValueMeaning":{"publicId":"13433682","version":"1","preferredName":"Kidney Disease and Quality of Life-36 Version 1 Questionnaire","longName":"13433682v1.00","preferredDefinition":"A standardized 36-item questionnaire that was developed by Hayes et al. in 2000 to assess the quality of life concerns of individuals with kidney disease and on dialysis; it contains five subscales, including physical component summary, mental component summary, burden of kidney disease, symptoms and problems, and effects of kidney disease on daily life subscales.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Kidney Disease and Quality of Life-36 Version 1 Questionnaire","conceptCode":"C193324","definition":"A standardized 36-item questionnaire that was developed by Hayes et al. in 2000 to assess the quality of life concerns of individuals with kidney disease and on dialysis; it contains five subscales, including physical component summary, mental component summary, burden of kidney disease, symptoms and problems, and effects of kidney disease on daily life subscales.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FA1BF9E6-4F52-75CF-E053-731AD00A4203","latestVersionIndicator":"Yes","beginDate":"2023-04-24","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-04-24","modifiedBy":"KUMMEROA","dateModified":"2023-04-24","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5D1F-0412-E063-731AD00A56D4","beginDate":"2023-04-24","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-10-20","modifiedBy":"KUMMEROA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"FES","valueDescription":null,"ValueMeaning":{"publicId":"13433683","version":"1","preferredName":"Falls Efficacy Scale Questionnaire","longName":"13433683v1.00","preferredDefinition":"A standardized 10-item questionnaire developed by Tinetti et al. in 1990 that utilizes an 11-point rating scale to assess fear of falling and perception of balance and stability during activities of daily living in the elderly population and in individuals diagnosed with Multiple Sclerosis.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Falls Efficacy Scale Questionnaire","conceptCode":"C193325","definition":"A standardized 10-item questionnaire developed by Tinetti et al. in 1990 that utilizes an 11-point rating scale to assess fear of falling and perception of balance and stability during activities of daily living in the elderly population and in individuals diagnosed with Multiple Sclerosis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FA1BF9E6-4F53-75CF-E053-731AD00A4203","latestVersionIndicator":"Yes","beginDate":"2023-04-24","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-04-24","modifiedBy":"KUMMEROA","dateModified":"2023-04-24","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5D20-0412-E063-731AD00A56D4","beginDate":"2023-04-24","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-10-20","modifiedBy":"KUMMEROA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"BORG RPE SCALE","valueDescription":null,"ValueMeaning":{"publicId":"14086867","version":"1","preferredName":"Borg Scale Rating of Perceived Exertion Questionnaire","longName":"14086867v1.00","preferredDefinition":"A scale for the subjective scoring of perceived exertion that ranges from 6: No exertion at all to 20: Maximal exertion. This scale was developed for use with healthy individuals where the score, multiplied by 10, might give an approximation of exercise heart rate.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Borg Scale Rating of Perceived Exertion Questionnaire","conceptCode":"C122957","definition":"A scale for the subjective scoring of perceived exertion that ranges from 6: No exertion at all to 20: Maximal exertion. This scale was developed for use with healthy individuals where the score, multiplied by 10, might give an approximation of exercise heart rate.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"00B4F58E-A87E-3233-E063-731AD00AD631","latestVersionIndicator":"Yes","beginDate":"2023-07-17","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-07-17","modifiedBy":"KUMMEROA","dateModified":"2023-07-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5D21-0412-E063-731AD00A56D4","beginDate":"2023-07-17","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-10-20","modifiedBy":"KUMMEROA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"FACIT-ITEM GP5 V4","valueDescription":null,"ValueMeaning":{"publicId":"14086868","version":"1","preferredName":"Functional Assessment of Chronic Illness Therapy-Item GP5 Version 4 Questionnaire","longName":"14086868v1.00","preferredDefinition":"No value exists.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Functional Assessment of Chronic Illness Therapy-Item GP5 Version 4 Questionnaire","conceptCode":"C199517","definition":"A single item from the fourth version of the Functional Assessment of Cancer Therapy - General core questionnaire that utilizes a five-point rating scale to assess how much a patient is bothered by side effects of cancer therapy.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"00B4F58E-A87F-3233-E063-731AD00AD631","latestVersionIndicator":"Yes","beginDate":"2023-07-17","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-07-17","modifiedBy":"KUMMEROA","dateModified":"2023-07-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5D22-0412-E063-731AD00A56D4","beginDate":"2023-07-17","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-10-20","modifiedBy":"KUMMEROA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"OGI","valueDescription":null,"ValueMeaning":{"publicId":"14086869","version":"1","preferredName":"Observer Global Impression Generic Modification Version Questionnaire","longName":"14086869v1.00","preferredDefinition":"No value exists.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Observer Global Impression Generic Modification Version Questionnaire","conceptCode":"C199518","definition":"A modified version of a standardized questionnaire published in 1976 by Guy et al. that was initially created to provide an observer-determined summary measure of a patient's global functioning prior to and after initiating a study medication. It has been modified for use in any disease/condition concept use case.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"00B4F58E-A880-3233-E063-731AD00AD631","latestVersionIndicator":"Yes","beginDate":"2023-07-17","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-07-17","modifiedBy":"KUMMEROA","dateModified":"2023-07-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5D23-0412-E063-731AD00A56D4","beginDate":"2023-07-17","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-10-20","modifiedBy":"KUMMEROA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"QSU-BRIEF","valueDescription":null,"ValueMeaning":{"publicId":"14086870","version":"1","preferredName":"Brief Questionnaire of Smoking Urges","longName":"14086870v1.00","preferredDefinition":"No value exists.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Brief Questionnaire of Smoking Urges","conceptCode":"C199519","definition":"A standardized self-administered 10-item questionnaire, developed in 2001 by Cox et al. as an abbreviated version of the original Questionnaire of Smoking Urges, that utilizes a seven-point rating scale to assess the respondent's feelings and thoughts about his or her desire to smoke cigarettes.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"00B4F58E-A881-3233-E063-731AD00AD631","latestVersionIndicator":"Yes","beginDate":"2023-07-17","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-07-17","modifiedBy":"KUMMEROA","dateModified":"2023-07-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08269B2E-5D24-0412-E063-731AD00A56D4","beginDate":"2023-07-17","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-10-20","modifiedBy":"KUMMEROA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"FACIT-SEARCHABLE ITEM LIBRARY PEDIATRIC","valueDescription":null,"ValueMeaning":{"publicId":"14549119","version":"1","preferredName":"Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric Version Questionnaire","longName":"14549119v1.00","preferredDefinition":"No value exists.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Functional Assessment of Chronic Illness Therapy-Searchable Item Library Pediatric Version Questionnaire","conceptCode":"C200920","definition":"No value exists.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0826A85C-310A-062B-E063-731AD00A36E1","latestVersionIndicator":"Yes","beginDate":"2023-10-20","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-10-20","modifiedBy":"KUMMEROA","dateModified":"2023-10-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0826A85C-310B-062B-E063-731AD00A36E1","beginDate":"2023-10-20","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-10-20","modifiedBy":"KUMMEROA","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"PROMIS IB V2.0 COGNITIVE FUNCTION SF 6A","valueDescription":null,"ValueMeaning":{"publicId":"14688605","version":"1","preferredName":"PROMIS Item Bank Version 2.0 Cognitive Function Short Form 6a Questionnaire","longName":"14688605v1.00","preferredDefinition":"No value exists.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"PROMIS Item Bank Version 2.0 Cognitive Function Short Form 6a Questionnaire","conceptCode":"C202501","definition":"No value exists.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0F3A80A5-CE3E-5406-E063-731AD00A24C6","latestVersionIndicator":"Yes","beginDate":"2024-01-18","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-18","modifiedBy":"KUMMEROA","dateModified":"2024-01-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F3A80A5-CE40-5406-E063-731AD00A24C6","beginDate":"2024-01-18","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-18","modifiedBy":"KUMMEROA","dateModified":"2024-01-18","deletedIndicator":"No"},{"value":"PROMIS IB V1.0 FATIGUE SF 7A","valueDescription":null,"ValueMeaning":{"publicId":"14688606","version":"1","preferredName":"PROMIS Item Bank Version 1.0 Fatigue Short Form 7a Questionnaire","longName":"14688606v1.00","preferredDefinition":"No value exists.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"PROMIS Item Bank Version 1.0 Fatigue Short Form 7a Questionnaire","conceptCode":"C202502","definition":"No value exists.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0F3A80A5-CE3F-5406-E063-731AD00A24C6","latestVersionIndicator":"Yes","beginDate":"2024-01-18","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-18","modifiedBy":"KUMMEROA","dateModified":"2024-01-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F3A80A5-CE41-5406-E063-731AD00A24C6","beginDate":"2024-01-18","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-18","modifiedBy":"KUMMEROA","dateModified":"2024-01-18","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2435019","version":"1","preferredName":"Conceptual Entity","preferredDefinition":"An organizational header for concepts representing mostly abstract entities.","longName":"C20181","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741B16D-87D8-26CD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"6626802","version":"1","preferredName":"CDISC Questionnaire Category Terminology Category","preferredDefinition":"Terminology associated with the questionnaire domain categories of the Clinical Data Interchange Standards Consortium (CDISC) Standard Data Tabulation Model (SDTM).:A grouping of items based on some commonality or by user defined characteristics.","longName":"C100129:C25372","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"CDISC Questionnaire Category Terminology","conceptCode":"C100129","definition":"Terminology associated with the questionnaire domain categories of the Clinical Data Interchange Standards Consortium (CDISC) Standard Data Tabulation Model (SDTM).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Category","conceptCode":"C25372","definition":"A grouping of items based on some commonality or by user defined characteristics.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"80D70FE5-B742-6A4C-E053-F662850A9EA8","latestVersionIndicator":"Yes","beginDate":"2019-02-01","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-02-01","modifiedBy":"ONEDATA","dateModified":"2019-02-01","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"CDISC:Clinical Data Interchange Standards Consortium","workflowStatus":"RELEASED","registrationStatus":"Application","id":"08269B38-5FD3-03FF-E063-731AD00A1013","latestVersionIndicator":"Yes","beginDate":"2019-02-01","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-10-20","modifiedBy":"KUMMEROA","dateModified":"2024-01-18","changeDescription":"2022-4-13 ak Updated to CT Package 49 release. 2022-1-12 ak Updated to CT Package 48 release. 2021-10-12 ak Updated to CT Package 47 release. 2021-7-15 ak Updated to CT Package 46 release. 2021-1-5 ak Updated to CT Package 44 release. 2020-9-29 ak Updated to CT Package 43 release. 2020-7-14 ak Updated to CT Package 42 release.  4/7/20 Updated to P41; tmt. Curated to support CDISC Initiative 6.6.19.","administrativeNotes":"2024.1.18 Updated to CT Package 56 release. ak 2023.10.27 Released per review. ak 2023.10.20 Updated to CT Package 55 release. ak 2023.9.12 Released per metrics report. ak 2023.7.17 Updated to CT Package 54 release. ak 2023.4.24 Updated to CT Package 53 release. ak 2023.2.22 Updated to CT Package 52 release. ak 2022.8.8 Updated to CT Package 50 release.  ak 2022.10.27 Updated to CT Package 51 release.  ak","unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"6338162","version":"1","longName":"CDISC (NCI Implementation)","context":"NCI Standards","ClassificationSchemeItems":[{"publicId":"7218795","version":"1","longName":"SDTM","context":"NCI Standards"},{"publicId":"7331364","version":"1","longName":"Questionnaires (QS) Domain","context":"NCI Standards"}]}],"AlternateNames":[{"name":"QS.QSCAT","type":"Map:SDTM IGv3.1.1","context":"NCIP"},{"name":"QS.QSCAT","type":"Map:SDTM IGv3.1.3","context":"NCIP"},{"name":"QS.QSCAT","type":"Map:SDTM IGv3.2","context":"NCIP"},{"name":"QS.QSCAT","type":"Map:SDTM IGv3.1.2","context":"NCIP"}],"ReferenceDocuments":[{"name":"PQT","type":"Preferred Question Text","description":"Category of Question","url":null,"context":"NCI Standards"},{"name":"CDISC Questionnaire Category Terminology","type":"SDTM Core","description":"Terminology associated with the questionnaire domain categories of the Clinical Data Interchange Standards Consortium (CDISC) Standard Data Tabulation Model (SDTM).","url":"https://ncit.nci.nih.gov/ncitbrowser/ajax?action=create_src_vs_tree&amp;vsd_uri=http%3A//evs.nci.nih.gov/valueset/CDISC/C100129","context":"NCI Standards"},{"name":"Required","type":"SDTM Core","description":"Required","url":null,"context":"NCI Standards"}],"origin":"CDISC:Clinical Data Interchange Standards Consortium","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"0826B2C8-0F45-0B1E-E063-731AD00A9185","latestVersionIndicator":"Yes","beginDate":"2019-02-18","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-10-20","modifiedBy":"KUMMEROA","dateModified":"2023-10-27","changeDescription":"2/18/19 Curated to support CDISC initiative; tmt.","administrativeNotes":"2023.10.27 Released per review. ak 2023.10.20 Created newer version to reflect Pkg 55 term removal. ak","unresolvedIssues":null,"deletedIndicator":"No"}}